{"parse":{"title":"Prostate-specific antigen","pageid":267922,"revid":859051569,"text":{"*":"<div class=\"mw-parser-output\"><table class=\"infobox\" style=\"width:26.4em\"><tbody><tr><th colspan=\"4\" style=\"text-align:center;font-size:125%;font-weight:bold\">KLK3</th></tr><tr><td colspan=\"4\" style=\"text-align:center\"><a href=\"/wiki/File:PSA_KLK3_PDB_2ZCK.png\" class=\"image\"><img alt=\"PSA KLK3 PDB 2ZCK.png\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/b9/PSA_KLK3_PDB_2ZCK.png/250px-PSA_KLK3_PDB_2ZCK.png\" width=\"250\" height=\"191\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/b9/PSA_KLK3_PDB_2ZCK.png/375px-PSA_KLK3_PDB_2ZCK.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b9/PSA_KLK3_PDB_2ZCK.png/500px-PSA_KLK3_PDB_2ZCK.png 2x\" data-file-width=\"1200\" data-file-height=\"919\" /></a></td></tr><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><table style=\"padding:0;border:none;margin:0;width:100%;text-align:left\"><tbody><tr><th colspan=\"4\" style=\"text-align:center;background-color:#ddd\">Available structures</th></tr><tr><th rowspan=\"2\" style=\"background-color:#c3fdb8;width:43px\"><a href=\"/wiki/Protein_Data_Bank\" title=\"Protein Data Bank\">PDB</a></th><td colspan=\"2\" style=\"background-color:#eee\">Ortholog search: <span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ebi.ac.uk/pdbe/searchResults.html?display=both&amp;term=P00757%20or%20P07288%20or%20M0QZF9\">PDBe</a> <a rel=\"nofollow\" class=\"external text\" href=\"http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=UpAccessionIdQuery&amp;accessionIdList=P00757,P07288,M0QZF9\">RCSB</a> </span></td></tr><tr><td><table class=\"collapsible collapsed\" style=\"padding:0;border:none;margin:0;width:100%;text-align:left\"><tbody><tr style=\"background-color:#ddd;text-align:center\"><th colspan=\"2\">List of PDB id codes</th></tr><tr><td colspan=\"2\" style=\"background-color:#eee\"><p><span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.rcsb.org/structure/2ZCH\">2ZCH</a>, <a rel=\"nofollow\" class=\"external text\" href=\"https://www.rcsb.org/structure/2ZCK\">2ZCK</a>, <a rel=\"nofollow\" class=\"external text\" href=\"https://www.rcsb.org/structure/2ZCL\">2ZCL</a>, <a rel=\"nofollow\" class=\"external text\" href=\"https://www.rcsb.org/structure/3QUM\">3QUM</a></span></p></td></tr></tbody></table></td></tr></tbody></table></td></tr><tr><th colspan=\"4\" style=\"text-align:center;background-color:#ddd\">Identifiers</th></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\"><span class=\"plainlinks\"><a href=\"/wiki/Gene_nomenclature\" title=\"Gene nomenclature\">Aliases</a></span></th><td colspan=\"3\" style=\"background:#eee\"><span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=6364\">KLK3</a></span>, APS, KLK2A1, PSA, hK3, kallikrein related peptidase 3, Prostate Specific Antigen</td></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\">External IDs</th><td colspan=\"3\" style=\"background-color:#eee\"><span class=\"plainlinks\"><a href=\"/wiki/Mendelian_Inheritance_in_Man\" class=\"mw-redirect\" title=\"Mendelian Inheritance in Man\">OMIM:</a> <a rel=\"nofollow\" class=\"external text\" href=\"https://omim.org/entry/176820\">176820</a> <a href=\"/wiki/Mouse_Genome_Informatics\" title=\"Mouse Genome Informatics\">MGI:</a> <a rel=\"nofollow\" class=\"external text\" href=\"http://www.informatics.jax.org/marker/MGI:97320\">97320</a> <a href=\"/wiki/HomoloGene\" title=\"HomoloGene\">HomoloGene:</a> <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=homologene&amp;dopt=HomoloGene&amp;list_uids=68141\">68141</a> <a href=\"/wiki/GeneCards\" title=\"GeneCards\">GeneCards:</a> <a rel=\"nofollow\" class=\"external text\" href=\"https://www.genecards.org/cgi-bin/carddisp.pl?gene=KLK3\">KLK3</a> </span></td></tr><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><table class=\"collapsible expand\" style=\"padding:0;border:none;margin:0;width:100%;text-align:left\"><tbody><tr><th colspan=\"4\" style=\"text-align:center;background-color:#ddd\">Gene location (Human)</th></tr><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><a href=\"/wiki/File:Ideogram_human_chromosome_19.svg\" class=\"image\" title=\"Chromosome 19 (human)\"><img alt=\"Chromosome 19 (human)\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/5/54/Ideogram_human_chromosome_19.svg/300px-Ideogram_human_chromosome_19.svg.png\" width=\"300\" height=\"120\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/5/54/Ideogram_human_chromosome_19.svg/450px-Ideogram_human_chromosome_19.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/54/Ideogram_human_chromosome_19.svg/600px-Ideogram_human_chromosome_19.svg.png 2x\" data-file-width=\"474\" data-file-height=\"189\" /></a></td></tr><tr><th scope=\"row\" width=\"15%\" style=\"background-color:#c3fdb8\"><a href=\"/wiki/Chromosome\" title=\"Chromosome\">Chr.</a></th><td colspan=\"3\" width=\"85%\" style=\"background-color:#eee\"><span class=\"plainlinks\"><a href=\"/wiki/Chromosome_19_(human)\" class=\"mw-redirect\" title=\"Chromosome 19 (human)\">Chromosome 19 (human)</a><sup id=\"cite_ref-refGRCh38Ensembl_1-0\" class=\"reference\"><a href=\"#cite_note-refGRCh38Ensembl-1\">&#91;1&#93;</a></sup></span></td></tr><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><div align=\"center\"><div style=\"position: relative; width: 300px;\"><a href=\"/wiki/File:Human_chromosome_19_ideogram.svg\" class=\"image\" title=\"Chromosome 19 (human)\"><img alt=\"Chromosome 19 (human)\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/b6/Human_chromosome_19_ideogram.svg/300px-Human_chromosome_19_ideogram.svg.png\" width=\"300\" height=\"58\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/b6/Human_chromosome_19_ideogram.svg/450px-Human_chromosome_19_ideogram.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b6/Human_chromosome_19_ideogram.svg/600px-Human_chromosome_19_ideogram.svg.png 2x\" data-file-width=\"1125\" data-file-height=\"216\" /></a><div style=\"position: absolute; left: 249.7959649335px; top: 2px; padding: 0;\"><a href=\"/wiki/File:HSR_1996_II_3.5e.svg\" class=\"image\" title=\"Genomic location for KLK3\"><img alt=\"Genomic location for KLK3\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/d/d8/HSR_1996_II_3.5e.svg/14px-HSR_1996_II_3.5e.svg.png\" width=\"14\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/d/d8/HSR_1996_II_3.5e.svg/21px-HSR_1996_II_3.5e.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/d8/HSR_1996_II_3.5e.svg/28px-HSR_1996_II_3.5e.svg.png 2x\" data-file-width=\"142\" data-file-height=\"142\" /></a></div><div style=\"position: absolute; left: 255.8px; top: 19px; padding: 0;\"><a href=\"/wiki/File:Red_rectangle_2x18.png\" class=\"image\" title=\"Genomic location for KLK3\"><img alt=\"Genomic location for KLK3\" src=\"//upload.wikimedia.org/wikipedia/commons/6/6a/Red_rectangle_2x18.png\" width=\"2\" height=\"18\" data-file-width=\"2\" data-file-height=\"18\" /></a></div></div></div></td></tr><tr><th scope=\"row\" rowspan=\"2\" width=\"15%\" style=\"background-color:#c3fdb8\"><a href=\"/wiki/Locus_(genetics)\" title=\"Locus (genetics)\">Band</a></th><td rowspan=\"2\" width=\"35%\" style=\"background-color:#eee\"><span class=\"plainlinks\">19q13.33</span></td><th scope=\"row\" style=\"background-color:#c3fdb8\">Start</th><td style=\"background-color:#eee\"><span class=\"plainlinks\">50,854,915 <a href=\"/wiki/Base_pair\" title=\"Base pair\">bp</a><sup id=\"cite_ref-refGRCh38Ensembl_1-1\" class=\"reference\"><a href=\"#cite_note-refGRCh38Ensembl-1\">&#91;1&#93;</a></sup></span></td></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\">End</th><td style=\"background-color:#eee\"><span class=\"plainlinks\">50,860,764 <a href=\"/wiki/Base_pair\" title=\"Base pair\">bp</a><sup id=\"cite_ref-refGRCh38Ensembl_1-2\" class=\"reference\"><a href=\"#cite_note-refGRCh38Ensembl-1\">&#91;1&#93;</a></sup></span></td></tr></tbody></table></td></tr><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><table class=\"collapsible collapsed\" style=\"padding:0;border:none;margin:0;width:100%;text-align:left\"><tbody><tr><th colspan=\"4\" style=\"text-align:center;background-color:#ddd\">Gene location (Mouse)</th></tr><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><a href=\"/wiki/File:Ideogram_house_mouse_chromosome_7.svg\" class=\"image\" title=\"Chromosome 7 (mouse)\"><img alt=\"Chromosome 7 (mouse)\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/e/e4/Ideogram_house_mouse_chromosome_7.svg/260px-Ideogram_house_mouse_chromosome_7.svg.png\" width=\"260\" height=\"111\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/e/e4/Ideogram_house_mouse_chromosome_7.svg/390px-Ideogram_house_mouse_chromosome_7.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/e4/Ideogram_house_mouse_chromosome_7.svg/520px-Ideogram_house_mouse_chromosome_7.svg.png 2x\" data-file-width=\"470\" data-file-height=\"200\" /></a></td></tr><tr><th scope=\"row\" width=\"15%\" style=\"background-color:#c3fdb8\"><a href=\"/wiki/Chromosome\" title=\"Chromosome\">Chr.</a></th><td colspan=\"3\" width=\"85%\" style=\"background-color:#eee\"><span class=\"plainlinks\">Chromosome 7 (mouse)<sup id=\"cite_ref-refGRCm38Ensembl_2-0\" class=\"reference\"><a href=\"#cite_note-refGRCm38Ensembl-2\">&#91;2&#93;</a></sup></span></td></tr><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><div align=\"center\"><div style=\"position: relative; width: 300px;\"><a href=\"/wiki/File:Ideogram_of_house_mouse_chromosome_7.svg\" class=\"image\" title=\"Chromosome 7 (mouse)\"><img alt=\"Chromosome 7 (mouse)\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/2/2c/Ideogram_of_house_mouse_chromosome_7.svg/300px-Ideogram_of_house_mouse_chromosome_7.svg.png\" width=\"300\" height=\"58\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/2/2c/Ideogram_of_house_mouse_chromosome_7.svg/450px-Ideogram_of_house_mouse_chromosome_7.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/2c/Ideogram_of_house_mouse_chromosome_7.svg/600px-Ideogram_of_house_mouse_chromosome_7.svg.png 2x\" data-file-width=\"1200\" data-file-height=\"231\" /></a><div style=\"position: absolute; left: 84.007171726649px; top: 2px; padding: 0;\"><a href=\"/wiki/File:HSR_1996_II_3.5e.svg\" class=\"image\" title=\"Genomic location for KLK3\"><img alt=\"Genomic location for KLK3\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/d/d8/HSR_1996_II_3.5e.svg/14px-HSR_1996_II_3.5e.svg.png\" width=\"14\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/d/d8/HSR_1996_II_3.5e.svg/21px-HSR_1996_II_3.5e.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/d8/HSR_1996_II_3.5e.svg/28px-HSR_1996_II_3.5e.svg.png 2x\" data-file-width=\"142\" data-file-height=\"142\" /></a></div><div style=\"position: absolute; left: 90px; top: 19px; padding: 0;\"><a href=\"/wiki/File:Red_rectangle_2x18.png\" class=\"image\" title=\"Genomic location for KLK3\"><img alt=\"Genomic location for KLK3\" src=\"//upload.wikimedia.org/wikipedia/commons/6/6a/Red_rectangle_2x18.png\" width=\"2\" height=\"18\" data-file-width=\"2\" data-file-height=\"18\" /></a></div></div></div></td></tr><tr><th scope=\"row\" rowspan=\"2\" width=\"15%\" style=\"background-color:#c3fdb8\"><a href=\"/wiki/Locus_(genetics)\" title=\"Locus (genetics)\">Band</a></th><td rowspan=\"2\" width=\"35%\" style=\"background-color:#eee\"><span class=\"plainlinks\">7 B3&#124;7 28.72 cM</span></td><th scope=\"row\" style=\"background-color:#c3fdb8\">Start</th><td style=\"background-color:#eee\"><span class=\"plainlinks\">44,207,435 <a href=\"/wiki/Base_pair\" title=\"Base pair\">bp</a><sup id=\"cite_ref-refGRCm38Ensembl_2-1\" class=\"reference\"><a href=\"#cite_note-refGRCm38Ensembl-2\">&#91;2&#93;</a></sup></span></td></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\">End</th><td style=\"background-color:#eee\"><span class=\"plainlinks\">44,211,754 <a href=\"/wiki/Base_pair\" title=\"Base pair\">bp</a><sup id=\"cite_ref-refGRCm38Ensembl_2-2\" class=\"reference\"><a href=\"#cite_note-refGRCm38Ensembl-2\">&#91;2&#93;</a></sup></span></td></tr></tbody></table></td></tr><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><table class=\"collapsible expand\" style=\"padding:0;border:none;margin:0;width:100%;text-align:left\"><tbody><tr><th colspan=\"4\" style=\"text-align:center;background-color:#ddd\"><a href=\"/wiki/Gene_expression\" title=\"Gene expression\">RNA expression</a> pattern</th></tr><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><a href=\"/wiki/File:PBB_GE_KLK3_204583_x_at_fs.png\" class=\"image\"><img alt=\"PBB GE KLK3 204583 x at fs.png\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/3/3c/PBB_GE_KLK3_204583_x_at_fs.png/250px-PBB_GE_KLK3_204583_x_at_fs.png\" width=\"250\" height=\"181\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/3/3c/PBB_GE_KLK3_204583_x_at_fs.png/375px-PBB_GE_KLK3_204583_x_at_fs.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/3/3c/PBB_GE_KLK3_204583_x_at_fs.png/500px-PBB_GE_KLK3_204583_x_at_fs.png 2x\" data-file-width=\"732\" data-file-height=\"530\" /></a><br /><br /><a href=\"/wiki/File:PBB_GE_KLK3_204582_s_at_fs.png\" class=\"image\"><img alt=\"PBB GE KLK3 204582 s at fs.png\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/a6/PBB_GE_KLK3_204582_s_at_fs.png/250px-PBB_GE_KLK3_204582_s_at_fs.png\" width=\"250\" height=\"181\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/a6/PBB_GE_KLK3_204582_s_at_fs.png/375px-PBB_GE_KLK3_204582_s_at_fs.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/a6/PBB_GE_KLK3_204582_s_at_fs.png/500px-PBB_GE_KLK3_204582_s_at_fs.png 2x\" data-file-width=\"732\" data-file-height=\"530\" /></a></td></tr><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"http://biogps.org/gene/354/\">More reference expression data</a></span></td></tr></tbody></table></td></tr><tr><td colspan=\"4\" style=\"text-align:center;background-color:#eee\"><table class=\"collapsible collapsed\" style=\"padding:0;border:none;margin:0;width:100%;text-align:left\"><tbody><tr><th colspan=\"4\" style=\"text-align:center;background-color:#ddd\"><a href=\"/wiki/Gene_ontology\" title=\"Gene ontology\">Gene ontology</a></th></tr><tr><th style=\"background-color:#c3fdb8\">Molecular function</th><td style=\"background-color:#eee\"><span class=\"plainlinks\"><big>\u2022</big> <a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0008233\">peptidase activity</a><br /><big>\u2022</big> <a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0008236\">serine-type peptidase activity</a><br /><big>\u2022</big> <a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0004175\">endopeptidase activity</a><br /><big>\u2022</big> <a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0016811\">hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides</a><br /><big>\u2022</big> <a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0005515\">protein binding</a><br /><big>\u2022</big> <a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0016787\">hydrolase activity</a><br /><big>\u2022</big> <a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0004252\">serine-type endopeptidase activity</a><br /></span></td></tr><tr><th style=\"background-color:#c3fdb8\">Cellular component</th><td style=\"background-color:#eee\"><span class=\"plainlinks\"><big>\u2022</big> <a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0070062\">extracellular exosome</a><br /><big>\u2022</big> <a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0005634\">cell nucleus</a><br /><big>\u2022</big> <a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0043234\">protein complex</a><br /><big>\u2022</big> <a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0005576\">extracellular region</a><br /><big>\u2022</big> <a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0005615\">extracellular space</a><br /></span></td></tr><tr><th style=\"background-color:#c3fdb8\">Biological process</th><td style=\"background-color:#eee\"><span class=\"plainlinks\"><big>\u2022</big> <a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0016525\">negative regulation of angiogenesis</a><br /><big>\u2022</big> <a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0044267\">cellular protein metabolic process</a><br /><big>\u2022</big> <a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0002778\">antibacterial peptide production</a><br /><big>\u2022</big> <a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/amigo/term/GO:0006508\">proteolysis</a><br /></span></td></tr><tr><td colspan=\"4\" style=\"background-color:#eee;text-align:center\">Sources:<a rel=\"nofollow\" class=\"external text\" href=\"http://amigo.geneontology.org/\">Amigo</a> / <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ebi.ac.uk/QuickGO/\">QuickGO</a></td></tr></tbody></table></td></tr><tr><th colspan=\"4\" style=\"text-align:center;background-color:#ddd\"><a href=\"/wiki/Ortholog\" class=\"mw-redirect\" title=\"Ortholog\">Orthologs</a></th></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\">Species</th><td><b>Human</b></td><td><b>Mouse</b></td></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\"><a href=\"/wiki/Entrez\" title=\"Entrez\">Entrez</a></th><td><table class=\"none\" style=\"padding:0;border:none;margin:0;width:100%;text-align:right\"><tbody><tr><th colspan=\"1\"><span class=\"plainlinks\"></span></th></tr><tr><td colspan=\"1\"><p class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&amp;cmd=retrieve&amp;dopt=default&amp;list_uids=354&amp;rn=1\">354</a></p></td></tr></tbody></table></td><td><table class=\"none\" style=\"padding:0;border:none;margin:0;width:100%;text-align:right\"><tbody><tr><th colspan=\"1\"><span class=\"plainlinks\"></span></th></tr><tr><td colspan=\"1\"><p class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&amp;cmd=retrieve&amp;dopt=default&amp;list_uids=18048&amp;rn=1\">18048</a></p></td></tr></tbody></table></td></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\"><a href=\"/wiki/Ensembl\" class=\"mw-redirect\" title=\"Ensembl\">Ensembl</a></th><td><table class=\"none\" style=\"padding:0;border:none;margin:0;width:100%;text-align:right\"><tbody><tr><th colspan=\"1\"><span class=\"plainlinks\"></span></th></tr><tr><td colspan=\"1\"><p class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.ensembl.org/Homo_sapiens/geneview?gene=ENSG00000142515;db=core\">ENSG00000142515</a></p></td></tr></tbody></table></td><td><table class=\"none\" style=\"padding:0;border:none;margin:0;width:100%;text-align:right\"><tbody><tr><th colspan=\"1\"><span class=\"plainlinks\"></span></th></tr><tr><td colspan=\"1\"><p class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.ensembl.org/Mus_musculus/geneview?gene=ENSMUSG00000066513;db=core\">ENSMUSG00000066513</a></p></td></tr></tbody></table></td></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\"><a href=\"/wiki/UniProt\" title=\"UniProt\">UniProt</a></th><td><table class=\"none\" style=\"padding:0;border:none;margin:0;width:100%;text-align:right\"><tbody><tr><th colspan=\"1\"><span class=\"plainlinks\"></span></th></tr><tr><td colspan=\"1\"><p class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.uniprot.org/uniprot/P07288\">P07288</a></p></td></tr></tbody></table></td><td><table style=\"padding:0;border:none;margin:0;width:100%;text-align:right\"><tbody><tr><th colspan=\"1\"><span class=\"plainlinks\"></span></th></tr><tr><td colspan=\"1\"><p class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.uniprot.org/uniprot/P00757\">P00757</a></p></td></tr></tbody></table></td></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\">RefSeq (mRNA)</th><td><table class=\"none\" style=\"padding:0;border:none;margin:0;width:100%;text-align:right\"><tbody><tr><th colspan=\"1\" class=\"plainlinks\"></th></tr><tr><td colspan=\"1\"><p><span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_001030047\">NM_001030047</a><br /><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_001030048\">NM_001030048</a><br /><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_001030049\">NM_001030049</a><br /><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_001030050\">NM_001030050</a><br /><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_001648\">NM_001648</a></span></p></td></tr></tbody></table></td><td><table class=\"none\" style=\"padding:0;border:none;margin:0;width:100%;text-align:right\"><tbody><tr><th colspan=\"1\" class=\"plainlinks\"></th></tr><tr><td colspan=\"1\"><p><span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_010915\">NM_010915</a></span></p></td></tr></tbody></table></td></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\">RefSeq (protein)</th><td><table class=\"none\" style=\"padding:0;border:none;margin:0;width:100%;text-align:right\"><tbody><tr><th colspan=\"1\" class=\"plainlinks\"></th></tr><tr><td colspan=\"1\"><p><span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_001025218\">NP_001025218</a><br /><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_001025219\">NP_001025219</a><br /><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_001639\">NP_001639</a></span></p></td></tr></tbody></table></td><td><table class=\"none\" style=\"padding:0;border:none;margin:0;width:100%;text-align:right\"><tbody><tr><th colspan=\"1\" class=\"plainlinks\"></th></tr><tr><td colspan=\"1\"><p><span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_035045\">NP_035045</a></span></p></td></tr></tbody></table></td></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\">Location (UCSC)</th><td><span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"https://genome.ucsc.edu/cgi-bin/hgTracks?org=Human&amp;db=hg38&amp;position=chr19:50854915-50860764\">Chr 19: 50.85 \u2013 50.86 Mb</a></span></td><td><span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"https://genome.ucsc.edu/cgi-bin/hgTracks?org=Mouse&amp;db=mm0&amp;position=chr7:44207435-44211754\">Chr 7: 44.21 \u2013 44.21 Mb</a></span></td></tr><tr><th scope=\"row\" style=\"background-color:#c3fdb8\"><a href=\"/wiki/PubMed\" title=\"PubMed\">PubMed</a> search</th><td><span class=\"plainlinks\"><sup id=\"cite_ref-3\" class=\"reference\"><a href=\"#cite_note-3\">&#91;3&#93;</a></sup></span></td><td><span class=\"plainlinks\"><sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup></span></td></tr><tr><td colspan=\"4\" style=\"text-align:center;font-size:x-small;background-color:#eee\"><a href=\"/wiki/Wikidata\" title=\"Wikidata\">Wikidata</a></td></tr><tr><td colspan=\"4\" style=\"text-align:center;font-size:x-small;background-color:#eee\"><table style=\"padding:0;border:none;margin:0;width:100%;text-align:center\"><tbody><tr><td colspan=\"2\" style=\"background-color:#eee;text-align:center;font-size:x-small\"><a href=\"https://www.wikidata.org/wiki/Q14859580\" class=\"extiw\" title=\"d:Q14859580\">View/Edit Human</a></td><td colspan=\"2\" style=\"background-color:#eee;text-align:center;font-size:x-small\"><a href=\"https://www.wikidata.org/wiki/Q18252640\" class=\"extiw\" title=\"d:Q18252640\">View/Edit Mouse</a></td></tr></tbody></table></td></tr></tbody></table>\n<p><b>Prostate-specific antigen</b> (<b>PSA</b>), also known as <b>gamma-seminoprotein</b> or <b>kallikrein-3</b> (<b>KLK3</b>), is a <a href=\"/wiki/Glycoprotein\" title=\"Glycoprotein\">glycoprotein</a> <a href=\"/wiki/Enzyme\" title=\"Enzyme\">enzyme</a> encoded in humans by the <i>KLK3</i> <a href=\"/wiki/Gene\" title=\"Gene\">gene</a>. PSA is a member of the <a href=\"/wiki/Kallikrein\" title=\"Kallikrein\">kallikrein</a>-related <a href=\"/wiki/Protease\" title=\"Protease\">peptidase</a> family and is secreted by the <a href=\"/wiki/Epithelium\" title=\"Epithelium\">epithelial cells</a> of the <a href=\"/wiki/Prostate\" title=\"Prostate\">prostate</a> gland. PSA is produced for the <a href=\"/wiki/Ejaculate\" class=\"mw-redirect\" title=\"Ejaculate\">ejaculate</a>, where it liquefies <a href=\"/wiki/Semen\" title=\"Semen\">semen</a> in the seminal coagulum and allows <a href=\"/wiki/Spermatozoon\" title=\"Spermatozoon\">sperm</a> to swim freely.<sup id=\"cite_ref-pmid12525533_5-0\" class=\"reference\"><a href=\"#cite_note-pmid12525533-5\">&#91;5&#93;</a></sup> It is also believed to be instrumental in dissolving <a href=\"/wiki/Cervix#Cervical_mucus\" title=\"Cervix\">cervical mucus</a>, allowing the entry of sperm into the <a href=\"/wiki/Uterus\" title=\"Uterus\">uterus</a>.<sup id=\"cite_ref-6\" class=\"reference\"><a href=\"#cite_note-6\">&#91;6&#93;</a></sup>\n</p><p>PSA is present in small quantities in the <a href=\"/wiki/Blood_plasma\" title=\"Blood plasma\">serum</a> of men with healthy prostates, but is often elevated in the presence of <a href=\"/wiki/Prostate_cancer\" title=\"Prostate cancer\">prostate cancer</a> or other prostate disorders.<sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup> PSA is not a unique indicator of prostate cancer, but may also detect <a href=\"/wiki/Prostatitis\" title=\"Prostatitis\">prostatitis</a> or <a href=\"/wiki/Benign_prostatic_hyperplasia\" title=\"Benign prostatic hyperplasia\">benign prostatic hyperplasia</a>.<sup id=\"cite_ref-pmid23708103_8-0\" class=\"reference\"><a href=\"#cite_note-pmid23708103-8\">&#91;8&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Medical_uses\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Medical uses</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-2\"><a href=\"#Prostate_cancer\"><span class=\"tocnumber\">1.1</span> <span class=\"toctext\">Prostate cancer</span></a>\n<ul>\n<li class=\"toclevel-3 tocsection-3\"><a href=\"#Screening\"><span class=\"tocnumber\">1.1.1</span> <span class=\"toctext\">Screening</span></a></li>\n<li class=\"toclevel-3 tocsection-4\"><a href=\"#Risk_stratification_and_staging\"><span class=\"tocnumber\">1.1.2</span> <span class=\"toctext\">Risk stratification and staging</span></a></li>\n<li class=\"toclevel-3 tocsection-5\"><a href=\"#Post-treatment_monitoring\"><span class=\"tocnumber\">1.1.3</span> <span class=\"toctext\">Post-treatment monitoring</span></a></li>\n<li class=\"toclevel-3 tocsection-6\"><a href=\"#Histology\"><span class=\"tocnumber\">1.1.4</span> <span class=\"toctext\">Histology</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-2 tocsection-7\"><a href=\"#Forensic_identification_of_semen\"><span class=\"tocnumber\">1.2</span> <span class=\"toctext\">Forensic identification of semen</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-8\"><a href=\"#Mechanism_of_action\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Mechanism of action</span></a></li>\n<li class=\"toclevel-1 tocsection-9\"><a href=\"#Biochemistry\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Biochemistry</span></a></li>\n<li class=\"toclevel-1 tocsection-10\"><a href=\"#History\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">History</span></a></li>\n<li class=\"toclevel-1 tocsection-11\"><a href=\"#Serum_levels\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Serum levels</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-12\"><a href=\"#PSA_velocity\"><span class=\"tocnumber\">5.1</span> <span class=\"toctext\">PSA velocity</span></a></li>\n<li class=\"toclevel-2 tocsection-13\"><a href=\"#Free_PSA\"><span class=\"tocnumber\">5.2</span> <span class=\"toctext\">Free PSA</span></a></li>\n<li class=\"toclevel-2 tocsection-14\"><a href=\"#Inactive_PSA\"><span class=\"tocnumber\">5.3</span> <span class=\"toctext\">Inactive PSA</span></a></li>\n<li class=\"toclevel-2 tocsection-15\"><a href=\"#Complexed_PSA\"><span class=\"tocnumber\">5.4</span> <span class=\"toctext\">Complexed PSA</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-16\"><a href=\"#PSA_in_other_biologic_fluids_and_tissues\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">PSA in other biologic fluids and tissues</span></a></li>\n<li class=\"toclevel-1 tocsection-17\"><a href=\"#Interactions\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">Interactions</span></a></li>\n<li class=\"toclevel-1 tocsection-18\"><a href=\"#See_also\"><span class=\"tocnumber\">8</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-19\"><a href=\"#References\"><span class=\"tocnumber\">9</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-20\"><a href=\"#Further_reading\"><span class=\"tocnumber\">10</span> <span class=\"toctext\">Further reading</span></a></li>\n<li class=\"toclevel-1 tocsection-21\"><a href=\"#External_links\"><span class=\"tocnumber\">11</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Medical_uses\">Medical uses</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prostate-specific_antigen&amp;action=edit&amp;section=1\" title=\"Edit section: Medical uses\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Prostate_cancer\">Prostate cancer</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prostate-specific_antigen&amp;action=edit&amp;section=2\" title=\"Edit section: Prostate cancer\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<h4><span class=\"mw-headline\" id=\"Screening\">Screening</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prostate-specific_antigen&amp;action=edit&amp;section=3\" title=\"Edit section: Screening\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<div role=\"note\" class=\"hatnote navigation-not-searchable\">Main article: <a href=\"/wiki/Prostate_cancer_screening\" title=\"Prostate cancer screening\">Prostate cancer screening</a></div>\n<p><a href=\"/wiki/Clinical_practice_guideline\" class=\"mw-redirect\" title=\"Clinical practice guideline\">Clinical practice guidelines</a> for prostate cancer <a href=\"/wiki/Screening_(medicine)\" title=\"Screening (medicine)\">screening</a> vary and are controversial due to uncertainty as to whether the benefits of screening ultimately outweigh the risks of <a href=\"/wiki/Overdiagnosis\" title=\"Overdiagnosis\">overdiagnosis</a> and over treatment.<sup id=\"cite_ref-Gomella2011_9-0\" class=\"reference\"><a href=\"#cite_note-Gomella2011-9\">&#91;9&#93;</a></sup>  In the United States, the <a href=\"/wiki/U.S._Food_and_Drug_Administration\" class=\"mw-redirect\" title=\"U.S. Food and Drug Administration\">U.S. Food and Drug Administration</a> (FDA) has approved the PSA test for annual screening of prostate cancer in men of age 50 and older. The patient needs to be informed of the risks and benefits of PSA testing prior to performing the test (see below). PSA levels between 4 and 10&#160;ng/mL (nanograms per milliliter) are considered to be suspicious and consideration should be given to confirming the abnormal PSA with a repeat test. If indicated, <a href=\"/wiki/Prostate_biopsy\" title=\"Prostate biopsy\">prostate biopsy</a> is performed to obtain tissue sample for histopathological analysis.  In the United Kingdom, the National Health Service (2018) does not mandate, nor advise for PSA test, but allows patients to decide based on their doctor's advice.<sup id=\"cite_ref-10\" class=\"reference\"><a href=\"#cite_note-10\">&#91;10&#93;</a></sup>\n</p><p>As of 2018 the UK <a href=\"/wiki/National_Health_Service\" title=\"National Health Service\">National Health Service</a> did not offer general PSA screening, for similar reasons.<sup id=\"cite_ref-11\" class=\"reference\"><a href=\"#cite_note-11\">&#91;11&#93;</a></sup>\n</p><p>While PSA testing may help 1000 in 1,000,000 avoid death due to prostate cancer, 4000 to 5000 in 1,000,000 would die from prostate cancer after 10 years even with screening. This means that PSA screening may reduce mortality from prostate cancer by up to 25%. Expected harms include anxiety for 100 \u2013 120 receiving false positives, biopsy pain, and other complications from biopsy for false positive tests. Of those found to have prostate cancer, frequent overtreatment is common because most cases of prostate cancer are not expected to cause any symptoms. Therefore, many will experience the side effects of treatment, such as for every 1000 men screened, 29 will experience erectile dysfunction, 18 will suffer urinary incontinence, 2 will have serious cardiovascular events, 1 will suffer pulmonary embolus or deep venous thrombosis, and 1 perioperative death. Since the expected harm relative to risk of death are perceived by patients as minimal, men found to have prostate cancer usually (up to 90% of cases) elect to receive treatment.<sup id=\"cite_ref-urlwww.uspreventiveservicestaskforce.org_12-0\" class=\"reference\"><a href=\"#cite_note-urlwww.uspreventiveservicestaskforce.org-12\">&#91;12&#93;</a></sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"Risk_stratification_and_staging\">Risk stratification and staging</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prostate-specific_antigen&amp;action=edit&amp;section=4\" title=\"Edit section: Risk stratification and staging\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>Men with prostate cancer may be characterized as low-, intermediate-, or high-risk for having/developing metastatic disease or dying of prostate cancer. PSA level is one of three variables on which the risk-stratification is based; the others are the grade of prostate cancer (<a href=\"/wiki/Gleason_grading_system\" title=\"Gleason grading system\">Gleason grading system</a>) and the stage of cancer based on physical examination and imaging studies. D'Amico Criteria for each risk category are as follows:<sup id=\"cite_ref-pmid9749478_13-0\" class=\"reference\"><a href=\"#cite_note-pmid9749478-13\">&#91;13&#93;</a></sup>\n</p>\n<dl><dd>Low-risk: PSA &lt; 10, Gleason score \u2264 6, AND clinical stage \u2264 T2a</dd>\n<dd>Intermediate-risk: PSA 10-20, Gleason score 7, OR clinical stage T2b/c</dd>\n<dd>High-risk: PSA &gt; 20, Gleason score \u2265 8, OR clinical stage \u2265 T3</dd></dl>\n<p>Given the relative simplicity of the 1998 D\u2019Amico criteria (above), other predictive models of risk stratification based on <a href=\"/wiki/Mathematical_probability\" class=\"mw-redirect\" title=\"Mathematical probability\">mathematical probability</a> constructs exist or have been proposed to allow for better matching of treatment decisions with disease features.<sup id=\"cite_ref-14\" class=\"reference\"><a href=\"#cite_note-14\">&#91;14&#93;</a></sup> \nStudies are being conducted into the incorporation of multiparametric <a href=\"/wiki/MRI\" class=\"mw-redirect\" title=\"MRI\">MRI</a> imaging results into <a href=\"/wiki/Nomogram\" title=\"Nomogram\">nomograms</a> that rely on PSA, Gleason grade and tumor stage.<sup id=\"cite_ref-15\" class=\"reference\"><a href=\"#cite_note-15\">&#91;15&#93;</a></sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"Post-treatment_monitoring\">Post-treatment monitoring</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prostate-specific_antigen&amp;action=edit&amp;section=5\" title=\"Edit section: Post-treatment monitoring\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>PSA levels are monitored periodically (e.g., every 6\u201336 months) after treatment for prostate cancer - more frequently in patients with high-risk disease, less frequently in patients with lower-risk disease. If surgical therapy (i.e., radical prostatectomy) is successful at removing all prostate tissue (and prostate cancer), PSA becomes undetectable within a few weeks. A subsequent rise in PSA level above 0.2&#160;ng/mL<sup id=\"cite_ref-16\" class=\"reference\"><a href=\"#cite_note-16\">&#91;16&#93;</a></sup> L<sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Disputed_statement\" class=\"mw-redirect\" title=\"Wikipedia:Disputed statement\"><span title=\"This claim has reliable sources with contradicting facts (February 2014)\">disputed</span></a>&#32;<span class=\"metadata\"> &#8211; <a href=\"/wiki/Talk:Prostate-specific_antigen#Post-treatment_monitoring:_no_references._Incorrect_units.3F\" title=\"Talk:Prostate-specific antigen\">discuss</a></span></i>&#93;</sup> is generally regarded as evidence of recurrent prostate cancer after a radical prostatectomy; less commonly, it may simply indicate residual benign prostate tissue.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (February 2014)\">citation needed</span></a></i>&#93;</sup>\n</p><p>Following radiation therapy of any type for prostate cancer, some PSA levels might be detected, even when the treatment ultimately proves to be successful. This makes it more difficult to interpret the relationship between PSA levels and recurrence/persistence of prostate cancer after radiation therapy. PSA levels may continue to decrease for several years after radiation therapy. The lowest level is referred to as the PSA nadir. A subsequent increase in PSA levels by 2.0&#160;ng/mL<sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Disputed_statement\" class=\"mw-redirect\" title=\"Wikipedia:Disputed statement\"><span title=\"This claim has reliable sources with contradicting facts (February 2014)\">disputed</span></a>&#32;<span class=\"metadata\"> &#8211; <a href=\"/wiki/Talk:Prostate-specific_antigen#Post-treatment_monitoring:_no_references._Incorrect_units.3F\" title=\"Talk:Prostate-specific antigen\">discuss</a></span></i>&#93;</sup> above the nadir is the currently accepted definition of prostate cancer recurrence after radiation therapy.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (February 2014)\">citation needed</span></a></i>&#93;</sup>\n</p><p>If recurrent prostate cancer is detected by a rise in PSA levels after curative treatment, it is referred to as a \"<a href=\"/wiki/Biochemical_recurrence\" title=\"Biochemical recurrence\">biochemical recurrence</a>\". The likelihood of developing recurrent prostate cancer after curative treatment is related to the pre-operative variables described in the preceding section (PSA level and grade/stage of cancer). Low-risk cancers are the least likely to recur, but they are also the least likely to have required treatment in the first place.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (February 2014)\">citation needed</span></a></i>&#93;</sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"Histology\">Histology</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prostate-specific_antigen&amp;action=edit&amp;section=6\" title=\"Edit section: Histology\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>PSA is produced in the <a href=\"/wiki/Epithelium\" title=\"Epithelium\">epithelial</a> cells of the prostate, and can be demonstrated in biopsy samples or other <a href=\"/wiki/Histology\" title=\"Histology\">histological</a> specimens using <a href=\"/wiki/Immunohistochemistry\" title=\"Immunohistochemistry\">immunohistochemistry</a>. Disruption of this epithelium, for example in inflammation or <a href=\"/wiki/Benign_prostatic_hyperplasia\" title=\"Benign prostatic hyperplasia\">benign prostatic hyperplasia</a>, may lead to some diffusion of the antigen into the tissue around the epithelium, and is the cause of elevated blood levels of PSA in these conditions.<sup id=\"cite_ref-Leong_17-0\" class=\"reference\"><a href=\"#cite_note-Leong-17\">&#91;17&#93;</a></sup>\n</p><p>More significantly, PSA remains present in prostate cells after they become malignant. Prostate cancer cells generally have variable or weak staining for PSA, due to the disruption of their normal functioning. Thus, individual prostate cancer cells produce less PSA than healthy cells; the raised serum levels in prostate cancer patients is due to the greatly increased number of such cells, not their individual activity. However, in most cases of prostate cancer, the cells remain positive for the antigen, which can therefore be used to identify <a href=\"/wiki/Metastasis\" title=\"Metastasis\">metastasis</a>. Since some high-grade prostate cancers may be entirely negative for PSA, however, histological analysis to identify such cases usually uses PSA in combination with other antibodies, such as <a href=\"/wiki/Prostatic_acid_phosphatase\" title=\"Prostatic acid phosphatase\">PSAP</a> and <a href=\"/wiki/CD57\" class=\"mw-redirect\" title=\"CD57\">CD57</a>.<sup id=\"cite_ref-Leong_17-1\" class=\"reference\"><a href=\"#cite_note-Leong-17\">&#91;17&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Forensic_identification_of_semen\">Forensic identification of semen</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prostate-specific_antigen&amp;action=edit&amp;section=7\" title=\"Edit section: Forensic identification of semen\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>PSA was first identified by researchers attempting to find a substance in seminal fluid that would aid in the investigation of rape cases.<sup id=\"cite_ref-18\" class=\"reference\"><a href=\"#cite_note-18\">&#91;18&#93;</a></sup> PSA is now used to indicate the presence of <a href=\"/wiki/Semen\" title=\"Semen\">semen</a> in forensic <a href=\"/wiki/Serology\" title=\"Serology\">serology</a>.<sup id=\"cite_ref-19\" class=\"reference\"><a href=\"#cite_note-19\">&#91;19&#93;</a></sup> The semen of adult males has PSA levels far in excess of those found in other tissues; therefore, a high level of PSA found in a sample is an indicator that semen may be present. Because PSA is a <a href=\"/wiki/Biomarker\" title=\"Biomarker\">biomarker</a> that is expressed independently of <a href=\"/wiki/Spermatozoon\" title=\"Spermatozoon\">spermatozoa</a>, it remains useful in identifying semen from <a href=\"/wiki/Vasectomy\" title=\"Vasectomy\">vasectomized</a> and <a href=\"/wiki/Azoospermia\" title=\"Azoospermia\">azoospermic</a> males.<sup id=\"cite_ref-aspermic_20-0\" class=\"reference\"><a href=\"#cite_note-aspermic-20\">&#91;20&#93;</a></sup>\n</p><p>PSA can also be found at low levels in other body fluids, such as urine and breast milk, thus setting a high minimum threshold of interpretation to rule out <a href=\"/wiki/Type_I_and_type_II_errors\" title=\"Type I and type II errors\">false positive</a> results and conclusively state that semen is present.<sup id=\"cite_ref-fluids_21-0\" class=\"reference\"><a href=\"#cite_note-fluids-21\">&#91;21&#93;</a></sup> While traditional tests such as crossover <a href=\"/wiki/Electrophoresis\" title=\"Electrophoresis\">electrophoresis</a> have a sufficiently low sensitivity to detect only seminal PSA, newer diagnostics tests developed from clinical <a href=\"/wiki/Prostate_cancer_screening\" title=\"Prostate cancer screening\">prostate cancer screening</a> methods have lowered the threshold of detection down to 4&#160;ng/mL.<sup id=\"cite_ref-22\" class=\"reference\"><a href=\"#cite_note-22\">&#91;22&#93;</a></sup> This level of antigen has been shown to be present in the peripheral blood of males with prostate cancer, and rarely in female urine samples and breast milk.<sup id=\"cite_ref-fluids_21-1\" class=\"reference\"><a href=\"#cite_note-fluids-21\">&#91;21&#93;</a></sup> No studies have been performed to assess the PSA levels in the tissues and secretions of pre-pubescent children. Therefore, the presence of PSA from a high sensitivity (4&#160;ng/mL) test cannot conclusively identify the presence of semen, so care must be taken with the interpretation of such results.\n</p>\n<h2><span class=\"mw-headline\" id=\"Mechanism_of_action\">Mechanism of action</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prostate-specific_antigen&amp;action=edit&amp;section=8\" title=\"Edit section: Mechanism of action\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The physiological function of KLK3 is the dissolution of the coagulum, the sperm entrapping gel composed of <a href=\"/wiki/Semenogelin\" title=\"Semenogelin\">semenogelins</a> and <a href=\"/wiki/Fibronectin\" title=\"Fibronectin\">fibronectin</a>. Its proteolytic action is effective in liquefying the coagulum so that the sperm can be liberated. The activity of PSA is well regulated. In the prostate it is present as an inactive pro-form which is activated through the action of <a href=\"/wiki/KLK2\" title=\"KLK2\">KLK2</a>, another kallikrein-related peptidase. In the prostate, zinc ion concentrations are ten times higher than in other bodily fluids. Zinc ions have a strong inhibitory effect on the activity of PSA and on that of KLK2, so that PSA is totally inactive. Further regulation is achieved through pH variations. Although its activity is increased by higher pH, the inhibitory effect of zinc also increases. The pH of semen is slightly alkaline and the concentrations of zinc are high. On ejaculation, semen is exposed to the acidic pH of the vagina, due to the presence of lactic acid. In fertile couples, the final vaginal pH after coitus approaches the 6-7 levels, which coincides well with reduced zinc inhibition of PSA. At these pH levels, the reduced PSA activity is countered by a decrease in zinc inhibition. Thus, the coagulum is slowly liquefied, releasing the sperm in a well regulated manner.\n</p>\n<h2><span class=\"mw-headline\" id=\"Biochemistry\">Biochemistry</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prostate-specific_antigen&amp;action=edit&amp;section=9\" title=\"Edit section: Biochemistry\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Prostate-specific antigen (PSA, also known as kallikrein III, seminin, semenogelase, \u03b3-seminoprotein and P-30 antigen) is a 34-<a href=\"/wiki/Atomic_mass_unit\" class=\"mw-redirect\" title=\"Atomic mass unit\">kD</a> <a href=\"/wiki/Glycoprotein\" title=\"Glycoprotein\">glycoprotein</a> produced almost exclusively by the <a href=\"/wiki/Prostate_gland\" class=\"mw-redirect\" title=\"Prostate gland\">prostate gland</a>. It is a <a href=\"/wiki/Serine_protease\" title=\"Serine protease\">serine protease</a> (<a href=\"/wiki/Enzyme_Commission_number\" title=\"Enzyme Commission number\">EC</a> <a rel=\"nofollow\" class=\"external text\" href=\"https://enzyme.expasy.org/EC/3.4.21.77\">3.4.21.77</a>) <a href=\"/wiki/Enzyme\" title=\"Enzyme\">enzyme</a>, the <a href=\"/wiki/Gene\" title=\"Gene\">gene</a> of which is located on the 19th <a href=\"/wiki/Chromosome\" title=\"Chromosome\">chromosome</a> (19q13) in humans.<sup id=\"cite_ref-pmid14607215_23-0\" class=\"reference\"><a href=\"#cite_note-pmid14607215-23\">&#91;23&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"History\">History</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prostate-specific_antigen&amp;action=edit&amp;section=10\" title=\"Edit section: History\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The discovery of prostate-specific antigen (PSA) is beset with controversy; as PSA is present in prostatic tissue and semen, it was independently discovered and given different names, thus adding to the controversy.<sup id=\"cite_ref-pmid17760888_24-0\" class=\"reference\"><a href=\"#cite_note-pmid17760888-24\">&#91;24&#93;</a></sup>\n</p><p>Flocks was the first to experiment with antigens in the prostate<sup id=\"cite_ref-pmid4629646_25-0\" class=\"reference\"><a href=\"#cite_note-pmid4629646-25\">&#91;25&#93;</a></sup> and 10 years later <a href=\"/wiki/Richard_J._Ablin\" title=\"Richard J. Ablin\">Ablin</a> reported the presence of precipitation antigens in the prostate.<sup id=\"cite_ref-pmid4977978_26-0\" class=\"reference\"><a href=\"#cite_note-pmid4977978-26\">&#91;26&#93;</a></sup>\n</p><p>In 1971, Mitsuwo Hara characterized a unique protein in the semen fluid, gamma-seminoprotein. Li and Beling, in 1973, isolated a protein, E1, from human semen in an attempt to find a novel method to achieve fertility control.<sup id=\"cite_ref-pmid4631694_27-0\" class=\"reference\"><a href=\"#cite_note-pmid4631694-27\">&#91;27&#93;</a></sup><sup id=\"cite_ref-pmid4213812_28-0\" class=\"reference\"><a href=\"#cite_note-pmid4213812-28\">&#91;28&#93;</a></sup>\n</p><p>In 1978, Sensabaugh identified semen-specific protein p30, but proved that it was similar to E1 protein, and that prostate was the source.<sup id=\"cite_ref-pmid744956_29-0\" class=\"reference\"><a href=\"#cite_note-pmid744956-29\">&#91;29&#93;</a></sup> In 1979, Wang purified a tissue-specific antigen from the prostate ('prostate antigen').<sup id=\"cite_ref-pmid89106_30-0\" class=\"reference\"><a href=\"#cite_note-pmid89106-30\">&#91;30&#93;</a></sup>\n</p><p>PSA was first measured quantitatively in the blood by Papsidero in 1980,<sup id=\"cite_ref-31\" class=\"reference\"><a href=\"#cite_note-31\">&#91;31&#93;</a></sup> and Stamey carried out the initial work on the clinical use of PSA as a marker of prostate cancer.\n</p>\n<h2><span class=\"mw-headline\" id=\"Serum_levels\">Serum levels</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prostate-specific_antigen&amp;action=edit&amp;section=11\" title=\"Edit section: Serum levels\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>PSA is normally present in the <a href=\"/wiki/Blood\" title=\"Blood\">blood</a> at very low levels. The <a href=\"/wiki/Reference_range\" title=\"Reference range\">reference range</a> of less than 4&#160;ng/mL for the first commercial PSA test, the Hybritech Tandem-R PSA test released in February 1986, was based on a study that found 99% of 472 apparently healthy men had a total PSA level below 4&#160;ng/mL\u2014the upper limit of normal is much less than 4&#160;ng/mL.<sup id=\"cite_ref-Kolota_2004_32-0\" class=\"reference\"><a href=\"#cite_note-Kolota_2004-32\">&#91;32&#93;</a></sup>\n</p><p>Increased levels of PSA may suggest the presence of prostate cancer. However, prostate cancer can also be present in the complete absence of an elevated PSA level, in which case the test result would be a <a href=\"/wiki/Type_I_and_type_II_errors\" title=\"Type I and type II errors\">false negative</a>.<sup id=\"cite_ref-33\" class=\"reference\"><a href=\"#cite_note-33\">&#91;33&#93;</a></sup>\n</p><p><a href=\"/wiki/Obesity\" title=\"Obesity\">Obesity</a> has been reported to reduce serum PSA levels.<sup id=\"cite_ref-34\" class=\"reference\"><a href=\"#cite_note-34\">&#91;34&#93;</a></sup> Delayed early detection may partially explain worse outcomes in obese men with early prostate cancer.<sup id=\"cite_ref-35\" class=\"reference\"><a href=\"#cite_note-35\">&#91;35&#93;</a></sup> After treatment, higher BMI also correlates to higher risk of recurrence.<sup id=\"cite_ref-36\" class=\"reference\"><a href=\"#cite_note-36\">&#91;36&#93;</a></sup>\n</p><p>PSA levels can be also increased by <a href=\"/wiki/Prostatitis\" title=\"Prostatitis\">prostatitis</a>, irritation, <a href=\"/wiki/Benign_prostatic_hyperplasia\" title=\"Benign prostatic hyperplasia\">benign prostatic hyperplasia</a> (BPH), and recent ejaculation,<sup id=\"cite_ref-ejac_37-0\" class=\"reference\"><a href=\"#cite_note-ejac-37\">&#91;37&#93;</a></sup><sup id=\"cite_ref-pmid7541857_38-0\" class=\"reference\"><a href=\"#cite_note-pmid7541857-38\">&#91;38&#93;</a></sup> producing a <a href=\"/wiki/False_positive\" class=\"mw-redirect\" title=\"False positive\">false positive</a> result. Digital <a href=\"/wiki/Rectal_examination\" title=\"Rectal examination\">rectal examination</a> (DRE) has been shown in several studies<sup id=\"cite_ref-pmid1372943_39-0\" class=\"reference\"><a href=\"#cite_note-pmid1372943-39\">&#91;39&#93;</a></sup> to produce an increase in PSA. However, the effect is clinically insignificant, since DRE causes the most substantial increases in patients with PSA levels already elevated over 4.0&#160;ng/mL.\n</p><p>The \"normal\" <a href=\"/wiki/Reference_range\" title=\"Reference range\">reference ranges</a> for prostate-specific antigen increase with age, as do the usual ranges in cancer:<sup id=\"cite_ref-40\" class=\"reference\"><a href=\"#cite_note-40\">&#91;40&#93;</a></sup>\n</p>\n<table class=\"wikitable\">\n<tbody><tr>\n<th>Age</th>\n<th colspan=\"2\">&lt;50</th>\n<th colspan=\"2\">50 - 59</th>\n<th colspan=\"2\">60 - 69</th>\n<th colspan=\"2\">&gt;70</th>\n<th>(years)\n</th></tr>\n<tr>\n<td></td>\n<td>Cancer</td>\n<td>No cancer</td>\n<td>Cancer</td>\n<td>No cancer</td>\n<td>Cancer</td>\n<td>No cancer</td>\n<td>Cancer</td>\n<td>No cancer</td>\n<td>\n</td></tr>\n<tr>\n<td>5th <a href=\"/wiki/Percentile\" title=\"Percentile\">percentile</a></td>\n<td>0.4</td>\n<td>0.3</td>\n<td>1.2</td>\n<td>0.3</td>\n<td>1.7</td>\n<td>0.3</td>\n<td>2.3</td>\n<td>0.4\n</td>\n<th rowspan=\"2\">(ng/mL)\n</th></tr>\n<tr>\n<td>95th percentile</td>\n<td>163.0</td>\n<td>2.5</td>\n<td>372.5</td>\n<td>4.7</td>\n<td>253.2</td>\n<td>8.3</td>\n<td>613.2</td>\n<td>17.8\n</td></tr></tbody></table>\n<h3><span class=\"mw-headline\" id=\"PSA_velocity\">PSA velocity</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prostate-specific_antigen&amp;action=edit&amp;section=12\" title=\"Edit section: PSA velocity\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Despite earlier findings,<sup id=\"cite_ref-41\" class=\"reference\"><a href=\"#cite_note-41\">&#91;41&#93;</a></sup> recent research suggests that the rate of increase of PSA (e.g. &gt;0.35&#160;ng/mL/yr, the 'PSA velocity'<sup id=\"cite_ref-42\" class=\"reference\"><a href=\"#cite_note-42\">&#91;42&#93;</a></sup>) is not a more specific marker for prostate cancer than the serum level of PSA.<sup id=\"cite_ref-43\" class=\"reference\"><a href=\"#cite_note-43\">&#91;43&#93;</a></sup>\n</p><p>However, the PSA rate of rise may have value in prostate cancer prognosis. Men with prostate cancer whose PSA level increased by more than 2.0&#160;ng per milliliter during the year before the diagnosis of prostate cancer have a higher risk of death from prostate cancer despite undergoing <a href=\"/wiki/Radical_retropubic_prostatectomy\" title=\"Radical retropubic prostatectomy\">radical prostatectomy</a>.<sup id=\"cite_ref-44\" class=\"reference\"><a href=\"#cite_note-44\">&#91;44&#93;</a></sup> PSA velocity (PSAV) was found in a 2008 study to be more useful than the PSA doubling time (PSA DT) to help identify those men with life-threatening disease before start of treatment.<sup id=\"cite_ref-45\" class=\"reference\"><a href=\"#cite_note-45\">&#91;45&#93;</a></sup>\n</p><p>Men who are known to be at risk for prostate cancer, and who decide to plot their PSA values as a function of time (i.e., years), may choose to use a <a href=\"/wiki/Semi-log_plot\" title=\"Semi-log plot\">semi-log plot</a>. An exponential growth in PSA values appears as a straight line<sup id=\"cite_ref-Semi-Log_46-0\" class=\"reference\"><a href=\"#cite_note-Semi-Log-46\">&#91;46&#93;</a></sup> on a semi-log plot, so that a new PSA value significantly above the straight line signals a <i>switch</i> to a new and significantly higher growth rate,<sup id=\"cite_ref-Semi-Log_46-1\" class=\"reference\"><a href=\"#cite_note-Semi-Log-46\">&#91;46&#93;</a></sup> i.e., a higher PSA velocity.\n</p>\n<h3><span class=\"mw-headline\" id=\"Free_PSA\">Free PSA</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prostate-specific_antigen&amp;action=edit&amp;section=13\" title=\"Edit section: Free PSA\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:302px;\"><a href=\"/wiki/File:Free_PSA_bar_graph.svg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/a1/Free_PSA_bar_graph.svg/300px-Free_PSA_bar_graph.svg.png\" width=\"300\" height=\"169\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/a1/Free_PSA_bar_graph.svg/450px-Free_PSA_bar_graph.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/a1/Free_PSA_bar_graph.svg/600px-Free_PSA_bar_graph.svg.png 2x\" data-file-width=\"567\" data-file-height=\"319\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Free_PSA_bar_graph.svg\" class=\"internal\" title=\"Enlarge\"></a></div>Risk of prostate cancer in two age groups based on <i>Free PSA</i> as&#160;% of Total PSA <sup id=\"cite_ref-47\" class=\"reference\"><a href=\"#cite_note-47\">&#91;47&#93;</a></sup></div></div></div>\n<p>Most PSA in the blood is bound to serum proteins. A small amount is not protein bound and is called 'free PSA'. In men with prostate cancer the ratio of free (unbound) PSA to total PSA is decreased. The risk of cancer increases if the free to total ratio is less than 25%. (See graph at right.) The lower the ratio is, the greater the probability of prostate cancer. Measuring the ratio of free to total PSA appears to be particularly promising for eliminating unnecessary <a href=\"/wiki/Biopsy\" title=\"Biopsy\">biopsies</a> in men with PSA levels between 4 and 10&#160;ng/mL.<sup id=\"cite_ref-48\" class=\"reference\"><a href=\"#cite_note-48\">&#91;48&#93;</a></sup> However, both total and free PSA increase immediately after ejaculation, returning slowly to baseline levels within 24 hours.<sup id=\"cite_ref-ejac_37-1\" class=\"reference\"><a href=\"#cite_note-ejac-37\">&#91;37&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Inactive_PSA\">Inactive PSA</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prostate-specific_antigen&amp;action=edit&amp;section=14\" title=\"Edit section: Inactive PSA\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The PSA test in 1994 failed to differentiate between prostate cancer and benign prostate hyperplasia (BPH) and the commercial assay kits for PSA did not provide correct PSA values.\n<sup id=\"cite_ref-Wu-1860080110_49-0\" class=\"reference\"><a href=\"#cite_note-Wu-1860080110-49\">&#91;49&#93;</a></sup> Thus with the introduction of the ratio of free to total PSA, the reliability of the test has improved and measuring the activity of the enzyme could add to the ratio of free to total PSA and further improve the diagnostic value of test.<sup id=\"cite_ref-50\" class=\"reference\"><a href=\"#cite_note-50\">&#91;50&#93;</a></sup> Proteolytically active PSA has been shown to have an anti-angiogenic effect <sup id=\"cite_ref-Mattsson-18386289_51-0\" class=\"reference\"><a href=\"#cite_note-Mattsson-18386289-51\">&#91;51&#93;</a></sup> and certain inactive subforms may be associated with prostate cancer, as shown by MAb 5D3D11, an antibody able to detect forms abundantly represented in sera from cancer patients.\n<sup id=\"cite_ref-Stura-22037582_52-0\" class=\"reference\"><a href=\"#cite_note-Stura-22037582-52\">&#91;52&#93;</a></sup>\nThe presence of inactive proenzyme forms of PSA is another potential indicator of disease.<sup id=\"cite_ref-Mikolajczyk-_53-0\" class=\"reference\"><a href=\"#cite_note-Mikolajczyk--53\">&#91;53&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Complexed_PSA\">Complexed PSA</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prostate-specific_antigen&amp;action=edit&amp;section=15\" title=\"Edit section: Complexed PSA\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>PSA exists in serum in the free (unbound) form and in a complex with <a href=\"/wiki/Alpha_1-antichymotrypsin\" title=\"Alpha 1-antichymotrypsin\">alpha 1-antichymotrypsin</a>; research has been conducted to see if measurements of complexed PSA are more specific and sensitive biomarkers for prostate cancer than other approaches.<sup id=\"cite_ref-Mikolajczyk_2002_54-0\" class=\"reference\"><a href=\"#cite_note-Mikolajczyk_2002-54\">&#91;54&#93;</a></sup><sup id=\"cite_ref-Naya_2004_55-0\" class=\"reference\"><a href=\"#cite_note-Naya_2004-55\">&#91;55&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"PSA_in_other_biologic_fluids_and_tissues\">PSA in other biologic fluids and tissues</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prostate-specific_antigen&amp;action=edit&amp;section=16\" title=\"Edit section: PSA in other biologic fluids and tissues\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<table class=\"wikitable\" style=\"margin: 2em auto 2em auto\" align=\"right\">\n<caption><b>Concentration of PSA in human body fluids</b>\n</caption>\n<tbody><tr>\n<th>Fluid</th>\n<th>PSA (ng/mL)\n</th></tr>\n<tr>\n<td>semen</td>\n<td><center>200,000 - 5.5 million</center>\n</td></tr>\n<tr>\n<td>amniotic fluid</td>\n<td><center>0.60 - 8.98</center>\n</td></tr>\n<tr>\n<td>breast milk</td>\n<td><center>0.47 - 100</center>\n</td></tr>\n<tr>\n<td>saliva</td>\n<td><center>0</center>\n</td></tr>\n<tr>\n<td>female urine</td>\n<td><center>0.12 - 3.72</center>\n</td></tr>\n<tr>\n<td>female serum</td>\n<td><center>0.01 - 0.53</center>\n</td></tr></tbody></table>\n<p>It is now clear that the term prostate-specific antigen is a <a href=\"/wiki/Misnomer\" title=\"Misnomer\">misnomer</a>: it is an <a href=\"/wiki/Antigen\" title=\"Antigen\">antigen</a> but is not specific to the prostate. Although present in large amounts in prostatic tissue and semen, it has been detected in other body fluids and tissues.<sup id=\"cite_ref-fluids_21-2\" class=\"reference\"><a href=\"#cite_note-fluids-21\">&#91;21&#93;</a></sup>\n</p><p>In women, PSA is found in <a href=\"/wiki/Female_ejaculation\" title=\"Female ejaculation\">female ejaculate</a> at concentrations roughly equal to that found in male semen.<sup id=\"cite_ref-wimpissinger_56-0\" class=\"reference\"><a href=\"#cite_note-wimpissinger-56\">&#91;56&#93;</a></sup> Other than semen and female ejaculate, the greatest concentrations of PSA in biological fluids are detected in breast milk and amniotic fluid. Low concentrations of PSA have been identified in the urethral glands, endometrium, normal breast tissue and salivary gland tissue. PSA also is found in the serum of women with breast, lung, or uterine cancer and in some patients with renal cancer.<sup id=\"cite_ref-57\" class=\"reference\"><a href=\"#cite_note-57\">&#91;57&#93;</a></sup>\n</p><p>Tissue samples can be stained for the presence of PSA in order to determine the origin of malignant cells that have metastasized.<sup id=\"cite_ref-pmid17667550_58-0\" class=\"reference\"><a href=\"#cite_note-pmid17667550-58\">&#91;58&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Interactions\">Interactions</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prostate-specific_antigen&amp;action=edit&amp;section=17\" title=\"Edit section: Interactions\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Prostate-specific antigen has been shown to <a href=\"/wiki/Protein-protein_interaction\" class=\"mw-redirect\" title=\"Protein-protein interaction\">interact</a> with <a href=\"/wiki/Protein_C_inhibitor\" title=\"Protein C inhibitor\">protein C inhibitor</a>.<sup id=\"cite_ref-pmid7509746_59-0\" class=\"reference\"><a href=\"#cite_note-pmid7509746-59\">&#91;59&#93;</a></sup><sup id=\"cite_ref-pmid8665956_60-0\" class=\"reference\"><a href=\"#cite_note-pmid8665956-60\">&#91;60&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prostate-specific_antigen&amp;action=edit&amp;section=18\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/Tumor_markers\" class=\"mw-redirect\" title=\"Tumor markers\">Tumor markers</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prostate-specific_antigen&amp;action=edit&amp;section=19\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist columns references-column-width\" style=\"-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;\">\n<ol class=\"references\">\n<li id=\"cite_note-refGRCh38Ensembl-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-refGRCh38Ensembl_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-refGRCh38Ensembl_1-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-refGRCh38Ensembl_1-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://May2017.archive.ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=ENSG00000142515\">GRCh38: Ensembl release 89: ENSG00000142515</a> - <a href=\"/wiki/Ensembl_genome_database_project\" title=\"Ensembl genome database project\">Ensembl</a>, May 2017</span>\n</li>\n<li id=\"cite_note-refGRCm38Ensembl-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-refGRCm38Ensembl_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-refGRCm38Ensembl_2-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-refGRCm38Ensembl_2-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://May2017.archive.ensembl.org/Mus_musculus/Gene/Summary?db=core;g=ENSMUSG00000066513\">GRCm38: Ensembl release 89: ENSMUSG00000066513</a> - <a href=\"/wiki/Ensembl_genome_database_project\" title=\"Ensembl genome database project\">Ensembl</a>, May 2017</span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&amp;cmd=Link&amp;LinkName=gene_pubmed&amp;from_uid=354\">\"Human PubMed Reference:\"</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Human+PubMed+Reference%3A&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fsites%2Fentrez%3Fdb%3Dgene%26cmd%3DLink%26LinkName%3Dgene_pubmed%26from_uid%3D354&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&amp;cmd=Link&amp;LinkName=gene_pubmed&amp;from_uid=18048\">\"Mouse PubMed Reference:\"</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Mouse+PubMed+Reference%3A&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fsites%2Fentrez%3Fdb%3Dgene%26cmd%3DLink%26LinkName%3Dgene_pubmed%26from_uid%3D18048&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid12525533-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid12525533_5-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Balk SP, Ko YJ, Bubley GJ (Jan 2003). \"Biology of prostate-specific antigen\". <i>Journal of Clinical Oncology</i>. <b>21</b> (2): 383\u201391. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1200/JCO.2003.02.083\">10.1200/JCO.2003.02.083</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12525533\">12525533</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Clinical+Oncology&amp;rft.atitle=Biology+of+prostate-specific+antigen&amp;rft.volume=21&amp;rft.issue=2&amp;rft.pages=383-91&amp;rft.date=2003-01&amp;rft_id=info%3Adoi%2F10.1200%2FJCO.2003.02.083&amp;rft_id=info%3Apmid%2F12525533&amp;rft.aulast=Balk&amp;rft.aufirst=SP&amp;rft.au=Ko%2C+YJ&amp;rft.au=Bubley%2C+GJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Hellstrom WJG, ed. (1999). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.andrologysociety.com/resources/handbook/ch.8.asp\">\"Chapter 8: What is the prostate and what is its function?\"</a>. <i>American Society of Andrology Handbook</i>. San Francisco: American Society of Andrology. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/1-891276-02-6\" title=\"Special:BookSources/1-891276-02-6\">1-891276-02-6</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Chapter+8%3A+What+is+the+prostate+and+what+is+its+function%3F&amp;rft.btitle=American+Society+of+Andrology+Handbook&amp;rft.place=San+Francisco&amp;rft.pub=American+Society+of+Andrology&amp;rft.date=1999&amp;rft.isbn=1-891276-02-6&amp;rft_id=http%3A%2F%2Fwww.andrologysociety.com%2Fresources%2Fhandbook%2Fch.8.asp&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><sup class=\"noprint Inline-Template\"><span style=\"white-space: nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Link_rot\" title=\"Wikipedia:Link rot\"><span title=\"&#160;Dead link since December 2016\">dead link</span></a></i>&#93;</span></sup></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, deKernion JB, Ratliff TL, Kavoussi LR, Dalkin BL (May 1994). \"Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men\". <i>The Journal of Urology</i>. <b>151</b> (5): 1283\u201390. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/7512659\">7512659</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Urology&amp;rft.atitle=Comparison+of+digital+rectal+examination+and+serum+prostate+specific+antigen+in+the+early+detection+of+prostate+cancer%3A+results+of+a+multicenter+clinical+trial+of+6%2C630+men&amp;rft.volume=151&amp;rft.issue=5&amp;rft.pages=1283-90&amp;rft.date=1994-05&amp;rft_id=info%3Apmid%2F7512659&amp;rft.aulast=Catalona&amp;rft.aufirst=WJ&amp;rft.au=Richie%2C+JP&amp;rft.au=Ahmann%2C+FR&amp;rft.au=Hudson%2C+MA&amp;rft.au=Scardino%2C+PT&amp;rft.au=Flanigan%2C+RC&amp;rft.au=deKernion%2C+JB&amp;rft.au=Ratliff%2C+TL&amp;rft.au=Kavoussi%2C+LR&amp;rft.au=Dalkin%2C+BL&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid23708103-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid23708103_8-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Velonas VM, Woo HH, dos Remedios CG, Assinder SJ (2013). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3709717\">\"Current status of biomarkers for prostate cancer\"</a>. <i>International Journal of Molecular Sciences</i>. <b>14</b> (6): 11034\u201360. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3390/ijms140611034\">10.3390/ijms140611034</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3709717\">3709717</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23708103\">23708103</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Journal+of+Molecular+Sciences&amp;rft.atitle=Current+status+of+biomarkers+for+prostate+cancer&amp;rft.volume=14&amp;rft.issue=6&amp;rft.pages=11034-60&amp;rft.date=2013&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3709717&amp;rft_id=info%3Apmid%2F23708103&amp;rft_id=info%3Adoi%2F10.3390%2Fijms140611034&amp;rft.aulast=Velonas&amp;rft.aufirst=VM&amp;rft.au=Woo%2C+HH&amp;rft.au=dos+Remedios%2C+CG&amp;rft.au=Assinder%2C+SJ&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3709717&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Gomella2011-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Gomella2011_9-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Gomella LG, Liu XS, Trabulsi EJ, Kelly WK, Myers R, Showalter T, Dicker A, Wender R (Oct 2011). \"Screening for prostate cancer: the current evidence and guidelines controversy\". <i>The Canadian Journal of Urology</i>. <b>18</b> (5): 5875\u201383. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22018148\">22018148</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Canadian+Journal+of+Urology&amp;rft.atitle=Screening+for+prostate+cancer%3A+the+current+evidence+and+guidelines+controversy&amp;rft.volume=18&amp;rft.issue=5&amp;rft.pages=5875-83&amp;rft.date=2011-10&amp;rft_id=info%3Apmid%2F22018148&amp;rft.aulast=Gomella&amp;rft.aufirst=LG&amp;rft.au=Liu%2C+XS&amp;rft.au=Trabulsi%2C+EJ&amp;rft.au=Kelly%2C+WK&amp;rft.au=Myers%2C+R&amp;rft.au=Showalter%2C+T&amp;rft.au=Dicker%2C+A&amp;rft.au=Wender%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-10\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.nhs.uk/livewell/prostatehealth/pages/psa-test.aspx\">\"Should I have a PSA test?\"</a>, NHS Choices, 27 February 2018</span>\n</li>\n<li id=\"cite_note-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-11\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.nhs.uk/Conditions/Cancer-of-the-prostate/Pages/Prevention.aspx\">\"Prostate cancer - PSA testing - NHS Choices\"</a>. NHS Choices. 3 January 2015.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Prostate+cancer+-+PSA+testing+-+NHS+Choices&amp;rft.pub=NHS+Choices&amp;rft.date=2015-01-03&amp;rft_id=http%3A%2F%2Fwww.nhs.uk%2FConditions%2FCancer-of-the-prostate%2FPages%2FPrevention.aspx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-urlwww.uspreventiveservicestaskforce.org-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-urlwww.uspreventiveservicestaskforce.org_12-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.uspreventiveservicestaskforce.org/prostatecancerscreening/prostatecancerscript.pdf\">\"Talking With Your Patients About Screening for Prostate Cancer\"</a> <span style=\"font-size:85%;\">(PDF)</span><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2012-07-02</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Talking+With+Your+Patients+About+Screening+for+Prostate+Cancer&amp;rft_id=http%3A%2F%2Fwww.uspreventiveservicestaskforce.org%2Fprostatecancerscreening%2Fprostatecancerscript.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid9749478-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid9749478_13-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA,  et al. (1998). \"Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer\". <i>JAMA</i>. <b>280</b> (11): 969\u201374. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/jama.280.11.969\">10.1001/jama.280.11.969</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9749478\">9749478</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Biochemical+outcome+after+radical+prostatectomy%2C+external+beam+radiation+therapy%2C+or+interstitial+radiation+therapy+for+clinically+localized+prostate+cancer&amp;rft.volume=280&amp;rft.issue=11&amp;rft.pages=969-74&amp;rft.date=1998&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.280.11.969&amp;rft_id=info%3Apmid%2F9749478&amp;rft.aulast=D%27Amico&amp;rft.aufirst=AV&amp;rft.au=Whittington%2C+R&amp;rft.au=Malkowicz%2C+SB&amp;rft.au=Schultz%2C+D&amp;rft.au=Blank%2C+K&amp;rft.au=Broderick%2C+GA&amp;rft.au=Tomaszewski%2C+JE&amp;rft.au=Renshaw%2C+AA&amp;rft.au=Kaplan%2C+I&amp;rft.au=Beard%2C+CJ&amp;rft.au=Wein%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-14\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Rodrigues G, Warde P, Pickles T, Crook J, Brundage M, Souhami L, Lukka H (April 2012). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3328553\">\"Pre-treatment risk stratification of prostate cancer patients: A critical review\"</a>. <i>Canadian Urological Association Journal</i>. <b>6</b> (2): 121\u20137. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.5489/cuaj.11085\">10.5489/cuaj.11085</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3328553\">3328553</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22511420\">22511420</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Canadian+Urological+Association+Journal&amp;rft.atitle=Pre-treatment+risk+stratification+of+prostate+cancer+patients%3A+A+critical+review&amp;rft.volume=6&amp;rft.issue=2&amp;rft.pages=121-7&amp;rft.date=2012-04&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3328553&amp;rft_id=info%3Apmid%2F22511420&amp;rft_id=info%3Adoi%2F10.5489%2Fcuaj.11085&amp;rft.aulast=Rodrigues&amp;rft.aufirst=G&amp;rft.au=Warde%2C+P&amp;rft.au=Pickles%2C+T&amp;rft.au=Crook%2C+J&amp;rft.au=Brundage%2C+M&amp;rft.au=Souhami%2C+L&amp;rft.au=Lukka%2C+H&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3328553&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><sup class=\"noprint Inline-Template\"><span style=\"white-space: nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Link_rot\" title=\"Wikipedia:Link rot\"><span title=\"&#160;Dead link since November 2016\">dead link</span></a></i>&#93;</span></sup></span>\n</li>\n<li id=\"cite_note-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-15\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Sperling D. <a rel=\"nofollow\" class=\"external text\" href=\"http://sperlingprostatecenter.com/mpmri-improves-the-accuracy-of-the-partin-tables-and-other-nomograms/\">\"mpMRI improves the accuracy of the Partin tables and other nomograms\"</a>. <i>Sperling Prostate Center</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">31 March</span> 2016</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Sperling+Prostate+Center&amp;rft.atitle=mpMRI+improves+the+accuracy+of+the+Partin+tables+and+other+nomograms&amp;rft.aulast=Sperling&amp;rft.aufirst=Dan&amp;rft_id=http%3A%2F%2Fsperlingprostatecenter.com%2Fmpmri-improves-the-accuracy-of-the-partin-tables-and-other-nomograms%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-16\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Freedland SJ, Sutter ME, Dorey F, Aronson WJ (Feb 2003). \"Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy. Prostate-specific antigen\". <i>Urology</i>. <b>61</b> (2): 365\u20139. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/s0090-4295%2802%2902268-9\">10.1016/s0090-4295(02)02268-9</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12597949\">12597949</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Urology&amp;rft.atitle=Defining+the+ideal+cutpoint+for+determining+PSA+recurrence+after+radical+prostatectomy.+Prostate-specific+antigen&amp;rft.volume=61&amp;rft.issue=2&amp;rft.pages=365-9&amp;rft.date=2003-02&amp;rft_id=info%3Adoi%2F10.1016%2Fs0090-4295%2802%2902268-9&amp;rft_id=info%3Apmid%2F12597949&amp;rft.aulast=Freedland&amp;rft.aufirst=SJ&amp;rft.au=Sutter%2C+ME&amp;rft.au=Dorey%2C+F&amp;rft.au=Aronson%2C+WJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Leong-17\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Leong_17-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Leong_17-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation book\">Leong, Anthony S-Y, Cooper, Kumarason, Leong, F Joel W-M (2003). <i>Manual of Diagnostic Cytology</i> (2nd ed.). Greenwich Medical Media, Ltd. pp.&#160;79\u201380. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/1-84110-100-1\" title=\"Special:BookSources/1-84110-100-1\">1-84110-100-1</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Manual+of+Diagnostic+Cytology&amp;rft.pages=79-80&amp;rft.edition=2nd&amp;rft.pub=Greenwich+Medical+Media%2C+Ltd.&amp;rft.date=2003&amp;rft.isbn=1-84110-100-1&amp;rft.au=Leong%2C+Anthony+S-Y&amp;rft.au=Cooper%2C+Kumarason&amp;rft.au=Leong%2C+F+Joel+W-M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-18\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hara M, Inorre T, Fukuyama T (1971). \"Some physicochemical characteristics of gamma-seminoprotein, an antigenic component specific for human seminal plasma\". <i>Jpn J Legal Med</i>. <b>25</b>: 322\u2013324.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Jpn+J+Legal+Med.&amp;rft.atitle=Some+physicochemical+characteristics+of+gamma-seminoprotein%2C+an+antigenic+component+specific+for+human+seminal+plasma&amp;rft.volume=25&amp;rft.pages=322-324&amp;rft.date=1971&amp;rft.aulast=Hara&amp;rft.aufirst=M&amp;rft.au=Inorre%2C+T&amp;rft.au=Fukuyama%2C+T&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-19\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Gartside BO, Brewer KJ, Strong CL (April 2003). <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20080409190231/http://www.fbi.gov/hq/lab/fsc/backissu/april2003/gartside.htm\">\"Estimation of Prostate-Specific Antigen (PSA) Extraction Efficiency from Forensic Samples Using the Seratec\u00e2 PSA Semiquant Semiquantitative Membrane Test\"</a>. <i>Forensic Science Communications</i>. <b>5</b> (2). Archived from <a rel=\"nofollow\" class=\"external text\" href=\"https://www.fbi.gov/hq/lab/fsc/backissu/april2003/gartside.htm\">the original</a> on 2008-04-09<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2008-05-11</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Forensic+Science+Communications&amp;rft.atitle=Estimation+of+Prostate-Specific+Antigen+%28PSA%29+Extraction+Efficiency+from+Forensic+Samples+Using+the+Seratec%C3%A2+PSA+Semiquant+Semiquantitative+Membrane+Test&amp;rft.volume=5&amp;rft.issue=2&amp;rft.date=2003-04&amp;rft.aulast=Gartside&amp;rft.aufirst=Bill+O.&amp;rft.au=Brewer%2C+Kevin+J.&amp;rft.au=Strong%2C+Carmella+L.&amp;rft_id=https%3A%2F%2Fwww.fbi.gov%2Fhq%2Flab%2Ffsc%2Fbackissu%2Fapril2003%2Fgartside.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-aspermic-20\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-aspermic_20-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hochmeister MN, Budowle B, Rudin O, Gehrig C, Borer U, Thali M, Dirnhofer R (Sep 1999). \"Evaluation of prostate-specific antigen (PSA) membrane test assays for the forensic identification of seminal fluid\". <i>Journal of Forensic Sciences</i>. Eighth International Symposium on Human Identification. <b>44</b> (5): 1057\u201360. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10486959\">10486959</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Forensic+Sciences&amp;rft.atitle=Evaluation+of+prostate-specific+antigen+%28PSA%29+membrane+test+assays+for+the+forensic+identification+of+seminal+fluid&amp;rft.volume=44&amp;rft.issue=5&amp;rft.pages=1057-60&amp;rft.date=1999-09&amp;rft_id=info%3Apmid%2F10486959&amp;rft.aulast=Hochmeister&amp;rft.aufirst=MN&amp;rft.au=Budowle%2C+B&amp;rft.au=Rudin%2C+O&amp;rft.au=Gehrig%2C+C&amp;rft.au=Borer%2C+U&amp;rft.au=Thali%2C+M&amp;rft.au=Dirnhofer%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-fluids-21\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-fluids_21-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-fluids_21-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-fluids_21-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Laux DL, Custis SE. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20050827025155/http://mafs.net/pdf/forensicdetectionsemen3.pdf\">\"Forensic Detection of Semen III.  Detection of PSA Using Membrane Based Tests: Sensitivity Issues with Regards to the Presence of PSA in Other Body Fluids\"</a> <span style=\"font-size:85%;\">(PDF)</span>. Midwestern Association of Forensic Scientists. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://mafs.net/pdf/forensicdetectionsemen3.pdf\">the original</a> <span style=\"font-size:85%;\">(<a href=\"/wiki/PDF\" title=\"PDF\">PDF</a>)</span> on 2005-08-27<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2008-05-11</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Forensic+Detection+of+Semen+III.++Detection+of+PSA+Using+Membrane+Based+Tests%3A+Sensitivity+Issues+with+Regards+to+the+Presence+of+PSA+in+Other+Body+Fluids&amp;rft.aulast=Laux&amp;rft.aufirst=DL&amp;rft.au=Custis%2C+SE&amp;rft_id=http%3A%2F%2Fmafs.net%2Fpdf%2Fforensicdetectionsemen3.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-22\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-22\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hochmeister MN, Budowle B, Rudin O, Gehrig C, Borer U, Thali M, Dirnhofer R (Sep 1999). <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20041024194221/http://journalsip.astm.org/jofs/PAGES/3097.htm\">\"Evaluation of prostate-specific antigen (PSA) membrane test assays for the forensic identification of seminal fluid\"</a>. <i>Journal of Forensic Sciences</i>. <b>44</b> (5): 1057\u201360. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10486959\">10486959</a>. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://journalsip.astm.org/jofs/PAGES/3097.htm\">the original</a> on 2004-10-24.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Forensic+Sciences&amp;rft.atitle=Evaluation+of+prostate-specific+antigen+%28PSA%29+membrane+test+assays+for+the+forensic+identification+of+seminal+fluid&amp;rft.volume=44&amp;rft.issue=5&amp;rft.pages=1057-60&amp;rft.date=1999-09&amp;rft_id=info%3Apmid%2F10486959&amp;rft.aulast=Hochmeister&amp;rft.aufirst=MN&amp;rft.au=Budowle%2C+B&amp;rft.au=Rudin%2C+O&amp;rft.au=Gehrig%2C+C&amp;rft.au=Borer%2C+U&amp;rft.au=Thali%2C+M&amp;rft.au=Dirnhofer%2C+R&amp;rft_id=http%3A%2F%2Fjournalsip.astm.org%2Fjofs%2FPAGES%2F3097.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid14607215-23\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid14607215_23-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Lilja H (Nov 2003). \"Biology of prostate-specific antigen\". <i>Urology</i>. <b>62</b> (5 Suppl 1): 27\u201333. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0090-4295%2803%2900775-1\">10.1016/S0090-4295(03)00775-1</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/14607215\">14607215</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Urology&amp;rft.atitle=Biology+of+prostate-specific+antigen&amp;rft.volume=62&amp;rft.issue=5+Suppl+1&amp;rft.pages=27-33&amp;rft.date=2003-11&amp;rft_id=info%3Adoi%2F10.1016%2FS0090-4295%2803%2900775-1&amp;rft_id=info%3Apmid%2F14607215&amp;rft.aulast=Lilja&amp;rft.aufirst=H&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid17760888-24\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid17760888_24-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Rao AR, Motiwala HG, Karim OM (Jan 2008). \"The discovery of prostate-specific antigen\". <i>BJU International</i>. <b>101</b> (1): 5\u201310. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1464-410X.2007.07138.x\">10.1111/j.1464-410X.2007.07138.x</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17760888\">17760888</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BJU+International&amp;rft.atitle=The+discovery+of+prostate-specific+antigen&amp;rft.volume=101&amp;rft.issue=1&amp;rft.pages=5-10&amp;rft.date=2008-01&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1464-410X.2007.07138.x&amp;rft_id=info%3Apmid%2F17760888&amp;rft.aulast=Rao&amp;rft.aufirst=AR&amp;rft.au=Motiwala%2C+HG&amp;rft.au=Karim%2C+OM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid4629646-25\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid4629646_25-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Flocks RH, Boatman DL, Hawtrey CE (Nov 1972). \"Tissue specific isoantigens in the dog prostate\". <i>Investigative Urology</i>. <b>10</b> (3): 215\u201320. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/4629646\">4629646</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Investigative+Urology&amp;rft.atitle=Tissue+specific+isoantigens+in+the+dog+prostate&amp;rft.volume=10&amp;rft.issue=3&amp;rft.pages=215-20&amp;rft.date=1972-11&amp;rft_id=info%3Apmid%2F4629646&amp;rft.aulast=Flocks&amp;rft.aufirst=RH&amp;rft.au=Boatman%2C+DL&amp;rft.au=Hawtrey%2C+CE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid4977978-26\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid4977978_26-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ablin RJ, Soanes WA, Gonder MJ (Jul 1969). \"Immunologic studies of the prostate. A review\". <i>International Surgery</i>. <b>52</b> (1): 8\u201321. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/4977978\">4977978</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Surgery&amp;rft.atitle=Immunologic+studies+of+the+prostate.+A+review&amp;rft.volume=52&amp;rft.issue=1&amp;rft.pages=8-21&amp;rft.date=1969-07&amp;rft_id=info%3Apmid%2F4977978&amp;rft.aulast=Ablin&amp;rft.aufirst=RJ&amp;rft.au=Soanes%2C+WA&amp;rft.au=Gonder%2C+MJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid4631694-27\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid4631694_27-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Li TS, Beling CG (Feb 1973). \"Isolation and characterization of two specific antigens of human seminal plasma\". <i>Fertility and Sterility</i>. <b>24</b> (2): 134\u201344. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/4631694\">4631694</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Fertility+and+Sterility&amp;rft.atitle=Isolation+and+characterization+of+two+specific+antigens+of+human+seminal+plasma&amp;rft.volume=24&amp;rft.issue=2&amp;rft.pages=134-44&amp;rft.date=1973-02&amp;rft_id=info%3Apmid%2F4631694&amp;rft.aulast=Li&amp;rft.aufirst=TS&amp;rft.au=Beling%2C+CG&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid4213812-28\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid4213812_28-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Li TS, Beling CG (Oct 1974). \"The effect of antibodies to two human seminal plasma-specific antigens on human sperm\". <i>Fertility and Sterility</i>. <b>25</b> (10): 851\u20136. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/4213812\">4213812</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Fertility+and+Sterility&amp;rft.atitle=The+effect+of+antibodies+to+two+human+seminal+plasma-specific+antigens+on+human+sperm&amp;rft.volume=25&amp;rft.issue=10&amp;rft.pages=851-6&amp;rft.date=1974-10&amp;rft_id=info%3Apmid%2F4213812&amp;rft.aulast=Li&amp;rft.aufirst=TS&amp;rft.au=Beling%2C+CG&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid744956-29\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid744956_29-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sensabaugh GF (Jan 1978). \"Isolation and characterization of a semen-specific protein from human seminal plasma: a potential new marker for semen identification\". <i>Journal of Forensic Sciences</i>. <b>23</b> (1): 106\u201315. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/744956\">744956</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Forensic+Sciences&amp;rft.atitle=Isolation+and+characterization+of+a+semen-specific+protein+from+human+seminal+plasma%3A+a+potential+new+marker+for+semen+identification&amp;rft.volume=23&amp;rft.issue=1&amp;rft.pages=106-15&amp;rft.date=1978-01&amp;rft_id=info%3Apmid%2F744956&amp;rft.aulast=Sensabaugh&amp;rft.aufirst=GF&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid89106-30\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid89106_30-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wang MC, Valenzuela LA, Murphy GP, Chu TM (Sep 1979). \"Purification of a human prostate specific antigen\". <i>Investigative Urology</i>. <b>17</b> (2): 159\u201363. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/89106\">89106</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Investigative+Urology&amp;rft.atitle=Purification+of+a+human+prostate+specific+antigen&amp;rft.volume=17&amp;rft.issue=2&amp;rft.pages=159-63&amp;rft.date=1979-09&amp;rft_id=info%3Apmid%2F89106&amp;rft.aulast=Wang&amp;rft.aufirst=MC&amp;rft.au=Valenzuela%2C+LA&amp;rft.au=Murphy%2C+GP&amp;rft.au=Chu%2C+TM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-31\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-31\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kuriyama M, Wang MC, Papsidero LD, Killian CS, Shimano T, Valenzuela L, Nishiura T, Murphy GP, Chu TM (Dec 1980). \"Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay\". <i>Cancer Research</i>. <b>40</b> (12): 4658\u201362. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/6159971\">6159971</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Research&amp;rft.atitle=Quantitation+of+prostate-specific+antigen+in+serum+by+a+sensitive+enzyme+immunoassay&amp;rft.volume=40&amp;rft.issue=12&amp;rft.pages=4658-62&amp;rft.date=1980-12&amp;rft_id=info%3Apmid%2F6159971&amp;rft.aulast=Kuriyama&amp;rft.aufirst=M&amp;rft.au=Wang%2C+MC&amp;rft.au=Papsidero%2C+LD&amp;rft.au=Killian%2C+CS&amp;rft.au=Shimano%2C+T&amp;rft.au=Valenzuela%2C+L&amp;rft.au=Nishiura%2C+T&amp;rft.au=Murphy%2C+GP&amp;rft.au=Chu%2C+TM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Kolota_2004-32\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Kolota_2004_32-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Gina K (May 30, 2004). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/2004/05/30/weekinreview/it-was-medical-gospel-but-it-wasn-t-true.html\">\"It Was Medical Gospel, but It Wasn't True\"</a>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>. p.&#160;47.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=It+Was+Medical+Gospel%2C+but+It+Wasn%27t+True&amp;rft.pages=47&amp;rft.date=2004-05-30&amp;rft.aulast=Gina&amp;rft.aufirst=Kolota&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2004%2F05%2F30%2Fweekinreview%2Fit-was-medical-gospel-but-it-wasn-t-true.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><br />\n<ul><li><cite class=\"citation journal\">Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL, Minasian LM, Ford LG, Lippman SM, Crawford ED, Crowley JJ, Coltman CA (May 2004). \"Prevalence of prostate cancer among men with a prostate-specific antigen level &lt; or =4.0 ng per milliliter\". <i>The New England Journal of Medicine</i>. <b>350</b> (22): 2239\u201346. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1056/NEJMoa031918\">10.1056/NEJMoa031918</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15163773\">15163773</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.atitle=Prevalence+of+prostate+cancer+among+men+with+a+prostate-specific+antigen+level+%3C+or+%3D4.0+ng+per+milliliter&amp;rft.volume=350&amp;rft.issue=22&amp;rft.pages=2239-46&amp;rft.date=2004-05&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa031918&amp;rft_id=info%3Apmid%2F15163773&amp;rft.aulast=Thompson&amp;rft.aufirst=IM&amp;rft.au=Pauler%2C+DK&amp;rft.au=Goodman%2C+PJ&amp;rft.au=Tangen%2C+CM&amp;rft.au=Lucia%2C+MS&amp;rft.au=Parnes%2C+HL&amp;rft.au=Minasian%2C+LM&amp;rft.au=Ford%2C+LG&amp;rft.au=Lippman%2C+SM&amp;rft.au=Crawford%2C+ED&amp;rft.au=Crowley%2C+JJ&amp;rft.au=Coltman%2C+CA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><cite class=\"citation journal\">Carter HB (May 2004). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3474980\">\"Prostate cancers in men with low PSA levels--must we find them?\"</a>. <i>The New England Journal of Medicine</i>. <b>350</b> (22): 2292\u20134. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1056/NEJMe048003\">10.1056/NEJMe048003</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3474980\">3474980</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15163780\">15163780</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.atitle=Prostate+cancers+in+men+with+low+PSA+levels--must+we+find+them%3F&amp;rft.volume=350&amp;rft.issue=22&amp;rft.pages=2292-4&amp;rft.date=2004-05&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3474980&amp;rft_id=info%3Apmid%2F15163780&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMe048003&amp;rft.aulast=Carter&amp;rft.aufirst=HB&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3474980&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><cite class=\"citation book\">Myrtle JF, Klimley PG, Ivor L, Bruni JF (1986). \"Clinical utility of prostate specific antigen (PSA) in the management of prostate cancer\". <i>Advances in Cancer Diagnostics</i>. San Diego: Hybritech Inc.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Clinical+utility+of+prostate+specific+antigen+%28PSA%29+in+the+management+of+prostate+cancer&amp;rft.btitle=Advances+in+Cancer+Diagnostics&amp;rft.place=San+Diego&amp;rft.pub=Hybritech+Inc&amp;rft.date=1986&amp;rft.aulast=Myrtle&amp;rft.aufirst=JF&amp;rft.au=Klimley%2C+PG&amp;rft.au=Ivor%2C+L&amp;rft.au=Bruni%2C+JF&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><cite class=\"citation book\">Mytrle JF, Ivor L (1989). \"Measurement of Prostate-Specific Antigen (PSA) in Serum by a Two-Site Immunometric Method (Hybritech Tandem-R/Tandem-E PSA)\".  In Catalona WJ, Coffey DS, Karr JP (eds.). <i>Clinical Aspects of Prostate Cancer. Assessment of New Diagnostic and Management Procedures. Proceedings of a workshop of the Prostate Cancer Working Group of the National Cancer Institute's Organ Systems Program, held October 16\u201319, 1988 at Prout's Neck, Maine, U.S.A</i>. New York: Elsevier. pp.&#160;161\u201371. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/0-444-01514-0\" title=\"Special:BookSources/0-444-01514-0\">0-444-01514-0</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Measurement+of+Prostate-Specific+Antigen+%28PSA%29+in+Serum+by+a+Two-Site+Immunometric+Method+%28Hybritech+Tandem-R%2FTandem-E+PSA%29&amp;rft.btitle=Clinical+Aspects+of+Prostate+Cancer.+Assessment+of+New+Diagnostic+and+Management+Procedures.+Proceedings+of+a+workshop+of+the+Prostate+Cancer+Working+Group+of+the+National+Cancer+Institute%27s+Organ+Systems+Program%2C+held+October+16%E2%80%9319%2C+1988+at+Prout%27s+Neck%2C+Maine%2C+U.S.A.&amp;rft.place=New+York&amp;rft.pages=161-71&amp;rft.pub=Elsevier&amp;rft.date=1989&amp;rft.isbn=0-444-01514-0&amp;rft.aulast=Mytrle&amp;rft.aufirst=JF&amp;rft.au=Ivor%2C+L&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><span class=\"citation-comment\" style=\"display:none; color:#33aa33; margin-left:0.3em\">CS1 maint: Uses editors parameter (<a href=\"/wiki/Category:CS1_maint:_Uses_editors_parameter\" title=\"Category:CS1 maint: Uses editors parameter\">link</a>) </span></li>\n<li><cite class=\"citation book\">Mytrle JF (1989). \"Normal Levels of Prostate-Specific Antigen (PSA)\".  In Catalona WJ, Coffey DS, Karr JP (eds.). <i>Clinical Aspects of Prostate Cancer. Assessment of New Diagnostic and Management Procedures. Proceedings of a workshop of the Prostate Cancer Working Group of the National Cancer Institute's Organ Systems Program, held October 16\u201319, 1988 at Prout's Neck, Maine, U.S.A</i>. New York: Elsevier. pp.&#160;183\u20139. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/0-444-01514-0\" title=\"Special:BookSources/0-444-01514-0\">0-444-01514-0</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Normal+Levels+of+Prostate-Specific+Antigen+%28PSA%29&amp;rft.btitle=Clinical+Aspects+of+Prostate+Cancer.+Assessment+of+New+Diagnostic+and+Management+Procedures.+Proceedings+of+a+workshop+of+the+Prostate+Cancer+Working+Group+of+the+National+Cancer+Institute%27s+Organ+Systems+Program%2C+held+October+16%E2%80%9319%2C+1988+at+Prout%27s+Neck%2C+Maine%2C+U.S.A.&amp;rft.place=New+York&amp;rft.pages=183-9&amp;rft.pub=Elsevier&amp;rft.date=1989&amp;rft.isbn=0-444-01514-0&amp;rft.au=Mytrle+JF&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><span class=\"citation-comment\" style=\"display:none; color:#33aa33; margin-left:0.3em\">CS1 maint: Uses editors parameter (<a href=\"/wiki/Category:CS1_maint:_Uses_editors_parameter\" title=\"Category:CS1 maint: Uses editors parameter\">link</a>) </span></li>\n<li><cite class=\"citation journal\">Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, Petros JA, Andriole GL (Apr 1991). \"Measurement of prostate-specific antigen in serum as a screening test for prostate cancer\". <i>The New England Journal of Medicine</i>. <b>324</b> (17): 1156\u201361. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1056/NEJM199104253241702\">10.1056/NEJM199104253241702</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/1707140\">1707140</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.atitle=Measurement+of+prostate-specific+antigen+in+serum+as+a+screening+test+for+prostate+cancer&amp;rft.volume=324&amp;rft.issue=17&amp;rft.pages=1156-61&amp;rft.date=1991-04&amp;rft_id=info%3Adoi%2F10.1056%2FNEJM199104253241702&amp;rft_id=info%3Apmid%2F1707140&amp;rft.aulast=Catalona&amp;rft.aufirst=WJ&amp;rft.au=Smith%2C+DS&amp;rft.au=Ratliff%2C+TL&amp;rft.au=Dodds%2C+KM&amp;rft.au=Coplen%2C+DE&amp;rft.au=Yuan%2C+JJ&amp;rft.au=Petros%2C+JA&amp;rft.au=Andriole%2C+GL&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><cite class=\"citation journal\">Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, deKernion JB, Ratliff TL, Kavoussi LR, Dalkin BL (May 1994). \"Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men\". <i>The Journal of Urology</i>. <b>151</b> (5): 1283\u201390. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/7512659\">7512659</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Urology&amp;rft.atitle=Comparison+of+digital+rectal+examination+and+serum+prostate+specific+antigen+in+the+early+detection+of+prostate+cancer%3A+results+of+a+multicenter+clinical+trial+of+6%2C630+men&amp;rft.volume=151&amp;rft.issue=5&amp;rft.pages=1283-90&amp;rft.date=1994-05&amp;rft_id=info%3Apmid%2F7512659&amp;rft.aulast=Catalona&amp;rft.aufirst=WJ&amp;rft.au=Richie%2C+JP&amp;rft.au=Ahmann%2C+FR&amp;rft.au=Hudson%2C+MA&amp;rft.au=Scardino%2C+PT&amp;rft.au=Flanigan%2C+RC&amp;rft.au=deKernion%2C+JB&amp;rft.au=Ratliff%2C+TL&amp;rft.au=Kavoussi%2C+LR&amp;rft.au=Dalkin%2C+BL&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li></ul>\n</span></li>\n<li id=\"cite_note-33\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-33\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL, Minasian LM, Ford LG, Lippman SM, Crawford ED, Crowley JJ, Coltman CA (May 2004). \"Prevalence of prostate cancer among men with a prostate-specific antigen level &lt; or =4.0 ng per milliliter\". <i>The New England Journal of Medicine</i>. <b>350</b> (22): 2239\u201346. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1056/NEJMoa031918\">10.1056/NEJMoa031918</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15163773\">15163773</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.atitle=Prevalence+of+prostate+cancer+among+men+with+a+prostate-specific+antigen+level+%3C+or+%3D4.0+ng+per+milliliter&amp;rft.volume=350&amp;rft.issue=22&amp;rft.pages=2239-46&amp;rft.date=2004-05&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa031918&amp;rft_id=info%3Apmid%2F15163773&amp;rft.aulast=Thompson&amp;rft.aufirst=IM&amp;rft.au=Pauler%2C+DK&amp;rft.au=Goodman%2C+PJ&amp;rft.au=Tangen%2C+CM&amp;rft.au=Lucia%2C+MS&amp;rft.au=Parnes%2C+HL&amp;rft.au=Minasian%2C+LM&amp;rft.au=Ford%2C+LG&amp;rft.au=Lippman%2C+SM&amp;rft.au=Crawford%2C+ED&amp;rft.au=Crowley%2C+JJ&amp;rft.au=Coltman%2C+CA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-34\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-34\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ba\u00f1ez LL, Hamilton RJ, Partin AW, Vollmer RT, Sun L, Rodriguez C, Wang Y, Terris MK, Aronson WJ, Presti JC, Kane CJ, Amling CL, Moul JW, Freedland SJ (Nov 2007). \"Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer\". <i>JAMA</i>. <b>298</b> (19): 2275\u201380. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/jama.298.19.2275\">10.1001/jama.298.19.2275</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18029831\">18029831</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Obesity-related+plasma+hemodilution+and+PSA+concentration+among+men+with+prostate+cancer&amp;rft.volume=298&amp;rft.issue=19&amp;rft.pages=2275-80&amp;rft.date=2007-11&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.298.19.2275&amp;rft_id=info%3Apmid%2F18029831&amp;rft.aulast=Ba%C3%B1ez&amp;rft.aufirst=LL&amp;rft.au=Hamilton%2C+RJ&amp;rft.au=Partin%2C+AW&amp;rft.au=Vollmer%2C+RT&amp;rft.au=Sun%2C+L&amp;rft.au=Rodriguez%2C+C&amp;rft.au=Wang%2C+Y&amp;rft.au=Terris%2C+MK&amp;rft.au=Aronson%2C+WJ&amp;rft.au=Presti%2C+JC&amp;rft.au=Kane%2C+CJ&amp;rft.au=Amling%2C+CL&amp;rft.au=Moul%2C+JW&amp;rft.au=Freedland%2C+SJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-35\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-35\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Robert Dreicer (2007-11-20). <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20080217021312/http://oncology-hematology.jwatch.org/cgi/content/full/2007/1120/1\">\"Why do obese men have lower PSA concentrations?\"</a>. <i>Journal Watch</i>. New England Journal of Medicine. <b>2007</b> (1120): 1. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://oncology-hematology.jwatch.org/cgi/content/full/2007/1120/1\">the original</a> on 2008-02-17<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2008-04-27</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+Watch&amp;rft.atitle=Why+do+obese+men+have+lower+PSA+concentrations%3F&amp;rft.volume=2007&amp;rft.issue=1120&amp;rft.pages=1&amp;rft.date=2007-11-20&amp;rft.au=Robert+Dreicer&amp;rft_id=http%3A%2F%2Foncology-hematology.jwatch.org%2Fcgi%2Fcontent%2Ffull%2F2007%2F1120%2F1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-36\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-36\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Cao Y, Ma J (Apr 2011). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3071449\">\"Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis\"</a>. <i>Cancer Prevention Research</i>. <b>4</b> (4): 486\u2013501. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1158/1940-6207.CAPR-10-0229\">10.1158/1940-6207.CAPR-10-0229</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3071449\">3071449</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21233290\">21233290</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Prevention+Research&amp;rft.atitle=Body+mass+index%2C+prostate+cancer-specific+mortality%2C+and+biochemical+recurrence%3A+a+systematic+review+and+meta-analysis&amp;rft.volume=4&amp;rft.issue=4&amp;rft.pages=486-501&amp;rft.date=2011-04&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3071449&amp;rft_id=info%3Apmid%2F21233290&amp;rft_id=info%3Adoi%2F10.1158%2F1940-6207.CAPR-10-0229&amp;rft.aulast=Cao&amp;rft.aufirst=Y&amp;rft.au=Ma%2C+J&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3071449&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-ejac-37\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-ejac_37-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-ejac_37-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Herschman JD, Smith DS, Catalona WJ (Aug 1997). \"Effect of ejaculation on serum total and free prostate-specific antigen concentrations\". <i>Urology</i>. <b>50</b> (2): 239\u201343. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0090-4295%2897%2900209-4\">10.1016/S0090-4295(97)00209-4</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9255295\">9255295</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Urology&amp;rft.atitle=Effect+of+ejaculation+on+serum+total+and+free+prostate-specific+antigen+concentrations&amp;rft.volume=50&amp;rft.issue=2&amp;rft.pages=239-43&amp;rft.date=1997-08&amp;rft_id=info%3Adoi%2F10.1016%2FS0090-4295%2897%2900209-4&amp;rft_id=info%3Apmid%2F9255295&amp;rft.aulast=Herschman&amp;rft.aufirst=JD&amp;rft.au=Smith%2C+DS&amp;rft.au=Catalona%2C+WJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid7541857-38\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid7541857_38-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Nadler RB, Humphrey PA, Smith DS, Catalona WJ, Ratliff TL (Aug 1995). \"Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels\". <i>The Journal of Urology</i>. <b>154</b> (2 Pt 1): 407\u201313. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0022-5347%2801%2967064-2\">10.1016/S0022-5347(01)67064-2</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/7541857\">7541857</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Urology&amp;rft.atitle=Effect+of+inflammation+and+benign+prostatic+hyperplasia+on+elevated+serum+prostate+specific+antigen+levels&amp;rft.volume=154&amp;rft.issue=2+Pt+1&amp;rft.pages=407-13&amp;rft.date=1995-08&amp;rft_id=info%3Adoi%2F10.1016%2FS0022-5347%2801%2967064-2&amp;rft_id=info%3Apmid%2F7541857&amp;rft.aulast=Nadler&amp;rft.aufirst=RB&amp;rft.au=Humphrey%2C+PA&amp;rft.au=Smith%2C+DS&amp;rft.au=Catalona%2C+WJ&amp;rft.au=Ratliff%2C+TL&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid1372943-39\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid1372943_39-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Crawford ED, Schutz MJ, Clejan S, Drago J, Resnick MI, Chodak GW, Gomella LG, Austenfeld M, Stone NN, Miles BJ (1992). \"The effect of digital rectal examination on prostate-specific antigen levels\". <i>JAMA</i>. <b>267</b> (16): 2227\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/jama.267.16.2227\">10.1001/jama.267.16.2227</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/1372943\">1372943</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=The+effect+of+digital+rectal+examination+on+prostate-specific+antigen+levels&amp;rft.volume=267&amp;rft.issue=16&amp;rft.pages=2227-8&amp;rft.date=1992&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.267.16.2227&amp;rft_id=info%3Apmid%2F1372943&amp;rft.aulast=Crawford&amp;rft.aufirst=ED&amp;rft.au=Schutz%2C+MJ&amp;rft.au=Clejan%2C+S&amp;rft.au=Drago%2C+J&amp;rft.au=Resnick%2C+MI&amp;rft.au=Chodak%2C+GW&amp;rft.au=Gomella%2C+LG&amp;rft.au=Austenfeld%2C+M&amp;rft.au=Stone%2C+NN&amp;rft.au=Miles%2C+BJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><br />\n<cite class=\"citation journal\">Chybowski FM, Bergstralh EJ, Oesterling JE (Jul 1992). \"The effect of digital rectal examination on the serum prostate specific antigen concentration: results of a randomized study\". <i>The Journal of Urology</i>. <b>148</b> (1): 83\u20136. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/1377290\">1377290</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Urology&amp;rft.atitle=The+effect+of+digital+rectal+examination+on+the+serum+prostate+specific+antigen+concentration%3A+results+of+a+randomized+study&amp;rft.volume=148&amp;rft.issue=1&amp;rft.pages=83-6&amp;rft.date=1992-07&amp;rft_id=info%3Apmid%2F1377290&amp;rft.aulast=Chybowski&amp;rft.aufirst=FM&amp;rft.au=Bergstralh%2C+EJ&amp;rft.au=Oesterling%2C+JE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><br />\n<cite class=\"citation journal\">Collins GN, Martin PJ, Wynn-Davies A, Brooman PJ, O'Reilly PH (May 1997). \"The effect of digital rectal examination, flexible cystoscopy and prostatic biopsy on free and total prostate specific antigen, and the free-to-total prostate specific antigen ratio in clinical practice\". <i>The Journal of Urology</i>. <b>157</b> (5): 1744\u20137. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0022-5347%2801%2964849-3\">10.1016/S0022-5347(01)64849-3</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9112518\">9112518</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Urology&amp;rft.atitle=The+effect+of+digital+rectal+examination%2C+flexible+cystoscopy+and+prostatic+biopsy+on+free+and+total+prostate+specific+antigen%2C+and+the+free-to-total+prostate+specific+antigen+ratio+in+clinical+practice&amp;rft.volume=157&amp;rft.issue=5&amp;rft.pages=1744-7&amp;rft.date=1997-05&amp;rft_id=info%3Adoi%2F10.1016%2FS0022-5347%2801%2964849-3&amp;rft_id=info%3Apmid%2F9112518&amp;rft.aulast=Collins&amp;rft.aufirst=GN&amp;rft.au=Martin%2C+PJ&amp;rft.au=Wynn-Davies%2C+A&amp;rft.au=Brooman%2C+PJ&amp;rft.au=O%27Reilly%2C+PH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><br />\n<cite class=\"citation journal\">Tarhan F, Or\u00e7un A, K\u00fc\u00e7\u00fckercan I, Camursoy N, Kuyumcuo\u011flu U (Dec 2005). \"Effect of prostatic massage on serum complexed prostate-specific antigen levels\". <i>Urology</i>. <b>66</b> (6): 1234\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.urology.2005.06.077\">10.1016/j.urology.2005.06.077</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16360449\">16360449</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Urology&amp;rft.atitle=Effect+of+prostatic+massage+on+serum+complexed+prostate-specific+antigen+levels&amp;rft.volume=66&amp;rft.issue=6&amp;rft.pages=1234-8&amp;rft.date=2005-12&amp;rft_id=info%3Adoi%2F10.1016%2Fj.urology.2005.06.077&amp;rft_id=info%3Apmid%2F16360449&amp;rft.aulast=Tarhan&amp;rft.aufirst=F&amp;rft.au=Or%C3%A7un%2C+A&amp;rft.au=K%C3%BC%C3%A7%C3%BCkercan%2C+I&amp;rft.au=Camursoy%2C+N&amp;rft.au=Kuyumcuo%C4%9Flu%2C+U&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-40\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-40\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Connolly D, Black A, Murray L, Gavin A, Keane P (2007). \"798 Population Based Age-Specific Reference Ranges for PSA\". <i>European Urology Supplements</i>. <b>6</b> (2): 222. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S1569-9056%2807%2960793-3\">10.1016/S1569-9056(07)60793-3</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Urology+Supplements&amp;rft.atitle=798+Population+Based+Age-Specific+Reference+Ranges+for+PSA&amp;rft.volume=6&amp;rft.issue=2&amp;rft.pages=222&amp;rft.date=2007&amp;rft_id=info%3Adoi%2F10.1016%2FS1569-9056%2807%2960793-3&amp;rft.aulast=Connolly&amp;rft.aufirst=D&amp;rft.au=Black%2C+A&amp;rft.au=Murray%2C+L&amp;rft.au=Gavin%2C+A&amp;rft.au=Keane%2C+P&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-41\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-41\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Carter HB, Pearson JD, Metter EJ, Brant LJ, Chan DW, Andres R, Fozard JL, Walsh PC (1992). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3461837\">\"Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease\"</a>. <i>JAMA</i>. <b>267</b> (16): 2215\u201320. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/jama.267.16.2215\">10.1001/jama.267.16.2215</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3461837\">3461837</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/1372942\">1372942</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Longitudinal+evaluation+of+prostate-specific+antigen+levels+in+men+with+and+without+prostate+disease&amp;rft.volume=267&amp;rft.issue=16&amp;rft.pages=2215-20&amp;rft.date=1992&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3461837&amp;rft_id=info%3Apmid%2F1372942&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.267.16.2215&amp;rft.aulast=Carter&amp;rft.aufirst=HB&amp;rft.au=Pearson%2C+JD&amp;rft.au=Metter%2C+EJ&amp;rft.au=Brant%2C+LJ&amp;rft.au=Chan%2C+DW&amp;rft.au=Andres%2C+R&amp;rft.au=Fozard%2C+JL&amp;rft.au=Walsh%2C+PC&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3461837&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-42\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-42\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.cancer.gov/cancertopics/types/prostate/research/psa-velocity-detection\">\"PSA Velocity Does Not Improve Prostate Cancer Detection\"</a>. 13 Apr 2011<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">25 April</span> 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=PSA+Velocity+Does+Not+Improve+Prostate+Cancer+Detection&amp;rft.date=2011-04-13&amp;rft_id=http%3A%2F%2Fwww.cancer.gov%2Fcancertopics%2Ftypes%2Fprostate%2Fresearch%2Fpsa-velocity-detection&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-43\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-43\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Carter HB (Apr 2006). \"Assessing risk: does this patient have prostate cancer?\". <i>Journal of the National Cancer Institute</i> <span style=\"font-size:85%;\">(Editorial)</span><span style=\"display:none;font-size:100%\" class=\"error citation-comment\"><code style=\"color:inherit; border:inherit; padding:inherit;\">&#124;format=</code> requires <code style=\"color:inherit; border:inherit; padding:inherit;\">&#124;url=</code> (<a href=\"/wiki/Help:CS1_errors#format_missing_url\" title=\"Help:CS1 errors\">help</a>)</span>. <b>98</b> (8): 506\u20137. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1093/jnci/djj155\">10.1093/jnci/djj155</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16622114\">16622114</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+National+Cancer+Institute&amp;rft.atitle=Assessing+risk%3A+does+this+patient+have+prostate+cancer%3F&amp;rft.volume=98&amp;rft.issue=8&amp;rft.pages=506-7&amp;rft.date=2006-04&amp;rft_id=info%3Adoi%2F10.1093%2Fjnci%2Fdjj155&amp;rft_id=info%3Apmid%2F16622114&amp;rft.aulast=Carter&amp;rft.aufirst=HB&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-44\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-44\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">D'Amico AV, Chen MH, Roehl KA, Catalona WJ (Jul 2004). \"Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy\". <i>The New England Journal of Medicine</i>. <b>351</b> (2): 125\u201335. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1056/NEJMoa032975\">10.1056/NEJMoa032975</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15247353\">15247353</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.atitle=Preoperative+PSA+velocity+and+the+risk+of+death+from+prostate+cancer+after+radical+prostatectomy&amp;rft.volume=351&amp;rft.issue=2&amp;rft.pages=125-35&amp;rft.date=2004-07&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa032975&amp;rft_id=info%3Apmid%2F15247353&amp;rft.aulast=D%27Amico&amp;rft.aufirst=AV&amp;rft.au=Chen%2C+MH&amp;rft.au=Roehl%2C+KA&amp;rft.au=Catalona%2C+WJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-45\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-45\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Loeb S, Kettermann A, Ferrucci L, Landis P, Metter EJ, Carter HB (Nov 2008). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2582974\">\"PSA doubling time versus PSA velocity to predict high-risk prostate cancer: data from the Baltimore Longitudinal Study of Aging\"</a>. <i>European Urology</i>. <b>54</b> (5): 1073\u201380. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.eururo.2008.06.076\">10.1016/j.eururo.2008.06.076</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2582974\">2582974</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18614274\">18614274</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Urology&amp;rft.atitle=PSA+doubling+time+versus+PSA+velocity+to+predict+high-risk+prostate+cancer%3A+data+from+the+Baltimore+Longitudinal+Study+of+Aging&amp;rft.volume=54&amp;rft.issue=5&amp;rft.pages=1073-80&amp;rft.date=2008-11&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2582974&amp;rft_id=info%3Apmid%2F18614274&amp;rft_id=info%3Adoi%2F10.1016%2Fj.eururo.2008.06.076&amp;rft.aulast=Loeb&amp;rft.aufirst=S&amp;rft.au=Kettermann%2C+A&amp;rft.au=Ferrucci%2C+L&amp;rft.au=Landis%2C+P&amp;rft.au=Metter%2C+EJ&amp;rft.au=Carter%2C+HB&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2582974&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Semi-Log-46\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Semi-Log_46-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Semi-Log_46-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20160224083006/http://wmueller.com/precalculus/families/semilog.html\">\"Semi-Log Transformations of Data\"</a>. Archived from the original on 24 February 2016<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">4 March</span> 2016</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Semi-Log+Transformations+of+Data&amp;rft_id=http%3A%2F%2Fwmueller.com%2Fprecalculus%2Ffamilies%2Fsemilog.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><span class=\"citation-comment\" style=\"display:none; color:#33aa33; margin-left:0.3em\">CS1 maint: BOT: original-url status unknown (<a href=\"/wiki/Category:CS1_maint:_BOT:_original-url_status_unknown\" title=\"Category:CS1 maint: BOT: original-url status unknown\">link</a>) </span>(Archived by WebCite\u00ae at )</span>\n</li>\n<li id=\"cite_note-47\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-47\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Catalona W, Partin A, Slawin K, Brawer M, Flanigan R, Patel A, Richie J, deKernion J, Walsh P, Scardino P, Lange P, Subong E, Parson R, Gasior G, Loveland K, Southwick P (1998). \"Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial\". <i>JAMA</i>. <b>279</b> (19): 1542\u20137. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/jama.279.19.1542\">10.1001/jama.279.19.1542</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9605898\">9605898</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Use+of+the+percentage+of+free+prostate-specific+antigen+to+enhance+differentiation+of+prostate+cancer+from+benign+prostatic+disease%3A+a+prospective+multicenter+clinical+trial&amp;rft.volume=279&amp;rft.issue=19&amp;rft.pages=1542-7&amp;rft.date=1998&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.279.19.1542&amp;rft_id=info%3Apmid%2F9605898&amp;rft.aulast=Catalona&amp;rft.aufirst=W&amp;rft.au=Partin%2C+A&amp;rft.au=Slawin%2C+K&amp;rft.au=Brawer%2C+M&amp;rft.au=Flanigan%2C+R&amp;rft.au=Patel%2C+A&amp;rft.au=Richie%2C+J&amp;rft.au=deKernion%2C+J&amp;rft.au=Walsh%2C+P&amp;rft.au=Scardino%2C+P&amp;rft.au=Lange%2C+P&amp;rft.au=Subong%2C+E&amp;rft.au=Parson%2C+R&amp;rft.au=Gasior%2C+G&amp;rft.au=Loveland%2C+K&amp;rft.au=Southwick%2C+P&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-48\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-48\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Catalona WJ, Smith DS, Ornstein DK (May 1997). \"Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements\". <i>JAMA</i>. <b>277</b> (18): 1452\u20135. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/jama.277.18.1452\">10.1001/jama.277.18.1452</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9145717\">9145717</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Prostate+cancer+detection+in+men+with+serum+PSA+concentrations+of+2.6+to+4.0+ng%2FmL+and+benign+prostate+examination.+Enhancement+of+specificity+with+free+PSA+measurements&amp;rft.volume=277&amp;rft.issue=18&amp;rft.pages=1452-5&amp;rft.date=1997-05&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.277.18.1452&amp;rft_id=info%3Apmid%2F9145717&amp;rft.aulast=Catalona&amp;rft.aufirst=WJ&amp;rft.au=Smith%2C+DS&amp;rft.au=Ornstein%2C+DK&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Wu-1860080110-49\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Wu-1860080110_49-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wu JT (1994). \"Assay for prostate specific antigen (PSA): problems and possible solutions\". <i>Journal of Clinical Laboratory Analysis</i>. <b>8</b> (1): 51\u201362. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/jcla.1860080110\">10.1002/jcla.1860080110</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/7513021\">7513021</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Clinical+Laboratory+Analysis&amp;rft.atitle=Assay+for+prostate+specific+antigen+%28PSA%29%3A+problems+and+possible+solutions&amp;rft.volume=8&amp;rft.issue=1&amp;rft.pages=51-62&amp;rft.date=1994&amp;rft_id=info%3Adoi%2F10.1002%2Fjcla.1860080110&amp;rft_id=info%3Apmid%2F7513021&amp;rft.aulast=Wu&amp;rft.aufirst=JT&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-50\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-50\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.sbir.gov/sbirsearch/detail/12931\">\"A bioelectronic assay for PSA activity\"</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=A+bioelectronic+assay+for+PSA+activity&amp;rft_id=http%3A%2F%2Fwww.sbir.gov%2Fsbirsearch%2Fdetail%2F12931&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Mattsson-18386289-51\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Mattsson-18386289_51-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Mattsson JM, Valmu L, Laakkonen P, Stenman UH, Koistinen H (Jun 2008). \"Structural characterization and anti-angiogenic properties of prostate-specific antigen isoforms in seminal fluid\". <i>The Prostate</i>. <b>68</b> (9): 945\u201354. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/pros.20751\">10.1002/pros.20751</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18386289\">18386289</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Prostate&amp;rft.atitle=Structural+characterization+and+anti-angiogenic+properties+of+prostate-specific+antigen+isoforms+in+seminal+fluid&amp;rft.volume=68&amp;rft.issue=9&amp;rft.pages=945-54&amp;rft.date=2008-06&amp;rft_id=info%3Adoi%2F10.1002%2Fpros.20751&amp;rft_id=info%3Apmid%2F18386289&amp;rft.aulast=Mattsson&amp;rft.aufirst=JM&amp;rft.au=Valmu%2C+L&amp;rft.au=Laakkonen%2C+P&amp;rft.au=Stenman%2C+UH&amp;rft.au=Koistinen%2C+H&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Stura-22037582-52\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Stura-22037582_52-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Stura EA, Muller BH, Bossus M, Michel S, Jolivet-Reynaud C, Ducancel F (Dec 2011). \"Crystal structure of human prostate-specific antigen in a sandwich antibody complex\". <i>Journal of Molecular Biology</i>. <b>414</b> (4): 530\u201344. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.jmb.2011.10.007\">10.1016/j.jmb.2011.10.007</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22037582\">22037582</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Molecular+Biology&amp;rft.atitle=Crystal+structure+of+human+prostate-specific+antigen+in+a+sandwich+antibody+complex&amp;rft.volume=414&amp;rft.issue=4&amp;rft.pages=530-44&amp;rft.date=2011-12&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jmb.2011.10.007&amp;rft_id=info%3Apmid%2F22037582&amp;rft.aulast=Stura&amp;rft.aufirst=EA&amp;rft.au=Muller%2C+BH&amp;rft.au=Bossus%2C+M&amp;rft.au=Michel%2C+S&amp;rft.au=Jolivet-Reynaud%2C+C&amp;rft.au=Ducancel%2C+F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Mikolajczyk--53\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Mikolajczyk-_53-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Mikolajczyk SD, Catalona WJ, Evans CL, Linton HJ, Millar LS, Marker KM, Katir D, Amirkhan A, Rittenhouse HG (Jun 2004). \"Proenzyme forms of prostate-specific antigen in serum improve the detection of prostate cancer\". <i>Clinical Chemistry</i>. <b>50</b> (6): 1017\u201325. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1373/clinchem.2003.026823\">10.1373/clinchem.2003.026823</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15054080\">15054080</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Chemistry&amp;rft.atitle=Proenzyme+forms+of+prostate-specific+antigen+in+serum+improve+the+detection+of+prostate+cancer&amp;rft.volume=50&amp;rft.issue=6&amp;rft.pages=1017-25&amp;rft.date=2004-06&amp;rft_id=info%3Adoi%2F10.1373%2Fclinchem.2003.026823&amp;rft_id=info%3Apmid%2F15054080&amp;rft.aulast=Mikolajczyk&amp;rft.aufirst=SD&amp;rft.au=Catalona%2C+WJ&amp;rft.au=Evans%2C+CL&amp;rft.au=Linton%2C+HJ&amp;rft.au=Millar%2C+LS&amp;rft.au=Marker%2C+KM&amp;rft.au=Katir%2C+D&amp;rft.au=Amirkhan%2C+A&amp;rft.au=Rittenhouse%2C+HG&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Mikolajczyk_2002-54\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Mikolajczyk_2002_54-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Mikolajczyk SD, Marks LS, Partin AW, Rittenhouse HG (2002). \"Free prostate-specific antigen in serum is becoming more complex\". <i>Urology</i>. <b>59</b> (6): 797\u2013802. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0090-4295%2801%2901605-3\">10.1016/S0090-4295(01)01605-3</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12031356\">12031356</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Urology&amp;rft.atitle=Free+prostate-specific+antigen+in+serum+is+becoming+more+complex&amp;rft.volume=59&amp;rft.issue=6&amp;rft.pages=797-802&amp;rft.date=2002&amp;rft_id=info%3Adoi%2F10.1016%2FS0090-4295%2801%2901605-3&amp;rft_id=info%3Apmid%2F12031356&amp;rft.aulast=Mikolajczyk&amp;rft.aufirst=SD&amp;rft.au=Marks%2C+LS&amp;rft.au=Partin%2C+AW&amp;rft.au=Rittenhouse%2C+HG&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Naya_2004-55\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Naya_2004_55-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Naya Y, Okihara K (2004). \"Role of complexed PSA in the early detection of prostate cancer\". <i>Journal of the National Comprehensive Cancer Network: JNCCN</i>. <b>2</b> (3): 209\u201312. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.6004/jnccn.2004.0019\">10.6004/jnccn.2004.0019</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19795605\">19795605</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+National+Comprehensive+Cancer+Network%3A+JNCCN&amp;rft.atitle=Role+of+complexed+PSA+in+the+early+detection+of+prostate+cancer&amp;rft.volume=2&amp;rft.issue=3&amp;rft.pages=209-12&amp;rft.date=2004&amp;rft_id=info%3Adoi%2F10.6004%2Fjnccn.2004.0019&amp;rft_id=info%3Apmid%2F19795605&amp;rft.aulast=Naya&amp;rft.aufirst=Y&amp;rft.au=Okihara%2C+K&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-wimpissinger-56\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-wimpissinger_56-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wimpissinger F, Stifter K, Grin W, Stackl W (Sep 2007). \"The female prostate revisited: perineal ultrasound and biochemical studies of female ejaculate\". <i>The Journal of Sexual Medicine</i>. <b>4</b> (5): 1388\u201393; discussion 1393. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1743-6109.2007.00542.x\">10.1111/j.1743-6109.2007.00542.x</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17634056\">17634056</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Sexual+Medicine&amp;rft.atitle=The+female+prostate+revisited%3A+perineal+ultrasound+and+biochemical+studies+of+female+ejaculate&amp;rft.volume=4&amp;rft.issue=5&amp;rft.pages=1388-93%3B+discussion+1393&amp;rft.date=2007-09&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1743-6109.2007.00542.x&amp;rft_id=info%3Apmid%2F17634056&amp;rft.aulast=Wimpissinger&amp;rft.aufirst=F&amp;rft.au=Stifter%2C+K&amp;rft.au=Grin%2C+W&amp;rft.au=Stackl%2C+W&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-57\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-57\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Stanley A Brosman. <a rel=\"nofollow\" class=\"external text\" href=\"http://www.emedicine.com/med/TOPIC3465.HTM#section~CharacteristicsofProstateSpecificAntigen\"><i>eMedicine: Prostate-Specific Antigen</i></a>. <a href=\"/wiki/WebMD\" title=\"WebMD\">WebMD</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2008-05-11</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=eMedicine%3A+Prostate-Specific+Antigen&amp;rft.pub=WebMD&amp;rft.au=Stanley+A+Brosman&amp;rft_id=http%3A%2F%2Fwww.emedicine.com%2Fmed%2FTOPIC3465.HTM%23section~CharacteristicsofProstateSpecificAntigen&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid17667550-58\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid17667550_58-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Chuang AY, DeMarzo AM, Veltri RW, Sharma RB, Bieberich CJ, Epstein JI (Aug 2007). \"Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma\". <i>The American Journal of Surgical Pathology</i>. <b>31</b> (8): 1246\u201355. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/PAS.0b013e31802f5d33\">10.1097/PAS.0b013e31802f5d33</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17667550\">17667550</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+American+Journal+of+Surgical+Pathology&amp;rft.atitle=Immunohistochemical+differentiation+of+high-grade+prostate+carcinoma+from+urothelial+carcinoma&amp;rft.volume=31&amp;rft.issue=8&amp;rft.pages=1246-55&amp;rft.date=2007-08&amp;rft_id=info%3Adoi%2F10.1097%2FPAS.0b013e31802f5d33&amp;rft_id=info%3Apmid%2F17667550&amp;rft.aulast=Chuang&amp;rft.aufirst=AY&amp;rft.au=DeMarzo%2C+AM&amp;rft.au=Veltri%2C+RW&amp;rft.au=Sharma%2C+RB&amp;rft.au=Bieberich%2C+CJ&amp;rft.au=Epstein%2C+JI&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid7509746-59\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid7509746_59-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Christensson A, Lilja H (Feb 1994). \"Complex formation between protein C inhibitor and prostate-specific antigen in vitro and in human semen\". <i>European Journal of Biochemistry / FEBS</i>. <b>220</b> (1): 45\u201353. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1432-1033.1994.tb18597.x\">10.1111/j.1432-1033.1994.tb18597.x</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/7509746\">7509746</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Biochemistry+%2F+FEBS&amp;rft.atitle=Complex+formation+between+protein+C+inhibitor+and+prostate-specific+antigen+in+vitro+and+in+human+semen&amp;rft.volume=220&amp;rft.issue=1&amp;rft.pages=45-53&amp;rft.date=1994-02&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1432-1033.1994.tb18597.x&amp;rft_id=info%3Apmid%2F7509746&amp;rft.aulast=Christensson&amp;rft.aufirst=A&amp;rft.au=Lilja%2C+H&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid8665956-60\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid8665956_60-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kise H, Nishioka J, Kawamura J, Suzuki K (May 1996). \"Characterization of semenogelin II and its molecular interaction with prostate-specific antigen and protein C inhibitor\". <i>European Journal of Biochemistry / FEBS</i>. <b>238</b> (1): 88\u201396. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1432-1033.1996.0088q.x\">10.1111/j.1432-1033.1996.0088q.x</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8665956\">8665956</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Biochemistry+%2F+FEBS&amp;rft.atitle=Characterization+of+semenogelin+II+and+its+molecular+interaction+with+prostate-specific+antigen+and+protein+C+inhibitor&amp;rft.volume=238&amp;rft.issue=1&amp;rft.pages=88-96&amp;rft.date=1996-05&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1432-1033.1996.0088q.x&amp;rft_id=info%3Apmid%2F8665956&amp;rft.aulast=Kise&amp;rft.aufirst=H&amp;rft.au=Nishioka%2C+J&amp;rft.au=Kawamura%2C+J&amp;rft.au=Suzuki%2C+K&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div>\n<h2><span class=\"mw-headline\" id=\"Further_reading\">Further reading</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prostate-specific_antigen&amp;action=edit&amp;section=20\" title=\"Edit section: Further reading\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<style data-mw-deduplicate=\"TemplateStyles:r853264625\">.mw-parser-output .refbegin{font-size:90%;margin-bottom:0.5em}.mw-parser-output .refbegin-hanging-indents>ul{list-style-type:none;margin-left:0}.mw-parser-output .refbegin-hanging-indents>ul>li,.mw-parser-output .refbegin-hanging-indents>dl>dd{margin-left:0;padding-left:3.2em;text-indent:-3.2em;list-style:none}.mw-parser-output .refbegin-100{font-size:100%}</style><div class=\"refbegin columns references-column-count references-column-count-2\" style=\"-moz-column-count: 2; -webkit-column-count: 2; column-count: 2;\">\n<ul><li><cite class=\"citation journal\">De Angelis G, Rittenhouse HG, Mikolajczyk SD, Blair Shamel L, Semjonow A (2007). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2002501\">\"Twenty Years of PSA: From Prostate Antigen to Tumor Marker\"</a>. <i>Reviews in Urology</i>. <b>9</b> (3): 113\u201323. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2002501\">2002501</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17934568\">17934568</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reviews+in+Urology&amp;rft.atitle=Twenty+Years+of+PSA%3A+From+Prostate+Antigen+to+Tumor+Marker&amp;rft.volume=9&amp;rft.issue=3&amp;rft.pages=113-23&amp;rft.date=2007&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2002501&amp;rft_id=info%3Apmid%2F17934568&amp;rft.aulast=De+Angelis&amp;rft.aufirst=G&amp;rft.au=Rittenhouse%2C+HG&amp;rft.au=Mikolajczyk%2C+SD&amp;rft.au=Blair+Shamel%2C+L&amp;rft.au=Semjonow%2C+A&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2002501&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><cite class=\"citation journal\">Henttu P, Vihko P (Jun 1994). \"Prostate-specific antigen and human glandular kallikrein: two kallikreins of the human prostate\". <i>Annals of Medicine</i>. <b>26</b> (3): 157\u201364. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3109/07853899409147884\">10.3109/07853899409147884</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/7521173\">7521173</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Medicine&amp;rft.atitle=Prostate-specific+antigen+and+human+glandular+kallikrein%3A+two+kallikreins+of+the+human+prostate&amp;rft.volume=26&amp;rft.issue=3&amp;rft.pages=157-64&amp;rft.date=1994-06&amp;rft_id=info%3Adoi%2F10.3109%2F07853899409147884&amp;rft_id=info%3Apmid%2F7521173&amp;rft.aulast=Henttu&amp;rft.aufirst=P&amp;rft.au=Vihko%2C+P&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><cite class=\"citation journal\">Diamandis EP, Yousef GM, Luo LY, Magklara A, Obiezu CV (Mar 2000). \"The new human kallikrein gene family: implications in carcinogenesis\". <i>Trends in Endocrinology and Metabolism</i>. <b>11</b> (2): 54\u201360. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S1043-2760%2899%2900225-8\">10.1016/S1043-2760(99)00225-8</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10675891\">10675891</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Trends+in+Endocrinology+and+Metabolism&amp;rft.atitle=The+new+human+kallikrein+gene+family%3A+implications+in+carcinogenesis&amp;rft.volume=11&amp;rft.issue=2&amp;rft.pages=54-60&amp;rft.date=2000-03&amp;rft_id=info%3Adoi%2F10.1016%2FS1043-2760%2899%2900225-8&amp;rft_id=info%3Apmid%2F10675891&amp;rft.aulast=Diamandis&amp;rft.aufirst=EP&amp;rft.au=Yousef%2C+GM&amp;rft.au=Luo%2C+LY&amp;rft.au=Magklara%2C+A&amp;rft.au=Obiezu%2C+CV&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><cite class=\"citation journal\">Lilja H (Nov 2003). \"Biology of prostate-specific antigen\". <i>Urology</i>. <b>62</b> (5 Suppl 1): 27\u201333. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0090-4295%2803%2900775-1\">10.1016/S0090-4295(03)00775-1</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/14607215\">14607215</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Urology&amp;rft.atitle=Biology+of+prostate-specific+antigen&amp;rft.volume=62&amp;rft.issue=5+Suppl+1&amp;rft.pages=27-33&amp;rft.date=2003-11&amp;rft_id=info%3Adoi%2F10.1016%2FS0090-4295%2803%2900775-1&amp;rft_id=info%3Apmid%2F14607215&amp;rft.aulast=Lilja&amp;rft.aufirst=H&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate-specific+antigen\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li></ul>\n</div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Prostate-specific_antigen&amp;action=edit&amp;section=21\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li>The <a href=\"/wiki/MEROPS\" title=\"MEROPS\">MEROPS</a> online database for peptidases and their inhibitors: <a rel=\"nofollow\" class=\"external text\" href=\"http://merops.sanger.ac.uk/cgi-bin/merops.cgi?id=S01.162\">S01.162</a></li>\n<li>American Cancer Society: Detailed Guide: Prostate Cancer <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20060901162604/http://www.cancer.org/docroot/CRI/content/CRI_2_4_3X_Can_prostate_cancer_be_found_early_36.asp\">Can Prostate Cancer Be Found Early?</a></li>\n<li>National Cancer Institute: <a rel=\"nofollow\" class=\"external text\" href=\"http://www.cancer.gov/cancertopics/factsheet/Detection/PSA\">The Prostate-Specific Antigen (PSA) Test: Questions and Answers</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"https://meshb.nlm.nih.gov/record/ui?name=Prostate-Specific%20Antigen\">Prostate-Specific+Antigen</a> at the US National Library of Medicine <a href=\"/wiki/Medical_Subject_Headings\" title=\"Medical Subject Headings\">Medical Subject Headings</a> (MeSH)</li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20090308005134/http://www.prostateuk.org/psa/psa.htm\">Prostate UK</a> Help us stop prostate diseases ruining lives</li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://labtestsonline.org/understanding/analytes/psa/tab/test\">PSA</a> at Lab Tests Online</li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.elisakits.co.uk/total-prostate-specific-antigen-total-psa-elisa-kit/\">Total PSA</a> ELISA assay procedure</li></ul>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Tumor_markers\" style=\"padding:3px\"><table class=\"nowraplinks collapsible autocollapse navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Tumor_markers\" title=\"Template:Tumor markers\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Tumor_markers\" title=\"Template talk:Tumor markers\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Tumor_markers&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Tumor_markers\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Tumor_marker\" title=\"Tumor marker\">Tumor markers</a></div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Blood</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Lymphoma\" title=\"Lymphoma\">Lymphoma</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Neprilysin\" title=\"Neprilysin\">Neprilysin</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Lymphosarcoma\" class=\"mw-redirect\" title=\"Lymphosarcoma\">Lymphosarcoma</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/CD3_(immunology)\" title=\"CD3 (immunology)\">CD3</a></li>\n<li><a href=\"/wiki/CD79A\" title=\"CD79A\">CD79a</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Endocrine</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Thyroid_cancer\" title=\"Thyroid cancer\">Thyroid cancer</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Thyroglobulin\" title=\"Thyroglobulin\">Thyroglobulin</a></li>\n<li><a href=\"/wiki/Medullary_thyroid_cancer\" title=\"Medullary thyroid cancer\">Medullary thyroid cancer</a> (<a href=\"/wiki/Calcitonin\" title=\"Calcitonin\">Calcitonin</a></li>\n<li><a href=\"/wiki/Carcinoembryonic_antigen\" title=\"Carcinoembryonic antigen\">Carcinoembryonic antigen</a>)</li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Pheochromocytoma\" title=\"Pheochromocytoma\">Pheochromocytoma</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Normetanephrine\" title=\"Normetanephrine\">Normetanephrine</a></li>\n<li><a href=\"/wiki/Enolase_2\" title=\"Enolase 2\">Enolase 2</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Neuroendocrine_tumor\" title=\"Neuroendocrine tumor\">Neuroendocrine tumors</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Synaptophysin\" title=\"Synaptophysin\">Synaptophysin</a></li>\n<li><a href=\"/wiki/Chromogranin_A\" title=\"Chromogranin A\">Chromogranin A</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Neuroblastoma\" title=\"Neuroblastoma\">Neuroblastoma</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Homovanillic_acid\" title=\"Homovanillic acid\">Homovanillic acid</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Nervous system</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Brain_tumor\" title=\"Brain tumor\">Brain tumor</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Proliferating_cell_nuclear_antigen\" title=\"Proliferating cell nuclear antigen\">PCNA</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Astrocytoma\" title=\"Astrocytoma\">Astrocytoma</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Glial_fibrillary_acidic_protein\" title=\"Glial fibrillary acidic protein\">Glial fibrillary acidic protein</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Neural_crest\" title=\"Neural crest\">NC</a>/<a href=\"/wiki/Melanoma\" title=\"Melanoma\">Melanoma</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/S100_protein\" title=\"S100 protein\">S100 protein</a></li>\n<li><a href=\"/wiki/Melanoma_inhibitory_activity\" title=\"Melanoma inhibitory activity\">Melanoma inhibitory activity</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Cardiovascular/<br />respiratory</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Lung_cancer\" title=\"Lung cancer\">Lung cancer</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Carcinoembryonic_antigen\" title=\"Carcinoembryonic antigen\">Carcinoembryonic antigen</a></li>\n<li><a href=\"/wiki/Enolase_2\" title=\"Enolase 2\">Enolase 2</a></li>\n<li><a href=\"/wiki/Glucose-6-phosphate_isomerase\" title=\"Glucose-6-phosphate isomerase\">Autocrine motility factor</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Hemangiosarcoma\" title=\"Hemangiosarcoma\">Hemangiosarcoma</a> (<a href=\"/wiki/Endothelium\" title=\"Endothelium\">endothelium</a>)</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Factor_VIII\" title=\"Factor VIII\">Factor VIII</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Digestive</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Colorectal_cancer\" title=\"Colorectal cancer\">Colorectal cancer</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/CA19-9\" title=\"CA19-9\">CA19-9</a></li>\n<li><a href=\"/wiki/Carcinoembryonic_antigen\" title=\"Carcinoembryonic antigen\">Carcinoembryonic antigen</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Pancreatic_cancer\" title=\"Pancreatic cancer\">Pancreatic cancer</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/CA19-9\" title=\"CA19-9\">CA19-9</a></li>\n<li><a href=\"/wiki/Carcinoembryonic_antigen\" title=\"Carcinoembryonic antigen\">Carcinoembryonic antigen</a></li>\n<li><a href=\"/wiki/CA_242_(tumor_marker)\" title=\"CA 242 (tumor marker)\">CA 242</a></li>\n<li><a href=\"/wiki/Tumor-associated_glycoprotein_72\" title=\"Tumor-associated glycoprotein 72\">Tumor-associated glycoprotein 72</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Hepatocellular_carcinoma\" title=\"Hepatocellular carcinoma\">Hepatocellular carcinoma</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Alpha-fetoprotein\" title=\"Alpha-fetoprotein\">Alpha-fetoprotein</a>/<a href=\"/wiki/AFP-L3\" title=\"AFP-L3\">AFP-L3</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Reproductive/<br />urinary/<br />breast</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Ovarian_cancer\" title=\"Ovarian cancer\">Ovarian tumor</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><i><a href=\"/wiki/Surface_epithelial-stromal_tumor\" title=\"Surface epithelial-stromal tumor\">Surface epithelial-stromal tumor</a></i>\n<ul><li><a href=\"/wiki/CA-125\" title=\"CA-125\">CA-125</a></li></ul></li>\n<li><i><a href=\"/wiki/Embryonal_carcinoma\" title=\"Embryonal carcinoma\">EC</a></i>\n<ul><li><a href=\"/wiki/CD30\" title=\"CD30\">CD30</a></li>\n<li><a href=\"/wiki/Human_chorionic_gonadotropin\" title=\"Human chorionic gonadotropin\">hCG</a></li></ul></li>\n<li><i><a href=\"/wiki/Endodermal_sinus_tumor\" title=\"Endodermal sinus tumor\">EST</a></i>\n<ul><li><a href=\"/wiki/Alpha-fetoprotein\" title=\"Alpha-fetoprotein\">Alpha-fetoprotein</a></li></ul></li>\n<li><i><a href=\"/wiki/Choriocarcinoma\" title=\"Choriocarcinoma\">Choriocarcinoma</a></i>\n<ul><li><a href=\"/wiki/Human_chorionic_gonadotropin\" title=\"Human chorionic gonadotropin\">hCG</a></li></ul></li>\n<li><i><a href=\"/wiki/Dysgerminoma\" title=\"Dysgerminoma\">Dysgerminoma</a></i>\n<ul><li><a href=\"/wiki/Lactate_dehydrogenase\" title=\"Lactate dehydrogenase\">LDH</a></li></ul></li>\n<li><i><a href=\"/wiki/Sertoli-Leydig_cell_tumour\" class=\"mw-redirect\" title=\"Sertoli-Leydig cell tumour\">Sertoli-Leydig cell tumour</a></i>\n<ul><li><a href=\"/wiki/Testosterone\" title=\"Testosterone\">Testosterone</a></li></ul></li>\n<li><i><a href=\"/wiki/Germ_cell_tumor\" title=\"Germ cell tumor\">GCT</a></i>\n<ul><li><a href=\"/wiki/Inhibin\" class=\"mw-redirect\" title=\"Inhibin\">Inhibin</a></li></ul></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Testicular_cancer\" title=\"Testicular cancer\">Testicular cancer</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Human_chorionic_gonadotropin\" title=\"Human chorionic gonadotropin\">\u03b2hCG</a></li>\n<li><a href=\"/wiki/Alpha-fetoprotein\" title=\"Alpha-fetoprotein\">Alpha-fetoprotein</a>/<a href=\"/wiki/AFP-L3\" title=\"AFP-L3\">AFP-L3</a></li>\n<li><a href=\"/wiki/CD30\" title=\"CD30\">CD30</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Prostate_cancer\" title=\"Prostate cancer\">Prostate cancer</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a class=\"mw-selflink selflink\">Prostate-specific antigen</a></li>\n<li><a href=\"/wiki/Prostatic_acid_phosphatase\" title=\"Prostatic acid phosphatase\">Prostatic acid phosphatase</a></li>\n<li><a href=\"/wiki/Glutamate_carboxypeptidase_II\" title=\"Glutamate carboxypeptidase II\">Glutamate carboxypeptidase II</a></li>\n<li><a href=\"/wiki/ERBB3\" title=\"ERBB3\">erbB-3 receptor</a></li>\n<li><a href=\"/wiki/Early_prostate_cancer_antigen-2\" title=\"Early prostate cancer antigen-2\">Early prostate cancer antigen-2</a></li>\n<li><a href=\"/wiki/SPINK1\" title=\"SPINK1\">SPINK1</a></li>\n<li><a href=\"/wiki/GOLM1\" title=\"GOLM1\">GOLM1</a></li>\n<li><a href=\"/wiki/PCA3\" title=\"PCA3\">PCA3</a></li>\n<li><a href=\"/wiki/TMPRSS2\" title=\"TMPRSS2\">TMPRSS2</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Germ_cell_tumor\" title=\"Germ cell tumor\">Germ cell tumor</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Homeobox_protein_NANOG\" title=\"Homeobox protein NANOG\">NANOG</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Bladder_cancer\" title=\"Bladder cancer\">Bladder cancer</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/ERBB3\" title=\"ERBB3\">erbB-3 receptor</a></li>\n<li><a href=\"/wiki/NMP22\" title=\"NMP22\">NMP22</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Breast_cancer\" title=\"Breast cancer\">Breast cancer</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/CA_15-3\" title=\"CA 15-3\">CA 15-3</a></li>\n<li><a href=\"/wiki/HER2/neu\" title=\"HER2/neu\">erbB-2 receptor</a></li>\n<li><a href=\"/wiki/ERBB3\" title=\"ERBB3\">erbB-3 receptor</a></li>\n<li><a href=\"/wiki/Cathepsin_D\" title=\"Cathepsin D\">Cathepsin D</a></li>\n<li><a href=\"/wiki/Ca_27-29\" class=\"mw-redirect\" title=\"Ca 27-29\">Ca 27-29</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">General histology</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Sarcoma\" title=\"Sarcoma\">Sarcoma</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Vimentin\" title=\"Vimentin\">Vimentin</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Carcinoma\" title=\"Carcinoma\">Carcinoma</a> (<a href=\"/wiki/Epithelium\" title=\"Epithelium\">epithelium</a>)</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Cytokeratin\" title=\"Cytokeratin\">Cytokeratin</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Musculoskeletal</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th id=\"Rhabdomyosarcoma\" scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Rhabdomyosarcoma\" title=\"Rhabdomyosarcoma\">Rhabdomyosarcoma</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Desmin\" title=\"Desmin\">Desmin</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr></tbody></table></div>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Endopeptidases:_serine_proteases/serine_endopeptidases_(EC_3.4.21)\" style=\"padding:3px\"><table class=\"nowraplinks collapsible autocollapse navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Serine_endopeptidases\" title=\"Template:Serine endopeptidases\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Serine_endopeptidases\" title=\"Template talk:Serine endopeptidases\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Serine_endopeptidases&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Endopeptidases:_serine_proteases/serine_endopeptidases_(EC_3.4.21)\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Endopeptidase\" title=\"Endopeptidase\">Endopeptidases</a>: <a href=\"/wiki/Serine_protease\" title=\"Serine protease\">serine proteases/serine endopeptidases</a> (<a href=\"/wiki/Enzyme_Commission_number\" title=\"Enzyme Commission number\">EC</a> <a href=\"/wiki/List_of_EC_numbers_(EC_3)#EC_3.4.21:_Serine_proteases\" title=\"List of EC numbers (EC 3)\">3.4.21</a>)</div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Digestive_enzyme\" title=\"Digestive enzyme\">Digestive enzymes</a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Enteropeptidase\" title=\"Enteropeptidase\">Enteropeptidase</a></li>\n<li><a href=\"/wiki/Trypsin\" title=\"Trypsin\">Trypsin</a></li>\n<li><a href=\"/wiki/Chymotrypsin\" title=\"Chymotrypsin\">Chymotrypsin</a></li>\n<li><a href=\"/wiki/Elastase\" title=\"Elastase\">Elastase</a>\n<ul><li><a href=\"/wiki/Neutrophil_elastase\" title=\"Neutrophil elastase\">Neutrophil</a></li>\n<li><a href=\"/wiki/Pancreatic_elastase\" title=\"Pancreatic elastase\">Pancreatic</a></li></ul></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Coagulation\" title=\"Coagulation\">Coagulation</a></th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><i>factors:</i> <a href=\"/wiki/Thrombin\" title=\"Thrombin\">Thrombin</a></li>\n<li><a href=\"/wiki/Factor_VII\" title=\"Factor VII\">Factor VIIa</a></li>\n<li><a href=\"/wiki/Factor_IX\" title=\"Factor IX\">Factor IXa</a></li>\n<li><a href=\"/wiki/Factor_X\" title=\"Factor X\">Factor Xa</a></li>\n<li><a href=\"/wiki/Factor_XI\" title=\"Factor XI\">Factor XIa</a></li>\n<li><a href=\"/wiki/Factor_XII\" title=\"Factor XII\">Factor XIIa</a></li>\n<li><a href=\"/wiki/Kallikrein\" title=\"Kallikrein\">Kallikrein</a>\n<ul><li><a class=\"mw-selflink selflink\">PSA</a></li>\n<li><a href=\"/wiki/KLK1\" title=\"KLK1\">KLK1</a></li>\n<li><a href=\"/wiki/KLK2\" title=\"KLK2\">KLK2</a></li>\n<li><a class=\"mw-selflink selflink\">KLK3</a></li>\n<li><a href=\"/wiki/KLK4\" title=\"KLK4\">KLK4</a></li>\n<li><a href=\"/wiki/KLK5\" title=\"KLK5\">KLK5</a></li>\n<li><a href=\"/wiki/KLK6\" title=\"KLK6\">KLK6</a></li>\n<li><a href=\"/wiki/KLK7\" title=\"KLK7\">KLK7</a></li>\n<li><a href=\"/wiki/KLK8\" title=\"KLK8\">KLK8</a></li>\n<li><a href=\"/wiki/KLK9\" title=\"KLK9\">KLK9</a></li>\n<li><a href=\"/wiki/KLK10\" title=\"KLK10\">KLK10</a></li>\n<li><a href=\"/wiki/KLK11\" title=\"KLK11\">KLK11</a></li>\n<li><a href=\"/wiki/KLK12\" title=\"KLK12\">KLK12</a></li>\n<li><a href=\"/wiki/KLK13\" title=\"KLK13\">KLK13</a></li>\n<li><a href=\"/wiki/KLK14\" title=\"KLK14\">KLK14</a></li>\n<li><a href=\"/wiki/KLK15\" title=\"KLK15\">KLK15</a></li></ul></li></ul>\n<ul><li><i><a href=\"/wiki/Fibrinolysis\" title=\"Fibrinolysis\">fibrinolysis</a>:</i> <a href=\"/wiki/Plasmin\" title=\"Plasmin\">Plasmin</a></li>\n<li><a href=\"/wiki/Plasminogen_activator\" title=\"Plasminogen activator\">Plasminogen activator</a>\n<ul><li><a href=\"/wiki/Tissue_plasminogen_activator\" title=\"Tissue plasminogen activator\">Tissue plasminogen activator</a></li>\n<li><a href=\"/wiki/Urokinase\" title=\"Urokinase\">Urinary plasminogen activator</a></li></ul></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Complement_system\" title=\"Complement system\">Complement system</a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Complement_factor_B\" title=\"Complement factor B\">Factor B</a></li>\n<li><a href=\"/wiki/Factor_D\" title=\"Factor D\">Factor D</a></li>\n<li><a href=\"/wiki/Complement_factor_I\" title=\"Complement factor I\">Factor I</a></li>\n<li><a href=\"/wiki/Mannose-binding_protein-associated_serine_protease\" title=\"Mannose-binding protein-associated serine protease\">MASP</a>\n<ul><li><a href=\"/wiki/MASP1_(protein)\" title=\"MASP1 (protein)\">MASP1</a></li>\n<li><a href=\"/wiki/MASP2_(protein)\" title=\"MASP2 (protein)\">MASP2</a></li></ul></li>\n<li><a href=\"/wiki/C3-convertase\" title=\"C3-convertase\">C3-convertase</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Other <a href=\"/wiki/Immune_system\" title=\"Immune system\">immune system</a></th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Chymase\" title=\"Chymase\">Chymase</a></li>\n<li><a href=\"/wiki/Granzyme\" title=\"Granzyme\">Granzyme</a></li>\n<li><a href=\"/wiki/Tryptase\" title=\"Tryptase\">Tryptase</a></li>\n<li><a href=\"/wiki/Proteinase_3\" title=\"Proteinase 3\">Proteinase 3/Myeloblastin</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Venom\" title=\"Venom\">Venombin</a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Ancrod\" title=\"Ancrod\">Ancrod</a></li>\n<li><a href=\"/wiki/Batroxobin\" title=\"Batroxobin\">Batroxobin</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Other</th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Acrosin\" title=\"Acrosin\">Acrosin</a></li>\n<li><a href=\"/wiki/Prolyl_endopeptidase\" title=\"Prolyl endopeptidase\">Prolyl endopeptidase</a></li>\n<li><a href=\"/wiki/Pronase\" title=\"Pronase\">Pronase</a></li>\n<li><a href=\"/wiki/Proprotein_convertase\" title=\"Proprotein convertase\">Proprotein convertases</a>\n<ul><li><a href=\"/wiki/Proprotein_convertase_1\" title=\"Proprotein convertase 1\">1</a></li>\n<li><a href=\"/wiki/Proprotein_convertase_2\" title=\"Proprotein convertase 2\">2</a></li></ul></li>\n<li><a href=\"/wiki/PRSS8\" title=\"PRSS8\">Prostasin</a></li>\n<li><a href=\"/wiki/Reelin\" title=\"Reelin\">Reelin</a></li>\n<li><a href=\"/wiki/Subtilisin\" title=\"Subtilisin\">Subtilisin</a>/<a href=\"/wiki/Furin\" title=\"Furin\">Furin</a></li>\n<li><a href=\"/wiki/Streptokinase\" title=\"Streptokinase\">Streptokinase</a></li>\n<li><a href=\"/wiki/Membrane-bound_transcription_factor_peptidase,_site_1\" class=\"mw-redirect\" title=\"Membrane-bound transcription factor peptidase, site 1\">S1P</a></li>\n<li><a href=\"/wiki/Cathepsin\" title=\"Cathepsin\">Cathepsin</a>\n<ul><li><a href=\"/wiki/Cathepsin_A\" title=\"Cathepsin A\">A</a></li>\n<li><a href=\"/wiki/Cathepsin_G\" title=\"Cathepsin G\">G</a></li></ul></li></ul>\n</div></td></tr></tbody></table></div>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Enzymes\" style=\"padding:3px\"><table class=\"nowraplinks collapsible autocollapse navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Enzymes\" title=\"Template:Enzymes\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Enzymes\" title=\"Template talk:Enzymes\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Enzymes&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Enzymes\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Enzyme\" title=\"Enzyme\">Enzymes</a></div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Activity</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Active_site\" title=\"Active site\">Active site</a></li>\n<li><a href=\"/wiki/Binding_site\" title=\"Binding site\">Binding site</a></li>\n<li><a href=\"/wiki/Catalytic_triad\" title=\"Catalytic triad\">Catalytic triad</a></li>\n<li><a href=\"/wiki/Oxyanion_hole\" title=\"Oxyanion hole\">Oxyanion hole</a></li>\n<li><a href=\"/wiki/Enzyme_promiscuity\" title=\"Enzyme promiscuity\">Enzyme promiscuity</a></li>\n<li><a href=\"/wiki/Catalytically_perfect_enzyme\" class=\"mw-redirect\" title=\"Catalytically perfect enzyme\">Catalytically perfect enzyme</a></li>\n<li><a href=\"/wiki/Coenzyme\" class=\"mw-redirect\" title=\"Coenzyme\">Coenzyme</a></li>\n<li><a href=\"/wiki/Cofactor_(biochemistry)\" title=\"Cofactor (biochemistry)\">Cofactor</a></li>\n<li><a href=\"/wiki/Enzyme_catalysis\" title=\"Enzyme catalysis\">Enzyme catalysis</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Regulation</th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Allosteric_regulation\" title=\"Allosteric regulation\">Allosteric regulation</a></li>\n<li><a href=\"/wiki/Cooperativity\" title=\"Cooperativity\">Cooperativity</a></li>\n<li><a href=\"/wiki/Enzyme_inhibitor\" title=\"Enzyme inhibitor\">Enzyme inhibitor</a></li>\n<li><a href=\"/wiki/Enzyme_activator\" title=\"Enzyme activator\">Enzyme activator</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Classification</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Enzyme_Commission_number\" title=\"Enzyme Commission number\">EC number</a></li>\n<li><a href=\"/wiki/Enzyme_superfamily\" class=\"mw-redirect\" title=\"Enzyme superfamily\">Enzyme superfamily</a></li>\n<li><a href=\"/wiki/Enzyme_family\" class=\"mw-redirect\" title=\"Enzyme family\">Enzyme family</a></li>\n<li><a href=\"/wiki/List_of_enzymes\" title=\"List of enzymes\">List of enzymes</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Kinetics</th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Enzyme_kinetics\" title=\"Enzyme kinetics\">Enzyme kinetics</a></li>\n<li><a href=\"/wiki/Eadie%E2%80%93Hofstee_diagram\" title=\"Eadie\u2013Hofstee diagram\">Eadie\u2013Hofstee diagram</a></li>\n<li><a href=\"/wiki/Hanes%E2%80%93Woolf_plot\" title=\"Hanes\u2013Woolf plot\">Hanes\u2013Woolf plot</a></li>\n<li><a href=\"/wiki/Lineweaver%E2%80%93Burk_plot\" title=\"Lineweaver\u2013Burk plot\">Lineweaver\u2013Burk plot</a></li>\n<li><a href=\"/wiki/Michaelis%E2%80%93Menten_kinetics\" title=\"Michaelis\u2013Menten kinetics\">Michaelis\u2013Menten kinetics</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Types</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><b>EC1 <a href=\"/wiki/Oxidoreductase\" title=\"Oxidoreductase\">Oxidoreductases</a></b> (<a href=\"/wiki/List_of_EC_numbers_(EC_1)\" title=\"List of EC numbers (EC 1)\">list</a>)</li>\n<li><b>EC2 <a href=\"/wiki/Transferase\" title=\"Transferase\">Transferases</a></b> (<a href=\"/wiki/List_of_EC_numbers_(EC_2)\" title=\"List of EC numbers (EC 2)\">list</a>)</li>\n<li><b>EC3 <a href=\"/wiki/Hydrolase\" title=\"Hydrolase\">Hydrolases</a></b> (<a href=\"/wiki/List_of_EC_numbers_(EC_3)\" title=\"List of EC numbers (EC 3)\">list</a>)</li>\n<li><b>EC4 <a href=\"/wiki/Lyase\" title=\"Lyase\">Lyases</a></b> (<a href=\"/wiki/List_of_EC_numbers_(EC_4)\" title=\"List of EC numbers (EC 4)\">list</a>)</li>\n<li><b>EC5 <a href=\"/wiki/Isomerase\" title=\"Isomerase\">Isomerases</a></b> (<a href=\"/wiki/List_of_EC_numbers_(EC_5)\" title=\"List of EC numbers (EC 5)\">list</a>)</li>\n<li><b>EC6 <a href=\"/wiki/Ligase\" title=\"Ligase\">Ligases</a></b> (<a href=\"/wiki/List_of_EC_numbers_(EC_6)\" title=\"List of EC numbers (EC 6)\">list</a>)</li></ul>\n</div></td></tr></tbody></table></div>\n<div class=\"noprint metadata\" role=\"navigation\" aria-label=\"Portals\" style=\"font-weight:bold;padding:0.3em 1.7em 0.1em;font-size:88%;text-align:center\"><ul style=\"margin:0.1em 0 0\"><li style=\"display:inline\"><span style=\"display:inline-block;white-space:nowrap\"><span style=\"margin:0 0.5em\"><a href=\"/wiki/File:TPI1_structure.png\" class=\"image\"><img alt=\"TPI1 structure.png\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/1c/TPI1_structure.png/24px-TPI1_structure.png\" width=\"24\" height=\"15\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/1c/TPI1_structure.png/36px-TPI1_structure.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/1c/TPI1_structure.png/48px-TPI1_structure.png 2x\" data-file-width=\"1452\" data-file-height=\"914\" /></a></span><a href=\"/wiki/Portal:Molecular_and_Cellular_Biology\" class=\"mw-redirect\" title=\"Portal:Molecular and Cellular Biology\">Molecular and Cellular Biology portal</a></span></li></ul></div>\n\n<!-- \nNewPP limit report\nParsed by mw2177\nCached time: 20180919030431\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 1.100 seconds\nReal time usage: 1.211 seconds\nPreprocessor visited node count: 4285/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 267999/2097152 bytes\nTemplate argument size: 4420/2097152 bytes\nHighest expansion depth: 12/40\nExpensive parser function count: 26/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 98805/5000000 bytes\nNumber of Wikibase entities loaded: 23/400\nLua time usage: 0.677/10.000 seconds\nLua memory usage: 7.49 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  971.640      1 -total\n 50.11%  486.915      1 Template:Reflist\n 36.76%  357.205     56 Template:Cite_journal\n 26.84%  260.789      1 Template:Infobox_gene\n  7.32%   71.127      7 Template:Fix\n  4.65%   45.194     11 Template:Navbox\n  4.64%   45.075      2 Template:Disputed_inline\n  3.63%   35.239     12 Template:Category_handler\n  3.21%   31.180      6 Template:Cite_book\n  3.13%   30.398      5 Template:Delink\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:267922-0!canonical and timestamp 20180919030430 and revision id 859051569\n -->\n</div>"},"langlinks":[{"lang":"ar","url":"https://ar.wikipedia.org/wiki/%D9%85%D8%B3%D8%AA%D8%B6%D8%AF_%D8%A8%D8%B1%D9%88%D8%B3%D8%AA%D8%A7%D8%AA%D9%8A_%D9%86%D9%88%D8%B9%D9%8A","langname":"Arabic","autonym":"\u0627\u0644\u0639\u0631\u0628\u064a\u0629","*":"\u0645\u0633\u062a\u0636\u062f \u0628\u0631\u0648\u0633\u062a\u0627\u062a\u064a \u0646\u0648\u0639\u064a"},{"lang":"ca","url":"https://ca.wikipedia.org/wiki/Antigen_prost%C3%A0tic_espec%C3%ADfic","langname":"Catalan","autonym":"catal\u00e0","*":"Antigen prost\u00e0tic espec\u00edfic"},{"lang":"cs","url":"https://cs.wikipedia.org/wiki/Prostatick%C3%BD_specifick%C3%BD_antigen","langname":"Czech","autonym":"\u010de\u0161tina","*":"Prostatick\u00fd specifick\u00fd antigen"},{"lang":"cy","url":"https://cy.wikipedia.org/wiki/KLK3","langname":"Welsh","autonym":"Cymraeg","*":"KLK3"},{"lang":"de","url":"https://de.wikipedia.org/wiki/Prostataspezifisches_Antigen","langname":"German","autonym":"Deutsch","*":"Prostataspezifisches Antigen"},{"lang":"es","url":"https://es.wikipedia.org/wiki/Ant%C3%ADgeno_prost%C3%A1tico_espec%C3%ADfico","langname":"Spanish","autonym":"espa\u00f1ol","*":"Ant\u00edgeno prost\u00e1tico espec\u00edfico"},{"lang":"fa","url":"https://fa.wikipedia.org/wiki/%D9%BE%D8%A7%D8%AF%DA%AF%D9%86_%D9%88%DB%8C%DA%98%D9%87_%D9%BE%D8%B1%D9%88%D8%B3%D8%AA%D8%A7%D8%AA","langname":"Persian","autonym":"\u0641\u0627\u0631\u0633\u06cc","*":"\u067e\u0627\u062f\u06af\u0646 \u0648\u06cc\u0698\u0647 \u067e\u0631\u0648\u0633\u062a\u0627\u062a"},{"lang":"fr","url":"https://fr.wikipedia.org/wiki/Antig%C3%A8ne_prostatique_sp%C3%A9cifique","langname":"French","autonym":"fran\u00e7ais","*":"Antig\u00e8ne prostatique sp\u00e9cifique"},{"lang":"hr","url":"https://hr.wikipedia.org/wiki/Antigen_specifi%C4%8Dan_za_prostatu","langname":"Croatian","autonym":"hrvatski","*":"Antigen specifi\u010dan za prostatu"},{"lang":"id","url":"https://id.wikipedia.org/wiki/Prostat_spesifik_antigen","langname":"Indonesian","autonym":"Bahasa Indonesia","*":"Prostat spesifik antigen"},{"lang":"it","url":"https://it.wikipedia.org/wiki/Antigene_prostatico_specifico","langname":"Italian","autonym":"italiano","*":"Antigene prostatico specifico"},{"lang":"hu","url":"https://hu.wikipedia.org/wiki/Prosztataspecifikus_antig%C3%A9n","langname":"Hungarian","autonym":"magyar","*":"Prosztataspecifikus antig\u00e9n"},{"lang":"nl","url":"https://nl.wikipedia.org/wiki/Prostaatspecifiek_antigeen","langname":"Dutch","autonym":"Nederlands","*":"Prostaatspecifiek antigeen"},{"lang":"ja","url":"https://ja.wikipedia.org/wiki/%E5%89%8D%E7%AB%8B%E8%85%BA%E7%89%B9%E7%95%B0%E6%8A%97%E5%8E%9F","langname":"Japanese","autonym":"\u65e5\u672c\u8a9e","*":"\u524d\u7acb\u817a\u7279\u7570\u6297\u539f"},{"lang":"no","url":"https://no.wikipedia.org/wiki/Prostataspesifikt_antigen","langname":"Norwegian","autonym":"norsk","*":"Prostataspesifikt antigen"},{"lang":"pl","url":"https://pl.wikipedia.org/wiki/Swoisty_antygen_sterczowy","langname":"Polish","autonym":"polski","*":"Swoisty antygen sterczowy"},{"lang":"pt","url":"https://pt.wikipedia.org/wiki/Ant%C3%ADgeno_prost%C3%A1tico_espec%C3%ADfico","langname":"Portuguese","autonym":"portugu\u00eas","*":"Ant\u00edgeno prost\u00e1tico espec\u00edfico"},{"lang":"ru","url":"https://ru.wikipedia.org/wiki/%D0%9F%D1%80%D0%BE%D1%81%D1%82%D0%B0%D1%82%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B9_%D1%81%D0%BF%D0%B5%D1%86%D0%B8%D1%84%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B9_%D0%B0%D0%BD%D1%82%D0%B8%D0%B3%D0%B5%D0%BD","langname":"Russian","autonym":"\u0440\u0443\u0441\u0441\u043a\u0438\u0439","*":"\u041f\u0440\u043e\u0441\u0442\u0430\u0442\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0441\u043f\u0435\u0446\u0438\u0444\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0430\u043d\u0442\u0438\u0433\u0435\u043d"},{"lang":"fi","url":"https://fi.wikipedia.org/wiki/Prostataspesifinen_antigeeni","langname":"Finnish","autonym":"suomi","*":"Prostataspesifinen antigeeni"},{"lang":"sv","url":"https://sv.wikipedia.org/wiki/Prostataspecifikt_antigen","langname":"Swedish","autonym":"svenska","*":"Prostataspecifikt antigen"},{"lang":"ta","url":"https://ta.wikipedia.org/wiki/%E0%AE%AE%E0%AF%81%E0%AE%A9%E0%AF%8D%E0%AE%A9%E0%AE%BF%E0%AE%B1%E0%AF%8D%E0%AE%95%E0%AF%81%E0%AE%9E%E0%AF%8D%E0%AE%9A%E0%AF%81%E0%AE%B0%E0%AE%AA%E0%AF%8D%E0%AE%AA%E0%AE%BF%E0%AE%95%E0%AF%8D%E0%AE%95%E0%AF%87_%E0%AE%89%E0%AE%B0%E0%AE%BF%E0%AE%A4%E0%AF%8D%E0%AE%A4%E0%AE%BE%E0%AE%A9_%E0%AE%AE%E0%AF%81%E0%AE%B1%E0%AE%BF%E0%AE%A4%E0%AF%82%E0%AE%A3%E0%AF%8D%E0%AE%9F%E0%AE%BF","langname":"Tamil","autonym":"\u0ba4\u0bae\u0bbf\u0bb4\u0bcd","*":"\u0bae\u0bc1\u0ba9\u0bcd\u0ba9\u0bbf\u0bb1\u0bcd\u0b95\u0bc1\u0b9e\u0bcd\u0b9a\u0bc1\u0bb0\u0baa\u0bcd\u0baa\u0bbf\u0b95\u0bcd\u0b95\u0bc7 \u0b89\u0bb0\u0bbf\u0ba4\u0bcd\u0ba4\u0bbe\u0ba9 \u0bae\u0bc1\u0bb1\u0bbf\u0ba4\u0bc2\u0ba3\u0bcd\u0b9f\u0bbf"},{"lang":"uk","url":"https://uk.wikipedia.org/wiki/KLK3","langname":"Ukrainian","autonym":"\u0443\u043a\u0440\u0430\u0457\u043d\u0441\u044c\u043a\u0430","*":"KLK3"},{"lang":"vi","url":"https://vi.wikipedia.org/wiki/Kh%C3%A1ng_nguy%C3%AAn_%C4%91%E1%BA%B7c_hi%E1%BB%87u_tuy%E1%BA%BFn_ti%E1%BB%81n_li%E1%BB%87t","langname":"Vietnamese","autonym":"Ti\u1ebfng Vi\u1ec7t","*":"Kh\u00e1ng nguy\u00ean \u0111\u1eb7c hi\u1ec7u tuy\u1ebfn ti\u1ec1n li\u1ec7t"},{"lang":"zh-yue","url":"https://zh-yue.wikipedia.org/wiki/%E5%89%8D%E5%88%97%E8%85%BA%E7%89%B9%E7%95%B0%E6%8A%97%E5%8E%9F","langname":"Cantonese","autonym":"\u7cb5\u8a9e","*":"\u524d\u5217\u817a\u7279\u7570\u6297\u539f"},{"lang":"zh","url":"https://zh.wikipedia.org/wiki/%E5%89%8D%E5%88%97%E8%85%BA%E7%89%B9%E5%BC%82%E6%8A%97%E5%8E%9F","langname":"Chinese","autonym":"\u4e2d\u6587","*":"\u524d\u5217\u817a\u7279\u5f02\u6297\u539f"}],"categories":[{"sortkey":"","hidden":"","*":"All_articles_with_dead_external_links"},{"sortkey":"","hidden":"","*":"Articles_with_dead_external_links_from_December_2016"},{"sortkey":"","hidden":"","*":"Articles_with_dead_external_links_from_November_2016"},{"sortkey":"","hidden":"","*":"CS1_maint:_Uses_editors_parameter"},{"sortkey":"","hidden":"","*":"Pages_using_citations_with_format_and_no_URL"},{"sortkey":"","hidden":"","*":"CS1_maint:_BOT:_original-url_status_unknown"},{"sortkey":"Prostate-Specific Antigen","*":"Genes_on_human_chromosome_19"},{"sortkey":"Prostate-Specific Antigen","hidden":"","*":"All_accuracy_disputes"},{"sortkey":"Prostate-Specific Antigen","hidden":"","*":"Articles_with_disputed_statements_from_February_2014"},{"sortkey":"Prostate-Specific Antigen","hidden":"","*":"All_articles_with_unsourced_statements"},{"sortkey":"Prostate-Specific Antigen","hidden":"","*":"Articles_with_unsourced_statements_from_February_2014"},{"sortkey":"Prostate-Specific Antigen","*":"Andrology"},{"sortkey":"Prostate-Specific Antigen","*":"Urology"},{"sortkey":"Prostate-Specific Antigen","*":"Tumor_markers"},{"sortkey":"Prostate-Specific Antigen","*":"EC_3.4.21"},{"sortkey":"Prostate-Specific Antigen","*":"Blood_tests"},{"sortkey":"Prostate-Specific Antigen","*":"Biomarkers"},{"sortkey":"Prostate-Specific Antigen","*":"Prostate_cancer"}],"links":[{"ns":14,"exists":"","*":"Category:Articles with disputed statements from February 2014"},{"ns":14,"exists":"","*":"Category:Articles with unsourced statements from February 2014"},{"ns":14,"exists":"","*":"Category:Articles with dead external links from December 2016"},{"ns":14,"exists":"","*":"Category:Articles with dead external links from November 2016"},{"ns":14,"exists":"","*":"Category:CS1 maint: BOT: original-url status unknown"},{"ns":14,"exists":"","*":"Category:CS1 maint: Uses editors parameter"},{"ns":10,"exists":"","*":"Template:Tumor markers"},{"ns":10,"exists":"","*":"Template:Serine endopeptidases"},{"ns":10,"exists":"","*":"Template:Enzymes"},{"ns":0,"exists":"","*":"AFP-L3"},{"ns":0,"exists":"","*":"Acrosin"},{"ns":0,"exists":"","*":"Active site"},{"ns":0,"exists":"","*":"Allosteric regulation"},{"ns":0,"exists":"","*":"Alpha-fetoprotein"},{"ns":0,"exists":"","*":"Alpha 1-antichymotrypsin"},{"ns":0,"exists":"","*":"Ancrod"},{"ns":0,"exists":"","*":"Antigen"},{"ns":0,"exists":"","*":"Astrocytoma"},{"ns":0,"exists":"","*":"Atomic mass unit"},{"ns":0,"exists":"","*":"Azoospermia"},{"ns":0,"exists":"","*":"Base pair"},{"ns":0,"exists":"","*":"Batroxobin"},{"ns":0,"exists":"","*":"Benign prostatic hyperplasia"},{"ns":0,"exists":"","*":"Binding site"},{"ns":0,"exists":"","*":"Biochemical recurrence"},{"ns":0,"exists":"","*":"Biomarker"},{"ns":0,"exists":"","*":"Biopsy"},{"ns":0,"exists":"","*":"Bladder cancer"},{"ns":0,"exists":"","*":"Blood"},{"ns":0,"exists":"","*":"Blood plasma"},{"ns":0,"exists":"","*":"Brain tumor"},{"ns":0,"exists":"","*":"Breast cancer"},{"ns":0,"exists":"","*":"C3-convertase"},{"ns":0,"exists":"","*":"CA-125"},{"ns":0,"exists":"","*":"CA19-9"},{"ns":0,"exists":"","*":"CA 15-3"},{"ns":0,"exists":"","*":"CA 242 (tumor marker)"},{"ns":0,"exists":"","*":"CD30"},{"ns":0,"exists":"","*":"CD3 (immunology)"},{"ns":0,"exists":"","*":"CD57"},{"ns":0,"exists":"","*":"CD79A"},{"ns":0,"exists":"","*":"Ca 27-29"},{"ns":0,"exists":"","*":"Calcitonin"},{"ns":0,"exists":"","*":"Carcinoembryonic antigen"},{"ns":0,"exists":"","*":"Carcinoma"},{"ns":0,"exists":"","*":"Catalytic triad"},{"ns":0,"exists":"","*":"Catalytically perfect enzyme"},{"ns":0,"exists":"","*":"Cathepsin"},{"ns":0,"exists":"","*":"Cathepsin A"},{"ns":0,"exists":"","*":"Cathepsin D"},{"ns":0,"exists":"","*":"Cathepsin G"},{"ns":0,"exists":"","*":"Cervix"},{"ns":0,"exists":"","*":"Choriocarcinoma"},{"ns":0,"exists":"","*":"Chromogranin A"},{"ns":0,"exists":"","*":"Chromosome"},{"ns":0,"exists":"","*":"Chromosome 19 (human)"},{"ns":0,"exists":"","*":"Chymase"},{"ns":0,"exists":"","*":"Chymotrypsin"},{"ns":0,"exists":"","*":"Clinical practice guideline"},{"ns":0,"exists":"","*":"Coagulation"},{"ns":0,"exists":"","*":"Coenzyme"},{"ns":0,"exists":"","*":"Cofactor (biochemistry)"},{"ns":0,"exists":"","*":"Colorectal cancer"},{"ns":0,"exists":"","*":"Complement factor B"},{"ns":0,"exists":"","*":"Complement factor I"},{"ns":0,"exists":"","*":"Complement system"},{"ns":0,"exists":"","*":"Cooperativity"},{"ns":0,"exists":"","*":"Cytokeratin"},{"ns":0,"exists":"","*":"Desmin"},{"ns":0,"exists":"","*":"Digestive enzyme"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Dysgerminoma"},{"ns":0,"exists":"","*":"ERBB3"},{"ns":0,"exists":"","*":"Eadie\u2013Hofstee diagram"},{"ns":0,"exists":"","*":"Early prostate cancer antigen-2"},{"ns":0,"exists":"","*":"Ejaculate"},{"ns":0,"exists":"","*":"Elastase"},{"ns":0,"exists":"","*":"Electrophoresis"},{"ns":0,"exists":"","*":"Embryonal carcinoma"},{"ns":0,"exists":"","*":"Endodermal sinus tumor"},{"ns":0,"exists":"","*":"Endopeptidase"},{"ns":0,"exists":"","*":"Endothelium"},{"ns":0,"exists":"","*":"Enolase 2"},{"ns":0,"exists":"","*":"Ensembl"},{"ns":0,"exists":"","*":"Ensembl genome database project"},{"ns":0,"exists":"","*":"Enteropeptidase"},{"ns":0,"exists":"","*":"Entrez"},{"ns":0,"exists":"","*":"Enzyme"},{"ns":0,"exists":"","*":"Enzyme Commission number"},{"ns":0,"exists":"","*":"Enzyme activator"},{"ns":0,"exists":"","*":"Enzyme catalysis"},{"ns":0,"exists":"","*":"Enzyme family"},{"ns":0,"exists":"","*":"Enzyme inhibitor"},{"ns":0,"exists":"","*":"Enzyme kinetics"},{"ns":0,"exists":"","*":"Enzyme promiscuity"},{"ns":0,"exists":"","*":"Enzyme superfamily"},{"ns":0,"exists":"","*":"Epithelium"},{"ns":0,"exists":"","*":"Factor D"},{"ns":0,"exists":"","*":"Factor IX"},{"ns":0,"exists":"","*":"Factor VII"},{"ns":0,"exists":"","*":"Factor VIII"},{"ns":0,"exists":"","*":"Factor X"},{"ns":0,"exists":"","*":"Factor XI"},{"ns":0,"exists":"","*":"Factor XII"},{"ns":0,"exists":"","*":"False positive"},{"ns":0,"exists":"","*":"Female ejaculation"},{"ns":0,"exists":"","*":"Fibrinolysis"},{"ns":0,"exists":"","*":"Fibronectin"},{"ns":0,"exists":"","*":"Furin"},{"ns":0,"exists":"","*":"GOLM1"},{"ns":0,"exists":"","*":"Gene"},{"ns":0,"exists":"","*":"GeneCards"},{"ns":0,"exists":"","*":"Gene expression"},{"ns":0,"exists":"","*":"Gene nomenclature"},{"ns":0,"exists":"","*":"Gene ontology"},{"ns":0,"exists":"","*":"Germ cell tumor"},{"ns":0,"exists":"","*":"Gleason grading system"},{"ns":0,"exists":"","*":"Glial fibrillary acidic protein"},{"ns":0,"exists":"","*":"Glucose-6-phosphate isomerase"},{"ns":0,"exists":"","*":"Glutamate carboxypeptidase II"},{"ns":0,"exists":"","*":"Glycoprotein"},{"ns":0,"exists":"","*":"Granzyme"},{"ns":0,"exists":"","*":"HER2/neu"},{"ns":0,"exists":"","*":"Hanes\u2013Woolf plot"},{"ns":0,"exists":"","*":"Hemangiosarcoma"},{"ns":0,"exists":"","*":"Hepatocellular carcinoma"},{"ns":0,"exists":"","*":"Histology"},{"ns":0,"exists":"","*":"Homeobox protein NANOG"},{"ns":0,"exists":"","*":"HomoloGene"},{"ns":0,"exists":"","*":"Homovanillic acid"},{"ns":0,"exists":"","*":"Human chorionic gonadotropin"},{"ns":0,"exists":"","*":"Hydrolase"},{"ns":0,"exists":"","*":"Immune system"},{"ns":0,"exists":"","*":"Immunohistochemistry"},{"ns":0,"exists":"","*":"Inhibin"},{"ns":0,"exists":"","*":"International Standard Book Number"},{"ns":0,"exists":"","*":"Isomerase"},{"ns":0,"exists":"","*":"KLK1"},{"ns":0,"exists":"","*":"KLK10"},{"ns":0,"exists":"","*":"KLK11"},{"ns":0,"exists":"","*":"KLK12"},{"ns":0,"exists":"","*":"KLK13"},{"ns":0,"exists":"","*":"KLK14"},{"ns":0,"exists":"","*":"KLK15"},{"ns":0,"exists":"","*":"KLK2"},{"ns":0,"exists":"","*":"KLK4"},{"ns":0,"exists":"","*":"KLK5"},{"ns":0,"exists":"","*":"KLK6"},{"ns":0,"exists":"","*":"KLK7"},{"ns":0,"exists":"","*":"KLK8"},{"ns":0,"exists":"","*":"KLK9"},{"ns":0,"exists":"","*":"Kallikrein"},{"ns":0,"exists":"","*":"Lactate dehydrogenase"},{"ns":0,"exists":"","*":"Ligase"},{"ns":0,"exists":"","*":"Lineweaver\u2013Burk plot"},{"ns":0,"exists":"","*":"List of EC numbers (EC 1)"},{"ns":0,"exists":"","*":"List of EC numbers (EC 2)"},{"ns":0,"exists":"","*":"List of EC numbers (EC 3)"},{"ns":0,"exists":"","*":"List of EC numbers (EC 4)"},{"ns":0,"exists":"","*":"List of EC numbers (EC 5)"},{"ns":0,"exists":"","*":"List of EC numbers (EC 6)"},{"ns":0,"exists":"","*":"List of enzymes"},{"ns":0,"exists":"","*":"Locus (genetics)"},{"ns":0,"exists":"","*":"Lung cancer"},{"ns":0,"exists":"","*":"Lyase"},{"ns":0,"exists":"","*":"Lymphoma"},{"ns":0,"exists":"","*":"Lymphosarcoma"},{"ns":0,"exists":"","*":"MASP1 (protein)"},{"ns":0,"exists":"","*":"MASP2 (protein)"},{"ns":0,"exists":"","*":"MEROPS"},{"ns":0,"exists":"","*":"MRI"},{"ns":0,"exists":"","*":"Mannose-binding protein-associated serine protease"},{"ns":0,"exists":"","*":"Mathematical probability"},{"ns":0,"exists":"","*":"Medical Subject Headings"},{"ns":0,"exists":"","*":"Medullary thyroid cancer"},{"ns":0,"exists":"","*":"Melanoma"},{"ns":0,"exists":"","*":"Melanoma inhibitory activity"},{"ns":0,"exists":"","*":"Membrane-bound transcription factor peptidase, site 1"},{"ns":0,"exists":"","*":"Mendelian Inheritance in Man"},{"ns":0,"exists":"","*":"Metastasis"},{"ns":0,"exists":"","*":"Michaelis\u2013Menten kinetics"},{"ns":0,"exists":"","*":"Misnomer"},{"ns":0,"exists":"","*":"Mouse Genome Informatics"},{"ns":0,"exists":"","*":"NMP22"},{"ns":0,"exists":"","*":"National Health Service"},{"ns":0,"exists":"","*":"Neprilysin"},{"ns":0,"exists":"","*":"Neural crest"},{"ns":0,"exists":"","*":"Neuroblastoma"},{"ns":0,"exists":"","*":"Neuroendocrine tumor"},{"ns":0,"exists":"","*":"Neutrophil elastase"},{"ns":0,"exists":"","*":"Nomogram"},{"ns":0,"exists":"","*":"Normetanephrine"},{"ns":0,"exists":"","*":"Obesity"},{"ns":0,"exists":"","*":"Ortholog"},{"ns":0,"exists":"","*":"Ovarian cancer"},{"ns":0,"exists":"","*":"Overdiagnosis"},{"ns":0,"exists":"","*":"Oxidoreductase"},{"ns":0,"exists":"","*":"Oxyanion hole"},{"ns":0,"exists":"","*":"PCA3"},{"ns":0,"exists":"","*":"PDF"},{"ns":0,"exists":"","*":"PRSS8"},{"ns":0,"exists":"","*":"Pancreatic cancer"},{"ns":0,"exists":"","*":"Pancreatic elastase"},{"ns":0,"exists":"","*":"Percentile"},{"ns":0,"exists":"","*":"Pheochromocytoma"},{"ns":0,"exists":"","*":"Plasmin"},{"ns":0,"exists":"","*":"Plasminogen activator"},{"ns":0,"exists":"","*":"Proliferating cell nuclear antigen"},{"ns":0,"exists":"","*":"Prolyl endopeptidase"},{"ns":0,"exists":"","*":"Pronase"},{"ns":0,"exists":"","*":"Proprotein convertase"},{"ns":0,"exists":"","*":"Proprotein convertase 1"},{"ns":0,"exists":"","*":"Proprotein convertase 2"},{"ns":0,"exists":"","*":"Prostate"},{"ns":0,"exists":"","*":"Prostate biopsy"},{"ns":0,"exists":"","*":"Prostate cancer"},{"ns":0,"exists":"","*":"Prostate cancer screening"},{"ns":0,"exists":"","*":"Prostate gland"},{"ns":0,"exists":"","*":"Prostatic acid phosphatase"},{"ns":0,"exists":"","*":"Prostatitis"},{"ns":0,"exists":"","*":"Protease"},{"ns":0,"exists":"","*":"Protein-protein interaction"},{"ns":0,"exists":"","*":"Protein C inhibitor"},{"ns":0,"exists":"","*":"Protein Data Bank"},{"ns":0,"exists":"","*":"Proteinase 3"},{"ns":0,"exists":"","*":"PubMed"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Radical retropubic prostatectomy"},{"ns":0,"exists":"","*":"Rectal examination"},{"ns":0,"exists":"","*":"Reelin"},{"ns":0,"exists":"","*":"Reference range"},{"ns":0,"exists":"","*":"Rhabdomyosarcoma"},{"ns":0,"exists":"","*":"Richard J. Ablin"},{"ns":0,"exists":"","*":"S100 protein"},{"ns":0,"exists":"","*":"SPINK1"},{"ns":0,"exists":"","*":"Sarcoma"},{"ns":0,"exists":"","*":"Screening (medicine)"},{"ns":0,"exists":"","*":"Semen"},{"ns":0,"exists":"","*":"Semenogelin"},{"ns":0,"exists":"","*":"Semi-log plot"},{"ns":0,"exists":"","*":"Serine protease"},{"ns":0,"exists":"","*":"Serology"},{"ns":0,"exists":"","*":"Sertoli-Leydig cell tumour"},{"ns":0,"exists":"","*":"Spermatozoon"},{"ns":0,"exists":"","*":"Streptokinase"},{"ns":0,"exists":"","*":"Subtilisin"},{"ns":0,"exists":"","*":"Surface epithelial-stromal tumor"},{"ns":0,"exists":"","*":"Synaptophysin"},{"ns":0,"exists":"","*":"TMPRSS2"},{"ns":0,"exists":"","*":"Testicular cancer"},{"ns":0,"exists":"","*":"Testosterone"},{"ns":0,"exists":"","*":"The New York Times"},{"ns":0,"exists":"","*":"Thrombin"},{"ns":0,"exists":"","*":"Thyroglobulin"},{"ns":0,"exists":"","*":"Thyroid cancer"},{"ns":0,"exists":"","*":"Tissue plasminogen activator"},{"ns":0,"exists":"","*":"Transferase"},{"ns":0,"exists":"","*":"Trypsin"},{"ns":0,"exists":"","*":"Tryptase"},{"ns":0,"exists":"","*":"Tumor-associated glycoprotein 72"},{"ns":0,"exists":"","*":"Tumor marker"},{"ns":0,"exists":"","*":"Tumor markers"},{"ns":0,"exists":"","*":"Type I and type II errors"},{"ns":0,"exists":"","*":"U.S. Food and Drug Administration"},{"ns":0,"exists":"","*":"UniProt"},{"ns":0,"exists":"","*":"Urokinase"},{"ns":0,"exists":"","*":"Uterus"},{"ns":0,"exists":"","*":"Vasectomy"},{"ns":0,"exists":"","*":"Venom"},{"ns":0,"exists":"","*":"Vimentin"},{"ns":0,"exists":"","*":"WebMD"},{"ns":0,"exists":"","*":"Wikidata"},{"ns":1,"exists":"","*":"Talk:Prostate-specific antigen"},{"ns":4,"exists":"","*":"Wikipedia:Citation needed"},{"ns":4,"exists":"","*":"Wikipedia:Disputed statement"},{"ns":4,"exists":"","*":"Wikipedia:Link rot"},{"ns":11,"exists":"","*":"Template talk:Enzymes"},{"ns":11,"exists":"","*":"Template talk:Serine endopeptidases"},{"ns":11,"exists":"","*":"Template talk:Tumor markers"},{"ns":12,"exists":"","*":"Help:CS1 errors"},{"ns":100,"exists":"","*":"Portal:Molecular and Cellular Biology"}],"templates":[{"ns":10,"exists":"","*":"Template:Infobox gene"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Main"},{"ns":10,"exists":"","*":"Template:Disputed inline"},{"ns":10,"exists":"","*":"Template:Fix"},{"ns":10,"exists":"","*":"Template:Category handler"},{"ns":10,"exists":"","*":"Template:Fix/category"},{"ns":10,"exists":"","*":"Template:Delink"},{"ns":10,"exists":"","*":"Template:Citation needed"},{"ns":10,"exists":"","*":"Template:EC number"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Column-width"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite book"},{"ns":10,"exists":"","*":"Template:Dead link"},{"ns":10,"exists":"","*":"Template:Cite news"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Refbegin"},{"ns":10,"exists":"","*":"Template:Refbegin/styles.css"},{"ns":10,"exists":"","*":"Template:Column-count"},{"ns":10,"exists":"","*":"Template:Refend"},{"ns":10,"exists":"","*":"Template:MeshName"},{"ns":10,"exists":"","*":"Template:MeSH name"},{"ns":10,"exists":"","*":"Template:Tumor markers"},{"ns":10,"exists":"","*":"Template:Navbox"},{"ns":10,"exists":"","*":"Template:Serine endopeptidases"},{"ns":10,"exists":"","*":"Template:Enzymes"},{"ns":10,"exists":"","*":"Template:Portal bar"},{"ns":828,"exists":"","*":"Module:Infobox gene"},{"ns":828,"exists":"","*":"Module:Navbar"},{"ns":828,"exists":"","*":"Module:Infobox3cols"},{"ns":828,"exists":"","*":"Module:InfoboxImage"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Main"},{"ns":828,"exists":"","*":"Module:Hatnote"},{"ns":828,"exists":"","*":"Module:Hatnote list"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Delink"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:String"},{"ns":828,"exists":"","*":"Module:Navbox"},{"ns":828,"exists":"","*":"Module:Portal bar"},{"ns":828,"exists":"","*":"Module:Portal"},{"ns":828,"exists":"","*":"Module:Portal/images/m"},{"ns":828,"exists":"","*":"Module:Portal/images/aliases"}],"images":["Lock-green.svg","PSA_KLK3_PDB_2ZCK.png","Ideogram_human_chromosome_19.svg","Human_chromosome_19_ideogram.svg","HSR_1996_II_3.5e.svg","Red_rectangle_2x18.png","Ideogram_house_mouse_chromosome_7.svg","Ideogram_of_house_mouse_chromosome_7.svg","PBB_GE_KLK3_204583_x_at_fs.png","PBB_GE_KLK3_204582_s_at_fs.png","Free_PSA_bar_graph.svg","TPI1_structure.png"],"externallinks":["http://May2017.archive.ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=ENSG00000142515","http://May2017.archive.ensembl.org/Mus_musculus/Gene/Summary?db=core;g=ENSMUSG00000066513","https://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Link&LinkName=gene_pubmed&from_uid=354","https://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Link&LinkName=gene_pubmed&from_uid=18048","//doi.org/10.1200/JCO.2003.02.083","//www.ncbi.nlm.nih.gov/pubmed/12525533","http://www.andrologysociety.com/resources/handbook/ch.8.asp","//www.ncbi.nlm.nih.gov/pubmed/7512659","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3709717","//doi.org/10.3390/ijms140611034","//www.ncbi.nlm.nih.gov/pubmed/23708103","//www.ncbi.nlm.nih.gov/pubmed/22018148","https://www.nhs.uk/livewell/prostatehealth/pages/psa-test.aspx","http://www.nhs.uk/Conditions/Cancer-of-the-prostate/Pages/Prevention.aspx","http://www.uspreventiveservicestaskforce.org/prostatecancerscreening/prostatecancerscript.pdf","//doi.org/10.1001/jama.280.11.969","//www.ncbi.nlm.nih.gov/pubmed/9749478","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3328553","//doi.org/10.5489/cuaj.11085","//www.ncbi.nlm.nih.gov/pubmed/22511420","http://sperlingprostatecenter.com/mpmri-improves-the-accuracy-of-the-partin-tables-and-other-nomograms/","//doi.org/10.1016/s0090-4295(02)02268-9","//www.ncbi.nlm.nih.gov/pubmed/12597949","https://web.archive.org/web/20080409190231/http://www.fbi.gov/hq/lab/fsc/backissu/april2003/gartside.htm","https://www.fbi.gov/hq/lab/fsc/backissu/april2003/gartside.htm","//www.ncbi.nlm.nih.gov/pubmed/10486959","https://web.archive.org/web/20050827025155/http://mafs.net/pdf/forensicdetectionsemen3.pdf","http://mafs.net/pdf/forensicdetectionsemen3.pdf","https://web.archive.org/web/20041024194221/http://journalsip.astm.org/jofs/PAGES/3097.htm","http://journalsip.astm.org/jofs/PAGES/3097.htm","//doi.org/10.1016/S0090-4295(03)00775-1","//www.ncbi.nlm.nih.gov/pubmed/14607215","//doi.org/10.1111/j.1464-410X.2007.07138.x","//www.ncbi.nlm.nih.gov/pubmed/17760888","//www.ncbi.nlm.nih.gov/pubmed/4629646","//www.ncbi.nlm.nih.gov/pubmed/4977978","//www.ncbi.nlm.nih.gov/pubmed/4631694","//www.ncbi.nlm.nih.gov/pubmed/4213812","//www.ncbi.nlm.nih.gov/pubmed/744956","//www.ncbi.nlm.nih.gov/pubmed/89106","//www.ncbi.nlm.nih.gov/pubmed/6159971","https://www.nytimes.com/2004/05/30/weekinreview/it-was-medical-gospel-but-it-wasn-t-true.html","//doi.org/10.1056/NEJMoa031918","//www.ncbi.nlm.nih.gov/pubmed/15163773","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3474980","//doi.org/10.1056/NEJMe048003","//www.ncbi.nlm.nih.gov/pubmed/15163780","//doi.org/10.1056/NEJM199104253241702","//www.ncbi.nlm.nih.gov/pubmed/1707140","//doi.org/10.1001/jama.298.19.2275","//www.ncbi.nlm.nih.gov/pubmed/18029831","https://web.archive.org/web/20080217021312/http://oncology-hematology.jwatch.org/cgi/content/full/2007/1120/1","http://oncology-hematology.jwatch.org/cgi/content/full/2007/1120/1","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3071449","//doi.org/10.1158/1940-6207.CAPR-10-0229","//www.ncbi.nlm.nih.gov/pubmed/21233290","//doi.org/10.1016/S0090-4295(97)00209-4","//www.ncbi.nlm.nih.gov/pubmed/9255295","//doi.org/10.1016/S0022-5347(01)67064-2","//www.ncbi.nlm.nih.gov/pubmed/7541857","//doi.org/10.1001/jama.267.16.2227","//www.ncbi.nlm.nih.gov/pubmed/1372943","//www.ncbi.nlm.nih.gov/pubmed/1377290","//doi.org/10.1016/S0022-5347(01)64849-3","//www.ncbi.nlm.nih.gov/pubmed/9112518","//doi.org/10.1016/j.urology.2005.06.077","//www.ncbi.nlm.nih.gov/pubmed/16360449","//doi.org/10.1016/S1569-9056(07)60793-3","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3461837","//doi.org/10.1001/jama.267.16.2215","//www.ncbi.nlm.nih.gov/pubmed/1372942","http://www.cancer.gov/cancertopics/types/prostate/research/psa-velocity-detection","//doi.org/10.1093/jnci/djj155","//www.ncbi.nlm.nih.gov/pubmed/16622114","//doi.org/10.1056/NEJMoa032975","//www.ncbi.nlm.nih.gov/pubmed/15247353","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2582974","//doi.org/10.1016/j.eururo.2008.06.076","//www.ncbi.nlm.nih.gov/pubmed/18614274","https://web.archive.org/web/20160224083006/http://wmueller.com/precalculus/families/semilog.html","//doi.org/10.1001/jama.279.19.1542","//www.ncbi.nlm.nih.gov/pubmed/9605898","//doi.org/10.1001/jama.277.18.1452","//www.ncbi.nlm.nih.gov/pubmed/9145717","//doi.org/10.1002/jcla.1860080110","//www.ncbi.nlm.nih.gov/pubmed/7513021","http://www.sbir.gov/sbirsearch/detail/12931","//doi.org/10.1002/pros.20751","//www.ncbi.nlm.nih.gov/pubmed/18386289","//doi.org/10.1016/j.jmb.2011.10.007","//www.ncbi.nlm.nih.gov/pubmed/22037582","//doi.org/10.1373/clinchem.2003.026823","//www.ncbi.nlm.nih.gov/pubmed/15054080","//doi.org/10.1016/S0090-4295(01)01605-3","//www.ncbi.nlm.nih.gov/pubmed/12031356","//doi.org/10.6004/jnccn.2004.0019","//www.ncbi.nlm.nih.gov/pubmed/19795605","//doi.org/10.1111/j.1743-6109.2007.00542.x","//www.ncbi.nlm.nih.gov/pubmed/17634056","http://www.emedicine.com/med/TOPIC3465.HTM#section~CharacteristicsofProstateSpecificAntigen","//doi.org/10.1097/PAS.0b013e31802f5d33","//www.ncbi.nlm.nih.gov/pubmed/17667550","//doi.org/10.1111/j.1432-1033.1994.tb18597.x","//www.ncbi.nlm.nih.gov/pubmed/7509746","//doi.org/10.1111/j.1432-1033.1996.0088q.x","//www.ncbi.nlm.nih.gov/pubmed/8665956","https://www.ebi.ac.uk/pdbe/searchResults.html?display=both&term=P00757%20or%20P07288%20or%20M0QZF9","http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=UpAccessionIdQuery&accessionIdList=P00757,P07288,M0QZF9","https://www.rcsb.org/structure/2ZCH","https://www.rcsb.org/structure/2ZCK","https://www.rcsb.org/structure/2ZCL","https://www.rcsb.org/structure/3QUM","https://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=6364","https://omim.org/entry/176820","http://www.informatics.jax.org/marker/MGI:97320","https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=homologene&dopt=HomoloGene&list_uids=68141","https://www.genecards.org/cgi-bin/carddisp.pl?gene=KLK3","http://biogps.org/gene/354/","http://amigo.geneontology.org/amigo/term/GO:0008233","http://amigo.geneontology.org/amigo/term/GO:0008236","http://amigo.geneontology.org/amigo/term/GO:0004175","http://amigo.geneontology.org/amigo/term/GO:0016811","http://amigo.geneontology.org/amigo/term/GO:0005515","http://amigo.geneontology.org/amigo/term/GO:0016787","http://amigo.geneontology.org/amigo/term/GO:0004252","http://amigo.geneontology.org/amigo/term/GO:0070062","http://amigo.geneontology.org/amigo/term/GO:0005634","http://amigo.geneontology.org/amigo/term/GO:0043234","http://amigo.geneontology.org/amigo/term/GO:0005576","http://amigo.geneontology.org/amigo/term/GO:0005615","http://amigo.geneontology.org/amigo/term/GO:0016525","http://amigo.geneontology.org/amigo/term/GO:0044267","http://amigo.geneontology.org/amigo/term/GO:0002778","http://amigo.geneontology.org/amigo/term/GO:0006508","http://amigo.geneontology.org/","https://www.ebi.ac.uk/QuickGO/","https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=retrieve&dopt=default&list_uids=354&rn=1","https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=retrieve&dopt=default&list_uids=18048&rn=1","http://www.ensembl.org/Homo_sapiens/geneview?gene=ENSG00000142515;db=core","http://www.ensembl.org/Mus_musculus/geneview?gene=ENSMUSG00000066513;db=core","https://www.uniprot.org/uniprot/P07288","https://www.uniprot.org/uniprot/P00757","https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_001030047","https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_001030048","https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_001030049","https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_001030050","https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_001648","https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_010915","https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_001025218","https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_001025219","https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_001639","https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_035045","https://genome.ucsc.edu/cgi-bin/hgTracks?org=Human&db=hg38&position=chr19:50854915-50860764","https://genome.ucsc.edu/cgi-bin/hgTracks?org=Mouse&db=mm0&position=chr7:44207435-44211754","https://enzyme.expasy.org/EC/3.4.21.77","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2002501","//www.ncbi.nlm.nih.gov/pubmed/17934568","//doi.org/10.3109/07853899409147884","//www.ncbi.nlm.nih.gov/pubmed/7521173","//doi.org/10.1016/S1043-2760(99)00225-8","//www.ncbi.nlm.nih.gov/pubmed/10675891","http://merops.sanger.ac.uk/cgi-bin/merops.cgi?id=S01.162","https://web.archive.org/web/20060901162604/http://www.cancer.org/docroot/CRI/content/CRI_2_4_3X_Can_prostate_cancer_be_found_early_36.asp","http://www.cancer.gov/cancertopics/factsheet/Detection/PSA","https://meshb.nlm.nih.gov/record/ui?name=Prostate-Specific%20Antigen","https://web.archive.org/web/20090308005134/http://www.prostateuk.org/psa/psa.htm","http://labtestsonline.org/understanding/analytes/psa/tab/test","http://www.elisakits.co.uk/total-prostate-specific-antigen-total-psa-elisa-kit/"],"sections":[{"toclevel":1,"level":"2","line":"Medical uses","number":"1","index":"1","fromtitle":"Prostate-specific_antigen","byteoffset":2439,"anchor":"Medical_uses"},{"toclevel":2,"level":"3","line":"Prostate cancer","number":"1.1","index":"2","fromtitle":"Prostate-specific_antigen","byteoffset":2457,"anchor":"Prostate_cancer"},{"toclevel":3,"level":"4","line":"Screening","number":"1.1.1","index":"3","fromtitle":"Prostate-specific_antigen","byteoffset":2480,"anchor":"Screening"},{"toclevel":3,"level":"4","line":"Risk stratification and staging","number":"1.1.2","index":"4","fromtitle":"Prostate-specific_antigen","byteoffset":5645,"anchor":"Risk_stratification_and_staging"},{"toclevel":3,"level":"4","line":"Post-treatment monitoring","number":"1.1.3","index":"5","fromtitle":"Prostate-specific_antigen","byteoffset":7988,"anchor":"Post-treatment_monitoring"},{"toclevel":3,"level":"4","line":"Histology","number":"1.1.4","index":"6","fromtitle":"Prostate-specific_antigen","byteoffset":10399,"anchor":"Histology"},{"toclevel":2,"level":"3","line":"Forensic identification of semen","number":"1.2","index":"7","fromtitle":"Prostate-specific_antigen","byteoffset":11949,"anchor":"Forensic_identification_of_semen"},{"toclevel":1,"level":"2","line":"Mechanism of action","number":"2","index":"8","fromtitle":"Prostate-specific_antigen","byteoffset":15550,"anchor":"Mechanism_of_action"},{"toclevel":1,"level":"2","line":"Biochemistry","number":"3","index":"9","fromtitle":"Prostate-specific_antigen","byteoffset":16861,"anchor":"Biochemistry"},{"toclevel":1,"level":"2","line":"History","number":"4","index":"10","fromtitle":"Prostate-specific_antigen","byteoffset":17509,"anchor":"History"},{"toclevel":1,"level":"2","line":"Serum levels","number":"5","index":"11","fromtitle":"Prostate-specific_antigen","byteoffset":20933,"anchor":"Serum_levels"},{"toclevel":2,"level":"3","line":"PSA velocity","number":"5.1","index":"12","fromtitle":"Prostate-specific_antigen","byteoffset":30254,"anchor":"PSA_velocity"},{"toclevel":2,"level":"3","line":"Free PSA","number":"5.2","index":"13","fromtitle":"Prostate-specific_antigen","byteoffset":33455,"anchor":"Free_PSA"},{"toclevel":2,"level":"3","line":"Inactive PSA","number":"5.3","index":"14","fromtitle":"Prostate-specific_antigen","byteoffset":35192,"anchor":"Inactive_PSA"},{"toclevel":2,"level":"3","line":"Complexed PSA","number":"5.4","index":"15","fromtitle":"Prostate-specific_antigen","byteoffset":37612,"anchor":"Complexed_PSA"},{"toclevel":1,"level":"2","line":"PSA in other biologic fluids and tissues","number":"6","index":"16","fromtitle":"Prostate-specific_antigen","byteoffset":38540,"anchor":"PSA_in_other_biologic_fluids_and_tissues"},{"toclevel":1,"level":"2","line":"Interactions","number":"7","index":"17","fromtitle":"Prostate-specific_antigen","byteoffset":41479,"anchor":"Interactions"},{"toclevel":1,"level":"2","line":"See also","number":"8","index":"18","fromtitle":"Prostate-specific_antigen","byteoffset":42388,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"9","index":"19","fromtitle":"Prostate-specific_antigen","byteoffset":42424,"anchor":"References"},{"toclevel":1,"level":"2","line":"Further reading","number":"10","index":"20","fromtitle":"Prostate-specific_antigen","byteoffset":42459,"anchor":"Further_reading"},{"toclevel":1,"level":"2","line":"External links","number":"11","index":"21","fromtitle":"Prostate-specific_antigen","byteoffset":43681,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Prostate-specific antigen","iwlinks":[{"prefix":"d","url":"https://www.wikidata.org/wiki/Q14859580","*":"d:Q14859580"},{"prefix":"d","url":"https://www.wikidata.org/wiki/Q18252640","*":"d:Q18252640"}],"properties":[{"name":"defaultsort","*":"Prostate-Specific Antigen"},{"name":"wikibase_item","*":"Q14859580"}]}}